data_2f76_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f76 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.751 0.31 . . . . 1.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 70.0 mt . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.99 0.424 . . . . 1.0 110.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.463 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.913 0.387 . . . . 1.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.424 ' CD1' ' HH ' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.488 ' HE ' ' CD1' ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.888 0.375 . . . . 1.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' HE1' ' X' ' 83' ' ' TRP . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.421 ' O ' ' OG1' ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' X' ' 69' ' ' THR . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.506 ' O ' ' CD1' ' X' ' 82' ' ' TYR . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.676 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CG2' ' NH2' ' X' ' 57' ' ' ARG . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.488 ' CD1' ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.85 0.357 . . . . 1.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 mt . . . . . 0 N--CA 1.462 0.144 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.533 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.549 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 41.8 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.43 ' N ' HD21 ' X' ' 68' ' ' ASN . 1.1 m-80 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' X' ' 82' ' ' TYR . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.494 ' CD1' HH21 ' X' ' 57' ' ' ARG . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.905 0.383 . . . . 1.0 110.651 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.762 0.315 . . . . 1.0 110.755 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.405 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.458 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 34.6 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.548 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.847 0.356 . . . . 1.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.412 ' HZ3' ' HZ1' ' X' ' 20' ' ' LYS . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.468 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.412 ' HZ1' ' HZ3' ' X' ' 16' ' ' LYS . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 54.9 mt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 121.109 0.481 . . . . 1.0 110.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.565 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.425 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.498 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.428 ' O ' ' OD2' ' X' ' 91' ' ' ASP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' CD2' ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.174 0.512 . . . . 1.0 110.005 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.614 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' X' ' 79' ' ' ALA . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.418 ' CD2' ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.341 . . . . 1.0 110.38 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.646 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.646 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.419 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.404 HG22 ' H ' ' X' ' 54' ' ' LYS . 43.9 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.116 0.484 . . . . 1.0 109.952 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.681 ' HZ3' ' NH2' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.681 ' NH2' ' HZ3' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.0 tm0? -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.4 ' CG ' HE21 ' X' ' 64' ' ' GLN . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.503 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.483 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 6' ' ' SER . . . . . 0.453 ' HG ' ' N ' ' X' ' 7' ' ' GLN . 29.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.87 0.367 . . . . 1.0 110.46 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . 0.453 ' N ' ' HG ' ' X' ' 6' ' ' SER . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.471 ' CG ' ' HZ1' ' X' ' 39' ' ' LYS . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.471 ' HZ1' ' CG ' ' X' ' 8' ' ' HIS . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.943 0.401 . . . . 1.0 110.337 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.494 ' NH2' ' HH ' ' X' ' 82' ' ' TYR . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' X' ' 69' ' ' THR . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.437 ' N ' HD21 ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.428 ' C ' ' N ' ' X' ' 79' ' ' ALA . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.909 0.385 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.467 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.467 HH12 ' CB ' ' X' ' 18' ' ' ALA . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.462 HG23 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.863 0.363 . . . . 1.0 110.198 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.514 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.462 ' H ' HG23 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' X' ' 68' ' ' ASN . 3.3 tm0? -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' X' ' 64' ' ' GLN . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.461 ' C ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.437 HD11 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' X' ' 86' ' ' ILE . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 3.8 p-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.773 0.321 . . . . 1.0 110.211 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.542 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' X' ' 22' ' ' ARG . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.542 HH12 ' CB ' ' X' ' 18' ' ' ALA . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' X' ' 39' ' ' LYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 57.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.869 0.366 . . . . 1.0 110.243 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.58 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.566 HE22 ' CG ' ' X' ' 68' ' ' ASN . 5.0 tp60 -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.566 ' CG ' HE22 ' X' ' 64' ' ' GLN . 1.1 m-80 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.408 HD11 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.488 ' CD1' ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.891 0.377 . . . . 1.0 110.567 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.507 ' C ' ' NH1' ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.507 ' NH1' ' C ' ' X' ' 18' ' ' ALA . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.4 HG22 ' H ' ' X' ' 54' ' ' LYS . 6.0 mt . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.458 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.403 ' HE2' HH21 ' X' ' 58' ' ' ARG . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.403 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' X' ' 69' ' ' THR . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.539 ' CZ ' ' O ' ' X' ' 25' ' ' LYS . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.839 0.352 . . . . 1.0 110.252 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.621 ' HZ2' ' HZ3' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.621 ' HZ3' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' X' ' 22' ' ' ARG . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' X' ' 39' ' ' LYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.159 0.504 . . . . 1.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.651 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.897 0.38 . . . . 1.0 110.459 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' X' ' 19' ' ' LEU . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.822 0.344 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.402 ' HB ' ' NH1' ' X' ' 57' ' ' ARG . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.666 ' NH1' ' NE1' ' X' ' 83' ' ' TRP . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.452 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.46 ' CG2' ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 46.8 t0 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.849 0.357 . . . . 1.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.403 HH11 HG12 ' X' ' 86' ' ' ILE . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' X' ' 37' ' ' PHE . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . 0.45 ' O ' ' OG1' ' X' ' 69' ' ' THR . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . 0.453 ' N ' HD21 ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 69' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.403 HG12 HH11 ' X' ' 22' ' ' ARG . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.899 0.381 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.542 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . 0.513 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.742 0.306 . . . . 1.0 110.576 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.524 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.402 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.892 0.377 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.662 ' HZ3' ' HZ3' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . 0.662 ' HZ3' ' HZ3' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.908 0.385 . . . . 1.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.569 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.672 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.1 tm0? -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 81' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' X' ' 82' ' ' TYR . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' X' ' 25' ' ' LYS . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.512 ' CD1' HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.838 0.351 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . 0.673 ' CG ' ' HZ1' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.616 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.616 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.673 ' HZ1' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 81' ' ' SER . . . . . 0.408 ' HG ' ' N ' ' X' ' 82' ' ' TYR . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.818 0.342 . . . . 1.0 110.516 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . 0.503 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.89 0.376 . . . . 1.0 110.258 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.602 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.695 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.413 ' CD1' HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . 0.503 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.791 0.329 . . . . 1.0 110.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' X' ' 19' ' ' LEU . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 23.5 mt . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.992 0.425 . . . . 1.0 110.174 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.629 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.629 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . 0.499 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.629 ' HH ' HH22 ' X' ' 57' ' ' ARG . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . 0.466 ' CD1' HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' X' X ' 6' ' ' SER . . . . . 0.44 ' OG ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 1.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 16' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 28' ' ' TYR . . . . . 0.515 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 38' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 39' ' ' LYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 39' ' ' LYS . . . . . 0.428 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' X' X ' 51' ' ' ILE . . . . . 0.421 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.805 0.336 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 53' ' ' ILE . . . . . 0.543 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 54' ' ' LYS . . . . . 0.421 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 64' ' ' GLN . . . . . 0.458 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 77' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' X' ' 80' ' ' PHE . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 80' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 82' ' ' TYR . . . . . 0.559 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' X' X ' 83' ' ' TRP . . . . . 0.52 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 85' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 87' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.04 98.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -107.74 120.6 42.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 1.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.83 -43.24 93.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.0 tp -108.69 130.34 55.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.443 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -145.44 159.95 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.327 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.98 -48.41 53.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -99.09 -12.04 20.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 1.0 110.855 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -141.94 89.47 8.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.439 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -2.11 11.93 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.15 1.9 . . . . 1.0 112.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.61 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 1.5 p90 -102.71 160.26 14.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.06 0.457 . . . . 1.0 110.366 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -144.57 67.46 14.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.62 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -54.09 144.04 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.758 2.305 . . . . 1.0 112.233 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -126.87 141.25 51.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.527 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' X' ' 55' ' ' ARG . 95.9 mt-10 -139.68 172.22 13.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.563 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.35 -37.49 92.02 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.421 ' O ' ' C ' ' X' ' 51' ' ' ILE . 70.9 p -79.03 165.43 23.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' X' ' 50' ' ' THR . 70.0 mt -36.7 107.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.366 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' X' ' 48' ' ' GLU . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.463 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.427 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.81 -44.24 86.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.63 -40.74 95.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.244 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' X' ' 95' ' ' VAL . 57.2 mtpt -62.22 -41.48 98.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.659 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.87 -3.38 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.61 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.5 t -116.8 132.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.336 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.423 ' OD1' ' NE2' ' X' ' 98' ' ' GLN . 7.3 t-20 60.92 73.02 0.64 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.27 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.8 141.54 92.47 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.557 2.171 . . . . 1.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . 0.423 ' NE2' ' OD1' ' X' ' 96' ' ' ASN . 93.7 mm-40 -131.08 147.84 52.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.03 133.6 68.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.578 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.247 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.09 2.84 77.05 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . 0.4 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mm-40 -63.36 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 1.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.04 90.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.531 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . 0.465 ' CD1' ' OE2' ' X' ' 9' ' ' GLU . 89.2 mt -64.04 -47.24 81.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 1.0 110.662 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p -150.78 -172.86 4.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.654 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.465 ' OE2' ' CD1' ' X' ' 5' ' ' LEU . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.424 ' CD1' ' HH ' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.488 ' HE ' ' CD1' ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.633 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.14 -45.21 92.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -97.67 -4.69 36.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.506 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.675 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -162.17 84.85 1.59 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.249 0.547 . . . . 1.0 110.49 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.525 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 35.1 Cg_exo -61.54 -31.47 87.38 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.476 2.117 . . . . 1.0 111.686 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.675 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.8 p90 -74.18 150.94 40.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.349 0.595 . . . . 1.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.592 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -163.5 43.66 0.1 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.272 -0.876 . . . . 1.0 110.809 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 49.3 Cg_exo -36.14 148.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.982 2.455 . . . . 1.0 112.46 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -134.18 135.24 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.568 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.07 175.08 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.444 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.94 97.19 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -85.33 164.19 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 1.0 110.151 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt -52.23 108.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.291 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' HE1' ' X' ' 83' ' ' TRP . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.414 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.421 ' O ' ' OG1' ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . 0.417 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' X' ' 69' ' ' THR . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.506 ' O ' ' CD1' ' X' ' 82' ' ' TYR . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.676 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.47 ' CG2' ' NH2' ' X' ' 57' ' ' ARG . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.488 ' CD1' ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' X' ' 93' ' ' LYS . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.18 -53.56 56.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -66.87 -42.26 85.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.382 . . . . 1.0 110.744 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' X' ' 90' ' ' ILE . 62.3 mmtt -114.1 119.02 35.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.175 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -101.73 -4.89 25.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.85 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.906 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -121.96 85.32 45.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.446 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.9 145.47 96.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.812 2.342 . . . . 1.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.48 154.48 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -124.96 135.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.465 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.575 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.53 -40.97 96.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.02 147.97 45.41 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.759 0.314 . . . . 1.0 110.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -108.68 122.66 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.26 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.5 tp -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -145.65 163.69 34.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.287 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -57.74 -49.6 76.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -95.28 -56.02 2.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.219 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' X' ' 38' ' ' VAL . 31.2 t 45.93 61.88 11.96 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.441 . . . . 1.0 111.248 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.74 -26.43 13.6 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.548 2.166 . . . . 1.0 110.787 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.48 ' HE1' ' CG2' ' X' ' 59' ' ' VAL . 0.0 OUTLIER -147.79 -168.58 3.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.559 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 173.47 -43.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.69 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -59.2 141.89 98.52 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.548 2.165 . . . . 1.0 112.715 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.531 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 69.3 tp60 -161.99 146.83 12.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.43 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -149.83 154.0 37.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.893 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.3 -32.79 6.34 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.354 -0.699 . . . . 1.0 111.354 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 67.0 p -139.65 167.27 22.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.322 -0.251 . . . . 1.0 110.322 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' X' ' 50' ' ' THR . 5.2 mt -35.42 126.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 O-C-N 123.535 0.522 . . . . 1.0 109.841 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.533 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' X' ' 47' ' ' GLN . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.549 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 41.8 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.43 ' N ' HD21 ' X' ' 68' ' ' ASN . 1.1 m-80 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.497 ' O ' ' CD1' ' X' ' 82' ' ' TYR . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.494 ' CD1' HH21 ' X' ' 57' ' ' ARG . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' X' ' 93' ' ' LYS . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.08 -48.95 79.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.95 -45.02 87.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.187 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' X' ' 90' ' ' ILE . 98.8 mttt -135.96 154.92 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 57.65 26.77 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.275 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.83 -28.97 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.21 78.47 0.31 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' X' ' 99' ' ' VAL . 46.4 Cg_exo -55.2 -35.88 92.02 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.83 2.353 . . . . 1.0 111.734 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 52.08 -87.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' X' ' 97' ' ' PRO . 38.1 t -122.4 131.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.808 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.57 58.84 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -130.89 132.94 45.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.722 0.296 . . . . 1.0 110.604 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.71 -41.26 92.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -113.26 126.07 55.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p -149.48 173.56 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.49 -52.22 14.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 72.5 p -98.75 -5.75 30.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 1.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.602 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.8 OUTLIER -147.49 85.53 6.69 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.238 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.13 -0.69 9.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.212 1.941 . . . . 1.0 112.631 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.602 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.1 p90 -103.54 157.88 16.75 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.265 0.555 . . . . 1.0 110.257 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -147.12 68.0 11.14 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.435 -0.802 . . . . 1.0 110.248 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.439 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 48.8 Cg_exo -53.65 141.14 64.88 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.688 2.259 . . . . 1.0 112.295 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -120.34 136.93 54.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.481 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.54 171.34 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.11 -40.6 93.83 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 23.7 p -82.56 164.6 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 57.6 mt -37.08 110.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.755 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.405 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.458 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 34.6 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.548 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' X' ' 92' ' ' LYS . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -98.24 -6.56 30.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' X' ' 88' ' ' GLU . 10.8 mmpt? 44.3 86.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 1.0 110.565 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' X' ' 95' ' ' VAL . 89.0 tttt -63.91 -35.01 79.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.491 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -40.47 -22.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' X' ' 93' ' ' LYS . 9.5 m -126.86 135.2 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.599 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 161.13 23.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.517 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.03 151.5 67.53 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.705 2.27 . . . . 1.0 112.162 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.29 154.28 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.58 -46.03 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 43.6 ttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.484 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.79 154.93 53.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -118.11 127.26 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.859 0.361 . . . . 1.0 110.68 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.418 ' O ' ' OE2' ' X' ' 9' ' ' GLU . 79.8 mm-40 -70.09 -41.1 74.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.787 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 35.8 tp -109.73 129.12 55.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.54 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p -149.58 167.9 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.706 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' X' ' 4' ' ' GLU . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.412 ' HZ3' ' HZ1' ' X' ' 20' ' ' LYS . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.468 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.412 ' HZ1' ' HZ3' ' X' ' 16' ' ' LYS . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.18 -31.92 68.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -98.27 -4.47 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.022 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -162.87 110.49 1.05 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.615 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.13 -18.14 18.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.506 2.138 . . . . 1.0 111.94 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.687 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 3.7 p90 -88.63 -171.1 3.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.475 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.57 ' N ' ' HD2' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 160.45 -54.01 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.434 -178.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_endo -63.25 143.42 89.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.688 2.259 . . . . 1.0 112.404 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.796 HE21 HH21 ' X' ' 55' ' ' ARG . 85.0 mt-30 -142.73 -153.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.277 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.15 129.37 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.27 -115.84 4.74 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.426 ' O ' ' C ' ' X' ' 51' ' ' ILE . 82.7 p -57.66 165.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' X' ' 50' ' ' THR . 54.9 mt -36.18 109.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.373 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.565 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.796 HH21 HE21 ' X' ' 47' ' ' GLN . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.425 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.498 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.461 ' CD1' ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.428 ' O ' ' OD2' ' X' ' 91' ' ' ASP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 -59.23 -42.4 90.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -63.9 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.583 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -74.86 -10.99 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.49 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -53.1 -19.53 2.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.486 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.67 148.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.433 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' X' ' 97' ' ' PRO . 1.4 m-20 171.85 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.581 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' X' ' 96' ' ' ASN . 65.8 Cg_endo -75.35 151.82 38.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.787 2.325 . . . . 1.0 112.142 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -107.74 126.07 52.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.29 131.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.602 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.58 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.44 21.18 67.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -128.4 125.5 38.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.699 0.285 . . . . 1.0 110.603 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.77 116.48 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.364 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.5 -105.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.309 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -150.14 167.03 28.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.418 ' NE ' ' CD2' ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' X' ' 42' ' ' CYS . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.02 -49.55 28.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 p -95.32 -5.91 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.608 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.615 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -148.65 80.6 8.19 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.061 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.41 -38.93 93.49 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.737 2.292 . . . . 1.0 112.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.615 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.8 p90 -66.22 -170.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.165 0.507 . . . . 1.0 110.677 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -179.87 -45.18 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.421 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.9 Cg_exo -67.76 150.46 79.0 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.788 2.325 . . . . 1.0 112.746 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' X' ' 55' ' ' ARG . 47.8 tp60 -163.66 154.91 16.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.333 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -116.71 140.27 49.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.654 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 -131.95 10.17 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.8 p -59.25 167.34 1.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' X' ' 50' ' ' THR . 7.6 mt -34.29 113.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.668 0.605 . . . . 1.0 110.005 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.614 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' X' ' 47' ' ' GLN . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' X' ' 79' ' ' ALA . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.418 ' CD2' ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.67 -44.5 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.46 -41.72 97.66 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.029 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' X' ' 95' ' ' VAL . 98.6 mttt -63.98 -40.38 96.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -44.18 -17.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.517 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' X' ' 93' ' ' LYS . 53.7 t -119.83 129.44 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.266 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.1 69.02 2.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.628 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.48 -40.73 71.05 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.876 2.384 . . . . 1.0 112.152 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.74 137.59 55.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.368 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.58 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.691 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.6 24.22 56.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.13 133.21 46.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.334 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 41.6 tp10 -59.72 -44.6 93.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.475 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.65 126.75 55.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.454 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -148.03 162.45 39.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.38 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.646 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.646 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.419 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.17 -40.98 95.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.2 p -98.3 -4.87 34.14 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.87 0.367 . . . . 1.0 111.257 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.657 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -164.59 98.29 0.88 Allowed Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.512 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.64 -4.88 15.84 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.147 1.898 . . . . 1.0 111.496 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.657 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 2.3 p90 -100.91 -174.2 2.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.328 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.7 -41.57 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.494 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_exo -60.32 142.16 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.452 2.101 . . . . 1.0 112.586 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.504 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 51.5 tt0 -174.66 163.04 3.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.442 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -117.54 150.33 39.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.567 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.97 -128.27 7.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 18.2 p -68.79 165.32 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' X' ' 50' ' ' THR . 43.9 mt -36.68 107.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.952 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.681 ' HZ3' ' NH2' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.504 ' NH2' ' OE1' ' X' ' 47' ' ' GLN . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.681 ' NH2' ' HZ3' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.0 tm0? -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.4 ' CG ' HE21 ' X' ' 64' ' ' GLN . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.503 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.483 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.56 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.22 -41.82 98.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 1.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' X' ' 95' ' ' VAL . 66.0 mttm -48.42 137.66 11.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.181 0.515 . . . . 1.0 110.193 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.63 4.25 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.964 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.485 ' H ' ' C ' ' X' ' 93' ' ' LYS . 95.4 t -76.91 95.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.33 71.9 0.95 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.64 145.25 98.61 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.843 2.362 . . . . 1.0 112.201 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -65.43 -45.04 85.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.716 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.14 134.67 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.22 -0.447 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.667 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.73 -166.9 45.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -103.56 132.67 49.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.65 0.262 . . . . 1.0 110.416 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -108.69 120.0 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.33 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' X' ' 5' ' ' LEU . 0.0 OUTLIER -103.21 -70.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.448 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 6' ' ' SER . . . . . 0.453 ' HG ' ' N ' ' X' ' 7' ' ' GLN . 29.1 t -147.58 149.02 31.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.46 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . 0.453 ' N ' ' HG ' ' X' ' 6' ' ' SER . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.471 ' CG ' ' HZ1' ' X' ' 39' ' ' LYS . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.666 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.517 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.99 -47.18 81.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.64 ' HG1' ' H ' ' X' ' 42' ' ' CYS . 69.5 p -99.92 -53.43 3.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 1.0 110.977 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.666 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.5 OUTLIER 37.02 64.79 2.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.93 -34.57 98.5 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.307 2.005 . . . . 1.0 110.982 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -129.33 -160.1 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.506 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.604 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 158.97 -37.83 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.23 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -60.68 148.93 90.0 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.537 2.158 . . . . 1.0 112.649 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' X' ' 48' ' ' GLU . 37.8 tt0 -96.68 157.75 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.597 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . 0.48 ' CD ' HH22 ' X' ' 55' ' ' ARG . 97.9 mt-10 -134.69 -112.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.412 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.07 2.74 19.2 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -133.33 163.4 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.7 0.286 . . . . 1.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mt -39.82 108.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.337 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.48 HH22 ' CD ' ' X' ' 48' ' ' GLU . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.494 ' NH2' ' HH ' ' X' ' 82' ' ' TYR . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . 0.519 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.414 ' O ' ' OG1' ' X' ' 69' ' ' THR . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.437 ' N ' HD21 ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.428 ' C ' ' N ' ' X' ' 79' ' ' ALA . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.504 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' X' ' 93' ' ' LYS . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.58 -47.32 63.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.82 -39.07 93.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 1.0 110.575 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' X' ' 90' ' ' ILE . 97.0 mttt -91.64 171.93 8.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 55.7 32.53 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.347 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -64.92 -44.07 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 1.0 110.833 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.411 ' N ' ' ND2' ' X' ' 96' ' ' ASN . 0.2 OUTLIER -162.17 76.24 2.15 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.688 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.47 144.43 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.023 2.482 . . . . 1.0 112.062 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.44 125.75 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.62 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.16 -45.93 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.518 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 51.6 ttp . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.953 -1.022 . . . . 1.0 110.656 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.591 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.64 63.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -117.31 126.23 52.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.885 0.374 . . . . 1.0 110.53 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.19 -39.94 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.505 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -114.76 129.55 56.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.565 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p -142.61 162.86 34.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.556 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.467 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.467 HH12 ' CB ' ' X' ' 18' ' ' ALA . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' X' ' 42' ' ' CYS . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.545 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -61.86 -46.05 91.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.3 p -97.68 -17.36 19.5 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.545 ' SG ' ' O ' ' X' ' 39' ' ' LYS . 0.0 OUTLIER 39.32 57.2 6.24 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-O 121.747 0.784 . . . . 1.0 110.979 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' X' ' 44' ' ' TRP . 8.3 Cg_exo -70.16 -27.65 24.27 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.019 1.813 . . . . 1.0 112.223 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.541 ' O ' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 50.86 119.16 0.0 OUTLIER 'General case' 0 C--N 1.339 0.146 0 O-C-N 123.645 0.591 . . . . 1.0 110.829 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -118.88 57.9 3.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.488 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.407 ' HA ' HH11 ' X' ' 55' ' ' ARG . 71.6 Cg_exo -31.5 134.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.147 2.564 . . . . 1.0 112.762 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -153.09 148.63 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.51 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -140.87 143.11 34.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.658 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.08 63.85 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.3 p -129.57 164.66 23.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.343 . . . . 1.0 110.345 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.462 HG23 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt -40.91 125.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.198 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.514 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.462 ' H ' HG23 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' X' ' 68' ' ' ASN . 3.3 tm0? -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' X' ' 64' ' ' GLN . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.461 ' C ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.437 HD11 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' X' ' 86' ' ' ILE . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' X' ' 93' ' ' LYS . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' X' ' 92' ' ' LYS . 3.8 p-10 -58.77 -44.37 90.61 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.575 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 67.2 mttm -65.31 -44.55 87.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.752 0.31 . . . . 1.0 110.895 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' X' ' 90' ' ' ILE . 99.3 mttt -134.97 139.48 44.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.179 0.514 . . . . 1.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.35 -4.36 59.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.185 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.19 161.18 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.764 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -137.75 75.53 43.05 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.675 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.9 142.7 98.39 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.889 2.393 . . . . 1.0 111.974 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -65.64 -41.89 92.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 33.6 m -65.14 -42.12 93.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.594 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 42.9 ttp . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.986 -1.006 . . . . 1.0 110.231 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.76 173.5 55.04 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -108.73 129.41 55.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.7 0.286 . . . . 1.0 110.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.42 -45.86 89.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 39.7 tp -110.64 129.99 55.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -147.5 162.08 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.211 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.542 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' X' ' 22' ' ' ARG . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.542 HH12 ' CB ' ' X' ' 18' ' ' ALA . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 -60.72 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 48.3 p -98.85 -34.22 10.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.752 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.9 OUTLIER -117.89 84.48 20.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.701 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.71 -2.63 12.72 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.035 1.823 . . . . 1.0 111.967 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.665 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.7 p90 -99.17 151.83 20.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.269 0.557 . . . . 1.0 110.834 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 5.0 p90 -167.81 46.2 0.1 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.23 -0.895 . . . . 1.0 110.62 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 43.8 Cg_endo -65.78 161.93 36.95 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 123.21 2.607 . . . . 1.0 112.746 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -108.6 155.81 20.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.699 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . 0.54 ' CD ' HH21 ' X' ' 55' ' ' ARG . 97.1 mt-10 -137.93 46.37 2.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 6.74 73.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.419 ' O ' ' C ' ' X' ' 51' ' ' ILE . 2.2 t -137.65 163.95 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' X' ' 50' ' ' THR . 57.7 mt -36.89 108.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.243 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.58 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.54 HH21 ' CD ' ' X' ' 48' ' ' GLU . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.566 HE22 ' CG ' ' X' ' 68' ' ' ASN . 5.0 tp60 -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.566 ' CG ' HE22 ' X' ' 64' ' ' GLN . 1.1 m-80 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.408 HD11 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.488 ' CD1' ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -51.43 -46.69 63.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.93 -40.64 96.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.117 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.69 163.09 24.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.738 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 56.82 12.12 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -125.9 133.52 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 0.1 OUTLIER 47.68 55.17 16.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.492 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 39.2 Cg_endo -67.51 147.59 77.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.763 2.309 . . . . 1.0 112.152 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -138.1 158.15 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.549 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.99 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.607 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.92 96.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.885 -0.886 . . . . 1.0 110.885 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -114.46 127.13 55.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 1.0 110.665 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 -38.61 87.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.498 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -104.74 129.17 53.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -135.94 164.37 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.466 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.507 ' C ' ' NH1' ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.507 ' NH1' ' C ' ' X' ' 18' ' ' ALA . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.12 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.505 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 23.7 m -94.72 -51.44 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.336 -0.546 . . . . 1.0 110.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.601 ' N ' ' O ' ' X' ' 38' ' ' VAL . 23.5 p 39.24 59.3 6.1 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.676 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.37 -31.62 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.733 2.289 . . . . 1.0 111.119 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.58 ' HE1' ' CG2' ' X' ' 59' ' ' VAL . 0.0 OUTLIER -141.28 -173.06 3.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.485 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.598 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 161.92 -40.05 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.662 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_exo -62.12 144.72 96.22 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.893 2.395 . . . . 1.0 112.264 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.678 ' NE2' ' H ' ' X' ' 55' ' ' ARG . 71.8 mt-30 -147.37 166.44 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.461 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -143.78 115.81 8.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.84 5.95 88.6 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 82.2 p -137.54 163.05 32.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.796 0.331 . . . . 1.0 110.657 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.465 ' O ' ' OE1' ' X' ' 47' ' ' GLN . 6.0 mt -59.55 126.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.885 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.525 ' O ' ' NE2' ' X' ' 47' ' ' GLN . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.458 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.403 ' HE2' HH21 ' X' ' 58' ' ' ARG . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.678 ' H ' ' NE2' ' X' ' 47' ' ' GLN . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.403 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . 0.58 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.424 ' O ' ' OG1' ' X' ' 69' ' ' THR . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.539 ' CZ ' ' O ' ' X' ' 25' ' ' LYS . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.78 -49.33 78.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -64.85 -41.11 95.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 1.0 110.615 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' X' ' 98' ' ' GLN . 64.1 tttp -63.37 -42.29 98.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.732 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -43.78 -17.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.635 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' X' ' 93' ' ' LYS . 30.7 m -132.32 159.78 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' X' ' 95' ' ' VAL . 0.9 OUTLIER 56.62 159.16 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.611 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 153.57 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.801 2.334 . . . . 1.0 112.218 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . 0.527 ' OE1' ' NZ ' ' X' ' 93' ' ' LYS . 57.1 tt0 -69.78 120.43 15.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.34 -33.51 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.421 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.656 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.24 -177.99 39.73 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.72 148.3 50.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.0 110.611 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.61 -39.54 80.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -104.82 123.72 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -132.03 156.97 45.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.252 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.621 ' HZ2' ' HZ3' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.621 ' HZ3' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' X' ' 22' ' ' ARG . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.65 ' O ' ' N ' ' X' ' 42' ' ' CYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.37 -48.41 81.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -99.47 -5.04 30.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.867 0.365 . . . . 1.0 111.35 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' CD2' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -159.34 93.55 1.79 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.114 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.544 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 25.6 Cg_exo -59.98 -0.41 0.87 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.234 1.956 . . . . 1.0 111.891 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.687 ' CD2' ' SG ' ' X' ' 42' ' ' CYS . 0.3 OUTLIER -67.53 130.17 42.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.635 0.731 . . . . 1.0 110.655 -178.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.594 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -155.28 39.5 0.11 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.683 -1.144 . . . . 1.0 110.451 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 44.6 Cg_endo -64.85 148.87 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.604 2.203 . . . . 1.0 112.499 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -145.12 92.15 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.903 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -172.41 147.21 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.05 -157.57 51.37 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.212 -0.755 . . . . 1.0 111.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.433 ' O ' ' C ' ' X' ' 51' ' ' ILE . 43.6 p -47.91 165.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' X' ' 50' ' ' THR . 22.7 mt -35.68 109.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 O-C-N 123.621 0.576 . . . . 1.0 110.006 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.651 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.651 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 -57.23 -50.65 72.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' X' ' 88' ' ' GLU . 70.7 mmtt -66.8 -42.34 86.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.359 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' X' ' 95' ' ' VAL . 88.6 tttt -65.42 -34.98 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.424 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -42.2 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.633 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 93' ' ' LYS . 31.8 m -65.07 -26.1 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' X' ' 99' ' ' VAL . 3.2 m-20 55.59 78.07 0.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.355 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.9 -31.53 73.76 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.866 2.377 . . . . 1.0 112.103 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.43 -37.14 79.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.575 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' X' ' 96' ' ' ASN . 46.8 t -122.27 132.49 70.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.663 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.567 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.59 41.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.701 -0.959 . . . . 1.0 110.701 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -134.08 155.33 50.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 1.0 110.406 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -66.26 -37.89 86.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 24.6 tp -105.03 127.22 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.408 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -136.36 147.95 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.459 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' X' ' 19' ' ' LEU . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.453 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.44 -48.97 77.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -97.88 -18.18 18.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.889 0.376 . . . . 1.0 111.447 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.4 OUTLIER -141.99 84.23 11.98 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.519 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.06 -38.01 96.9 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.022 2.481 . . . . 1.0 111.977 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.643 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 10.3 p90 -70.78 138.0 50.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.995 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 19.0 p90 -151.01 42.49 0.23 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.764 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 50.6 Cg_exo -41.61 153.61 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.659 2.239 . . . . 1.0 112.537 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -151.05 158.03 43.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.422 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' X' ' 50' ' ' THR . 85.4 tt0 -140.39 158.17 44.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -36.87 -54.83 1.43 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.405 ' O ' ' O ' ' X' ' 48' ' ' GLU . 80.6 p -74.69 164.13 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -50.61 109.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.235 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.402 ' HB ' ' NH1' ' X' ' 57' ' ' ARG . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.666 ' NH1' ' NE1' ' X' ' 83' ' ' TRP . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.452 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.46 ' CG2' ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 46.8 t0 -41.88 -30.3 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.81 -42.02 98.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.196 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' X' ' 95' ' ' VAL . 99.1 mttt -64.34 156.41 29.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.077 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 58.13 4.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.8 t -124.08 128.89 74.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.352 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.428 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 5.6 m120 46.52 54.7 15.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.8 Cg_endo -65.76 -22.51 56.9 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.778 2.319 . . . . 1.0 112.15 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -64.67 -42.88 95.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.583 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -123.0 133.61 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.398 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.544 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.68 -175.14 50.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -134.59 160.73 37.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.663 0.268 . . . . 1.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -113.68 128.09 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.9 128.79 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.593 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p -149.04 163.31 37.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.647 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.403 HH11 HG12 ' X' ' 86' ' ' ILE . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' X' ' 37' ' ' PHE . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.22 -52.45 14.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 p -97.99 -4.62 35.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.047 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -146.05 83.86 8.38 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 1.0 110.37 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.47 -39.0 89.85 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.52 2.147 . . . . 1.0 111.555 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.593 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 8.7 p90 -68.67 -168.51 0.12 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.593 ' C ' ' CD1' ' X' ' 45' ' ' PHE . 0.2 OUTLIER 160.25 -56.74 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.484 -178.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 23.6 Cg_endo -57.85 141.99 96.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.644 2.23 . . . . 1.0 112.376 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.524 ' OE1' ' NE ' ' X' ' 55' ' ' ARG . 53.3 tt0 -155.98 155.28 32.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.98 162.34 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.676 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 -117.19 5.67 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 16.7 p -67.74 167.5 13.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.198 -0.297 . . . . 1.0 110.198 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' X' ' 50' ' ' THR . 3.9 mt -34.77 110.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' X' ' 47' ' ' GLN . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.524 ' NE ' ' OE1' ' X' ' 47' ' ' GLN . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . 0.45 ' O ' ' OG1' ' X' ' 69' ' ' THR . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . 0.453 ' N ' HD21 ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 69' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' X' ' 65' ' ' ASP . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.403 HG12 HH11 ' X' ' 22' ' ' ARG . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -51.56 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -43.11 98.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.974 0.416 . . . . 1.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' X' ' 95' ' ' VAL . 60.9 mttm -60.53 -41.84 95.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.652 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -47.55 -14.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.414 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' X' ' 93' ' ' LYS . 55.3 t -122.02 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.937 0.399 . . . . 1.0 110.347 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 0.2 OUTLIER 177.4 -44.2 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.669 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 33.4 Cg_exo -59.8 146.67 95.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.771 2.314 . . . . 1.0 112.213 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -66.96 -38.34 85.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.705 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 147.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.516 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.585 179.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . -66.0 -36.73 92.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.33 -43.24 95.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.922 0.391 . . . . 1.0 110.67 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.3 -43.0 74.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.618 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' X' ' 2' ' ' GLY . 33.8 tp -122.82 131.69 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.597 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p -143.41 163.91 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.525 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' X' ' 26' ' ' VAL . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.542 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . 0.513 ' C ' ' HZ2' ' X' ' 16' ' ' LYS . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.8 -51.09 61.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -98.17 -10.42 24.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.261 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.719 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -147.41 82.65 8.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.486 0.66 . . . . 1.0 110.41 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.0 -27.6 79.7 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.297 1.998 . . . . 1.0 111.59 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.719 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 12.6 p90 -74.64 145.08 43.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.304 0.573 . . . . 1.0 110.63 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.585 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 57.9 t80 -157.1 44.59 0.21 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 87.2 Cg_exo -37.14 149.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.844 2.363 . . . . 1.0 112.266 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -132.28 131.81 42.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.373 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -128.82 -178.63 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.562 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.98 83.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 46.0 p -81.68 164.61 21.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 1.0 110.402 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt -46.16 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.576 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' X' ' 46' ' ' PRO . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.524 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.46 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.402 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 -62.4 -49.49 75.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' X' ' 88' ' ' GLU . 66.8 mmtt -64.15 -40.44 96.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' X' ' 95' ' ' VAL . 65.2 tttm -80.69 134.43 35.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.47 . . . . 1.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -142.18 4.63 1.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.875 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.523 ' O ' ' NZ ' ' X' ' 93' ' ' LYS . 69.5 t -122.33 134.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.266 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.454 ' ND2' ' C ' ' X' ' 96' ' ' ASN . 0.0 OUTLIER -142.2 159.22 59.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.667 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 147.78 70.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.836 2.357 . . . . 1.0 111.874 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -135.8 155.39 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.28 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.93 129.3 75.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.481 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.562 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.18 93.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 53.35 -172.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.644 0.259 . . . . 1.0 110.386 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -110.53 117.96 34.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.4 tp -103.87 125.57 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p -138.98 163.04 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.675 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.662 ' HZ3' ' HZ3' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . 0.662 ' HZ3' ' HZ3' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.21 -48.6 78.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 41' ' ' THR . . . . . 0.616 ' HG1' ' H ' ' X' ' 42' ' ' CYS . 22.7 p -94.59 -55.49 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.41 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' X' ' 38' ' ' VAL . 35.5 t 45.53 61.43 12.31 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.959 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' X' ' 42' ' ' CYS . 20.6 Cg_exo -66.08 -31.28 46.07 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.553 2.168 . . . . 1.0 111.157 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.597 ' HE1' ' CG2' ' X' ' 59' ' ' VAL . 0.0 OUTLIER -148.34 -179.84 7.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.316 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 177.33 -45.45 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.245 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.5 Cg_exo -70.01 123.47 10.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.975 2.45 . . . . 1.0 111.856 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' X' ' 52' ' ' ASP . 61.6 mt-30 -152.54 151.81 31.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.369 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -145.59 121.61 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -78.91 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.321 -0.712 . . . . 1.0 111.321 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -77.37 164.12 25.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.945 0.402 . . . . 1.0 110.426 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt -49.1 117.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.435 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.46 ' O ' ' NE2' ' X' ' 47' ' ' GLN . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.569 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.672 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . 0.597 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.1 tm0? -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.431 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 81' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' X' ' 82' ' ' TYR . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' X' ' 25' ' ' LYS . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.512 ' CD1' HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -50.56 -43.58 56.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -63.61 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 1.0 110.506 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.15 136.22 49.91 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.366 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -96.5 -4.5 41.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.25 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.21 161.9 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.633 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -166.97 74.98 1.06 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 1.0 110.605 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -60.88 148.76 91.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.046 2.497 . . . . 1.0 111.875 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -129.83 150.73 51.0 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.618 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.32 -46.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.463 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.674 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.284 -0.635 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 5.23 69.92 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -139.09 149.17 44.24 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.418 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -64.84 -42.63 94.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.885 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 31.0 tp -109.4 131.46 55.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.414 . . . . 1.0 110.504 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p -149.24 166.09 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . 0.673 ' CG ' ' HZ1' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.616 ' NZ ' ' CD1' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.616 ' CD1' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' X' ' 42' ' ' CYS . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.673 ' HZ1' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.85 -50.65 72.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -98.46 -26.49 14.43 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.178 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -127.15 82.18 68.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.443 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.09 -30.47 91.53 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.977 2.451 . . . . 1.0 111.81 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.647 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 8.5 p90 -76.78 144.85 38.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.42 0.629 . . . . 1.0 111.215 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.591 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 6.6 p90 -163.99 43.22 0.09 OUTLIER Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.666 -1.152 . . . . 1.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.2 Cg_endo -64.36 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.945 2.43 . . . . 1.0 111.802 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.478 HE22 ' NH1' ' X' ' 55' ' ' ARG . 87.6 mt-30 58.15 130.91 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.012 0.434 . . . . 1.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -147.02 -17.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.535 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.36 -103.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.402 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.9 p -66.69 164.24 17.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' X' ' 50' ' ' THR . 12.6 mt -39.83 108.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . . . . . . . . . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.478 ' NH1' HE22 ' X' ' 47' ' ' GLN . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 81' ' ' SER . . . . . 0.408 ' HG ' ' N ' ' X' ' 82' ' ' TYR . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' X' ' 93' ' ' LYS . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.03 -47.52 86.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.77 -45.03 88.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.731 0.3 . . . . 1.0 111.311 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' X' ' 94' ' ' GLU . 68.3 mttm -142.07 163.92 31.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.546 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' X' ' 93' ' ' LYS . 30.0 tt0 83.83 22.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.606 0.567 . . . . 1.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.75 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 48.71 75.24 0.68 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.515 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.45 147.66 90.38 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.103 2.535 . . . . 1.0 112.202 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.542 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.84 132.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.496 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.363 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . 103.38 167.05 25.62 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.24 -38.68 92.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.382 . . . . 1.0 110.701 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -50.94 69.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' X' ' 2' ' ' GLY . 35.3 tp -115.39 130.96 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.519 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p -147.8 162.94 38.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . 0.503 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.15 -45.63 90.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 45.7 p -96.81 -8.97 29.72 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 1.0 111.07 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.669 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -157.17 85.53 2.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.397 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.41 -37.88 96.3 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.604 2.202 . . . . 1.0 111.568 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.669 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 9.9 p90 -70.47 178.44 2.95 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.109 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 165.37 -41.1 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.612 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 24.9 Cg_exo -63.33 143.61 89.38 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.529 2.153 . . . . 1.0 112.641 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.493 ' OE1' ' CZ ' ' X' ' 55' ' ' ARG . 44.5 tt0 -173.2 166.75 4.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.141 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -120.25 161.33 21.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.96 -134.52 11.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.961 -0.855 . . . . 1.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 56.1 m -58.25 163.76 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 mt -39.21 108.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.258 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.602 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.493 ' CZ ' ' OE1' ' X' ' 47' ' ' GLN . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.695 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.413 ' CD1' HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . 0.503 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.51 -50.25 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.79 -42.34 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.884 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' X' ' 95' ' ' VAL . 87.8 tttt -64.05 -40.84 97.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.414 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -50.33 -13.64 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' X' ' 93' ' ' LYS . 38.6 t -113.13 131.19 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -130.5 75.3 79.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' X' ' 99' ' ' VAL . 58.4 Cg_endo -81.29 -12.61 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.796 2.331 . . . . 1.0 112.124 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 53.29 -85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.581 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' X' ' 97' ' ' PRO . 48.7 t -121.42 132.31 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.594 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.425 -0.584 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.05 -35.48 92.04 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 42.14 -115.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.694 0.283 . . . . 1.0 110.489 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.02 116.34 27.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.334 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 tp -116.37 129.03 56.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.342 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p -145.42 164.32 31.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.445 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' X' ' 19' ' ' LEU . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . 0.469 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -70.11 -34.11 72.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.5 p -95.57 -10.25 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 1.0 110.685 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.669 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -154.35 107.93 2.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.821 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.4 -10.93 20.75 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 121.968 1.779 . . . . 1.0 111.61 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.669 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.3 p90 -95.41 -173.1 2.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.233 0.539 . . . . 1.0 110.428 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.578 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.61 -40.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 1.0 110.49 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 34.7 Cg_exo -60.29 143.85 99.5 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.343 2.029 . . . . 1.0 112.659 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -164.52 149.81 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.31 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.82 152.06 29.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.532 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.75 -117.93 5.49 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.436 ' O ' ' C ' ' X' ' 51' ' ' ILE . 59.4 p -68.5 165.66 18.54 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' X' ' 50' ' ' THR . 23.5 mt -35.98 109.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.174 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.629 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.629 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . 0.499 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.629 ' HH ' HH22 ' X' ' 57' ' ' ARG . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . 0.466 ' CD1' HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.04 -41.68 88.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.69 -39.39 93.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.884 0.374 . . . . 1.0 110.569 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.673 ' C ' ' H ' ' X' ' 95' ' ' VAL . 99.1 mttt -57.87 -40.4 80.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.18 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.33 -7.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.653 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.673 ' H ' ' C ' ' X' ' 93' ' ' LYS . 31.3 m -135.46 163.33 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.13 76.52 73.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.625 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' X' ' 99' ' ' VAL . 41.1 Cg_exo -56.01 -34.13 91.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.809 2.34 . . . . 1.0 112.128 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -38.93 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' X' ' 97' ' ' PRO . 39.2 t -115.95 129.26 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.364 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.513 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.57 162.96 34.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.08 131.15 51.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.7 0.285 . . . . 1.0 110.344 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.37 119.12 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.592 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.8 tp -108.82 124.68 50.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.424 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 6' ' ' SER . . . . . 0.44 ' OG ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p -149.12 168.2 23.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 16' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 22' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 28' ' ' TYR . . . . . 0.515 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 38' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 39' ' ' LYS . . . . . 0.428 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -62.09 -49.05 77.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.1 p -98.02 -20.05 17.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.724 -0.39 . . . . 1.0 111.397 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 42' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.1 OUTLIER -138.45 91.66 12.3 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.013 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.06 -1.19 11.14 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.485 2.123 . . . . 1.0 111.823 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 44' ' ' TRP . . . . . 0.659 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 1.4 p90 -109.26 -165.42 1.01 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.763 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 45' ' ' PHE . . . . . 0.47 ' CG ' ' C ' ' X' ' 44' ' ' TRP . 0.3 OUTLIER -178.84 62.2 0.14 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.725 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 46' ' ' PRO . . . . . 0.562 ' O ' ' NE ' ' X' ' 55' ' ' ARG . 37.7 Cg_exo -56.73 148.58 64.65 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.617 2.211 . . . . 1.0 111.926 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 47' ' ' GLN . . . . . 0.427 ' OE1' ' OG1' ' X' ' 50' ' ' THR . 1.4 mm-40 174.03 152.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.623 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -171.94 127.52 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.549 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -22.37 40.47 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 50' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' X' ' 47' ' ' GLN . 23.3 p -134.73 164.46 27.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.755 0.312 . . . . 1.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 51' ' ' ILE . . . . . 0.421 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt -41.85 126.15 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 53' ' ' ILE . . . . . 0.543 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 54' ' ' LYS . . . . . 0.421 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 55' ' ' ARG . . . . . 0.562 ' NE ' ' O ' ' X' ' 46' ' ' PRO . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 64' ' ' GLN . . . . . 0.458 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 77' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' X' ' 80' ' ' PHE . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 80' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 82' ' ' TYR . . . . . 0.559 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' X' X ' 83' ' ' TRP . . . . . 0.52 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 85' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' X' ' 85' ' ' LEU . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 87' ' ' LYS . . . . . 0.52 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -48.75 -45.23 39.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.82 -41.83 99.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 1.0 110.37 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 93' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' X' ' 95' ' ' VAL . 99.4 mttt -62.7 -40.69 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.742 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -45.74 -16.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.434 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 95' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' X' ' 93' ' ' LYS . 49.2 t -121.24 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 96' ' ' ASN . . . . . 0.501 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 5.3 m-20 50.05 51.19 10.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.47 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 97' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.6 Cg_endo -64.38 149.54 89.91 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.951 2.434 . . . . 1.0 111.998 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -111.15 127.08 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.457 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.54 134.58 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.579 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.588 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.751 0.31 . . . . 1.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' X' ' 15' ' ' LEU . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.429 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.695 ' O ' HD12 ' X' ' 85' ' ' LEU . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 27' ' ' LYS . . . . . 0.459 ' N ' HG12 ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.408 HG13 ' N ' ' X' ' 39' ' ' LYS . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.408 ' N ' HG13 ' X' ' 38' ' ' VAL . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.434 HG22 ' H ' ' X' ' 54' ' ' LYS . 70.0 mt . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.99 0.424 . . . . 1.0 110.366 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.741 HD12 HD11 ' X' ' 90' ' ' ILE . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.434 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.695 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.741 HD11 HD12 ' X' ' 53' ' ' ILE . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.913 0.387 . . . . 1.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.565 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.465 HD22 ' HE1' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.709 ' HE ' HD13 ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.888 0.375 . . . . 1.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.901 ' NH2' HG21 ' X' ' 86' ' ' ILE . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.459 ' O ' HG23 ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 69' ' ' THR . . . . . 0.459 HG23 ' O ' ' X' ' 65' ' ' ASP . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.908 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.687 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.908 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.709 HD13 ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.85 0.357 . . . . 1.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.496 HD11 ' CE2' ' X' ' 11' ' ' TYR . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' X' ' 82' ' ' TYR . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.586 ' O ' HD12 ' X' ' 85' ' ' LEU . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.505 ' HE2' HE22 ' X' ' 64' ' ' GLN . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.467 HG22 ' H ' ' X' ' 54' ' ' LYS . 5.2 mt . . . . . 0 N--CA 1.462 0.144 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.644 HD12 HD11 ' X' ' 90' ' ' ILE . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.467 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.581 HH21 HD13 ' X' ' 86' ' ' ILE . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' X' ' 60' ' ' GLY . 8.2 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' X' ' 64' ' ' GLN . 9.3 m-20 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.422 ' O ' ' OE1' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.837 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.586 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.837 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.509 HD22 ' HD2' ' X' ' 22' ' ' ARG . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.644 HD11 HD12 ' X' ' 53' ' ' ILE . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.905 0.383 . . . . 1.0 110.651 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' X' ' 11' ' ' TYR . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' X' ' 89' ' ' LEU . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' X' ' 82' ' ' TYR . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.579 HD11 ' OD2' ' X' ' 91' ' ' ASP . 57.6 mt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.762 0.315 . . . . 1.0 110.755 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.75 HD12 HD11 ' X' ' 90' ' ' ILE . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.465 ' H ' HG22 ' X' ' 51' ' ' ILE . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.597 HE22 ' HA ' ' X' ' 77' ' ' VAL . 8.3 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.597 ' HA ' HE22 ' X' ' 64' ' ' GLN . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.467 HG23 ' H ' ' X' ' 78' ' ' THR . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.418 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.456 HD13 HH21 ' X' ' 57' ' ' ARG . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' X' ' 22' ' ' ARG . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.75 HD11 HD12 ' X' ' 53' ' ' ILE . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.579 ' OD2' HD11 ' X' ' 51' ' ' ILE . 75.5 m-20 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.847 0.356 . . . . 1.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.671 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.671 HD11 ' CE2' ' X' ' 11' ' ' TYR . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' X' ' 22' ' ' ARG . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.753 ' O ' HD12 ' X' ' 85' ' ' LEU . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' X' ' 82' ' ' TYR . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.439 HG22 ' H ' ' X' ' 54' ' ' LYS . 54.9 mt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 121.109 0.481 . . . . 1.0 110.373 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.621 HD12 HD11 ' X' ' 90' ' ' ILE . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.439 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.402 ' O ' HG23 ' X' ' 59' ' ' VAL . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.41 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.402 HG23 ' O ' ' X' ' 55' ' ' ARG . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.536 HE21 ' C ' ' X' ' 75' ' ' VAL . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.536 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.753 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.54 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' CH2' ' X' ' 83' ' ' TRP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.513 HD22 ' CD ' ' X' ' 22' ' ' ARG . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.621 HD11 HD12 ' X' ' 53' ' ' ILE . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.631 ' OE2' HD22 ' X' ' 32' ' ' LEU . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.405 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' X' ' 11' ' ' TYR . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.498 HD12 HG21 ' X' ' 24' ' ' VAL . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.835 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.498 HG21 HD12 ' X' ' 19' ' ' LEU . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.631 HD22 ' OE2' ' X' ' 9' ' ' GLU . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.436 ' CG ' HG11 ' X' ' 75' ' ' VAL . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.563 HG22 ' H ' ' X' ' 54' ' ' LYS . 7.6 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.174 0.512 . . . . 1.0 110.005 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.635 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.563 ' H ' HG22 ' X' ' 51' ' ' ILE . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.653 ' O ' HG23 ' X' ' 69' ' ' THR . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.555 ' OD1' HG13 ' X' ' 77' ' ' VAL . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 69' ' ' THR . . . . . 0.653 HG23 ' O ' ' X' ' 65' ' ' ASP . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.526 HG23 ' O ' ' X' ' 75' ' ' VAL . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.555 HG13 ' OD1' ' X' ' 68' ' ' ASN . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.863 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.48 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.608 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.863 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.835 HD22 ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.627 HD11 HD12 ' X' ' 53' ' ' ILE . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.341 . . . . 1.0 110.38 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.436 HD12 HG21 ' X' ' 24' ' ' VAL . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.436 HG21 HD12 ' X' ' 19' ' ' LEU . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.417 HG22 HG12 ' X' ' 24' ' ' VAL . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 31' ' ' LEU . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.425 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.453 HG22 ' H ' ' X' ' 54' ' ' LYS . 43.9 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.116 0.484 . . . . 1.0 109.952 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.699 ' NZ ' ' HE ' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.553 ' O ' HG23 ' X' ' 59' ' ' VAL . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.699 ' HE ' ' NZ ' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.553 HG23 ' O ' ' X' ' 55' ' ' ARG . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.57 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.564 HD11 HD12 ' X' ' 53' ' ' ILE . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.87 0.367 . . . . 1.0 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.402 HD23 ' HD2' ' X' ' 22' ' ' ARG . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.642 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.505 ' CE2' HD22 ' X' ' 32' ' ' LEU . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.635 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' X' ' 28' ' ' TYR . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.635 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.456 HG23 HD13 ' X' ' 90' ' ' ILE . 26.7 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.943 0.401 . . . . 1.0 110.337 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.624 HD12 HD11 ' X' ' 90' ' ' ILE . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.582 ' OE1' HG12 ' X' ' 77' ' ' VAL . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.46 HD22 ' N ' ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.582 HG12 ' OE1' ' X' ' 64' ' ' GLN . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.681 ' OH ' HD11 ' X' ' 86' ' ' ILE . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.642 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.681 HD11 ' OH ' ' X' ' 82' ' ' TYR . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.611 HD22 ' NE ' ' X' ' 22' ' ' ARG . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.624 HD11 HD12 ' X' ' 53' ' ' ILE . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.909 0.385 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.485 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.401 ' HA ' HH11 ' X' ' 22' ' ' ARG . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' X' ' 89' ' ' LEU . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.459 HG13 ' N ' ' X' ' 39' ' ' LYS . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.459 ' N ' HG13 ' X' ' 38' ' ' VAL . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.51 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.863 0.363 . . . . 1.0 110.198 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.545 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.51 ' H ' HG22 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.644 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.501 HD13 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.718 HD22 ' NE ' ' X' ' 22' ' ' ARG . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.404 HD13 HG23 ' X' ' 51' ' ' ILE . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 3.8 p-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.773 0.321 . . . . 1.0 110.211 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' O ' HG12 ' X' ' 12' ' ' VAL . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.67 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' X' ' 24' ' ' VAL . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.815 ' HE ' HD13 ' X' ' 89' ' ' LEU . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' X' ' 82' ' ' TYR . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.498 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.476 HG13 ' N ' ' X' ' 39' ' ' LYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.562 HG22 ' H ' ' X' ' 54' ' ' LYS . 57.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.869 0.366 . . . . 1.0 110.243 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.681 HD12 HD11 ' X' ' 90' ' ' ILE . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.562 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.756 HE22 ' CG ' ' X' ' 68' ' ' ASN . 0.0 OUTLIER -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.557 ' O ' HG23 ' X' ' 69' ' ' THR . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.756 ' CG ' HE22 ' X' ' 64' ' ' GLN . 3.6 m-20 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 69' ' ' THR . . . . . 0.557 HG23 ' O ' ' X' ' 65' ' ' ASP . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.447 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.494 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.609 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.815 HD13 ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.681 HD11 HD12 ' X' ' 53' ' ' ILE . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.891 0.377 . . . . 1.0 110.567 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.541 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.55 ' HZ2' HD12 ' X' ' 31' ' ' LEU . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.776 ' O ' HG23 ' X' ' 21' ' ' THR . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.608 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.439 ' HA ' HH11 ' X' ' 22' ' ' ARG . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.776 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.758 ' NE ' HD13 ' X' ' 89' ' ' LEU . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' X' ' 82' ' ' TYR . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.55 HD12 ' HZ2' ' X' ' 16' ' ' LYS . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.472 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.44 HG22 ' H ' ' X' ' 54' ' ' LYS . 6.0 mt . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.63 HD12 HD11 ' X' ' 90' ' ' ILE . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.44 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.473 ' O ' HG23 ' X' ' 59' ' ' VAL . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.436 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.473 HG23 ' O ' ' X' ' 55' ' ' ARG . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 67' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' X' ' 73' ' ' GLU . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.43 ' HB2' ' CD2' ' X' ' 67' ' ' TYR . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.422 ' HA ' HD22 ' X' ' 68' ' ' ASN . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.607 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.407 ' H ' HG23 ' X' ' 78' ' ' THR . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' X' ' 26' ' ' VAL . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.44 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.758 HD13 ' NE ' ' X' ' 22' ' ' ARG . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.63 HD11 HD12 ' X' ' 53' ' ' ILE . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.839 0.352 . . . . 1.0 110.252 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' X' ' 11' ' ' TYR . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.468 ' HZ2' ' NZ ' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.468 ' NZ ' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.513 ' O ' HD12 ' X' ' 85' ' ' LEU . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' X' ' 39' ' ' LYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.159 0.504 . . . . 1.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' X' ' 86' ' ' ILE . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' X' ' 75' ' ' VAL . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.642 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.513 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' X' ' 53' ' ' ILE . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.642 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.489 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.897 0.38 . . . . 1.0 110.459 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.419 ' O ' HG23 ' X' ' 21' ' ' THR . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.498 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.419 HG23 ' O ' ' X' ' 17' ' ' GLN . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.723 ' O ' HD12 ' X' ' 85' ' ' LEU . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.528 HG12 HG22 ' X' ' 26' ' ' VAL . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.528 HG22 HG12 ' X' ' 24' ' ' VAL . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.527 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.42 HG13 ' N ' ' X' ' 39' ' ' LYS . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.42 ' N ' HG13 ' X' ' 38' ' ' VAL . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.41 HG22 ' CG ' ' X' ' 54' ' ' LYS . 32.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.822 0.344 . . . . 1.0 110.235 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.443 ' HB ' ' NH1' ' X' ' 57' ' ' ARG . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.41 ' CG ' HG22 ' X' ' 51' ' ' ILE . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.834 ' NH2' HG21 ' X' ' 86' ' ' ILE . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.723 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.834 HG21 ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' X' ' 91' ' ' ASP . 46.8 t0 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.849 0.357 . . . . 1.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.404 ' O ' HG12 ' X' ' 12' ' ' VAL . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.429 HD23 ' HD2' ' X' ' 22' ' ' ARG . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.728 ' O ' HD12 ' X' ' 85' ' ' LEU . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' X' ' 82' ' ' TYR . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.446 ' CG ' HG21 ' X' ' 75' ' ' VAL . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.489 HG13 ' N ' ' X' ' 39' ' ' LYS . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.489 ' N ' HG13 ' X' ' 38' ' ' VAL . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.522 HG22 ' H ' ' X' ' 54' ' ' LYS . 3.9 mt . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.522 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 68' ' ' ASN . . . . . 0.474 HD22 ' N ' ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.446 HG21 ' CG ' ' X' ' 37' ' ' PHE . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.463 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.728 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' X' ' 53' ' ' ILE . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' X' ' 22' ' ' ARG . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.424 HD12 HG22 ' X' ' 86' ' ' ILE . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.899 0.381 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 17' ' ' GLN . . . . . 0.422 ' O ' HG23 ' X' ' 21' ' ' THR . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.548 HD23 ' HE1' ' X' ' 82' ' ' TYR . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 21' ' ' THR . . . . . 0.422 HG23 ' O ' ' X' ' 17' ' ' GLN . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.716 ' O ' HD12 ' X' ' 85' ' ' LEU . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' CE ' ' X' ' 33' ' ' LYS . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' X' ' 31' ' ' LEU . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.469 ' CE ' ' HB1' ' X' ' 29' ' ' ALA . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.476 HG13 ' N ' ' X' ' 39' ' ' LYS . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.742 0.306 . . . . 1.0 110.576 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.536 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 55' ' ' ARG . . . . . 0.427 ' O ' HG23 ' X' ' 59' ' ' VAL . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' X' ' 55' ' ' ARG . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.716 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HE ' ' X' ' 22' ' ' ARG . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.892 0.377 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' X' ' 15' ' ' LEU . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.501 HG13 ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 13' ' ' GLU . . . . . 0.501 ' N ' HG13 ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' X' ' 11' ' ' TYR . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 20' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.768 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.432 ' CG1' HG13 ' X' ' 26' ' ' VAL . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' X' ' 82' ' ' TYR . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.655 ' OH ' HD22 ' X' ' 32' ' ' LEU . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.582 HD11 HG21 ' X' ' 26' ' ' VAL . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.655 HD22 ' OH ' ' X' ' 28' ' ' TYR . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.472 ' O ' HG12 ' X' ' 38' ' ' VAL . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 35' ' ' PHE . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.908 0.385 . . . . 1.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.661 HD12 HD11 ' X' ' 90' ' ' ILE . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.815 HH21 HD13 ' X' ' 86' ' ' ILE . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.594 ' CD2' HG12 ' X' ' 26' ' ' VAL . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.422 ' HA ' HD12 ' X' ' 86' ' ' ILE . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.515 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.815 HD13 HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.768 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.661 HD11 HD12 ' X' ' 53' ' ' ILE . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.838 0.351 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 8' ' ' HIS . . . . . 0.576 ' CG ' ' HZ3' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' X' ' 32' ' ' LEU . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' X' ' 22' ' ' ARG . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.589 ' CZ ' HD23 ' X' ' 89' ' ' LEU . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' X' ' 82' ' ' TYR . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.516 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.601 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 32' ' ' LEU . . . . . 0.579 HD11 ' HG2' ' X' ' 9' ' ' GLU . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.601 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.498 HG13 ' N ' ' X' ' 39' ' ' LYS . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.403 HG21 ' HE ' ' X' ' 57' ' ' ARG . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.431 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 66' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.49 HG23 HH12 ' X' ' 22' ' ' ARG . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.589 HD23 ' CZ ' ' X' ' 22' ' ' ARG . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.425 HD12 HG22 ' X' ' 86' ' ' ILE . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.818 0.342 . . . . 1.0 110.516 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.577 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' X' ' 11' ' ' TYR . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.434 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.515 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' X' ' 82' ' ' TYR . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' X' ' 31' ' ' LEU . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 37' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' X' ' 75' ' ' VAL . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.89 0.376 . . . . 1.0 110.258 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.704 HD12 HD11 ' X' ' 90' ' ' ILE . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.409 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.718 HH21 HD13 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 65' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' X' ' 64' ' ' GLN . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 71' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 72' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.495 HG21 ' CG ' ' X' ' 37' ' ' PHE . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.434 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.49 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.718 HD13 HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.515 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.704 HD11 HD12 ' X' ' 53' ' ' ILE . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.791 0.329 . . . . 1.0 110.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.597 ' CE2' HD11 ' X' ' 15' ' ' LEU . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' X' ' 11' ' ' TYR . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 19' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.558 ' O ' HD12 ' X' ' 85' ' ' LEU . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.567 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.596 HG22 ' H ' ' X' ' 54' ' ' LYS . 23.5 mt . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.992 0.425 . . . . 1.0 110.174 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.659 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.596 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.659 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 58' ' ' ARG . . . . . 0.483 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.808 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.558 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.808 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.413 HD13 ' HD2' ' X' ' 22' ' ' ARG . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.622 HD11 HD12 ' X' ' 53' ' ' ILE . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' X' X ' 6' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 1.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 11' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' X' ' 15' ' ' LEU . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 15' ' ' LEU . . . . . 0.559 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 22' ' ' ARG . . . . . 0.681 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 28' ' ' TYR . . . . . 0.495 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 29' ' ' ALA . . . . . 0.459 ' HB1' ' CG ' ' X' ' 33' ' ' LYS . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 31' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' X' ' 82' ' ' TYR . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB1' ' X' ' 29' ' ' ALA . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 38' ' ' VAL . . . . . 0.537 HG13 ' N ' ' X' ' 39' ' ' LYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 39' ' ' LYS . . . . . 0.537 ' N ' HG13 ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' X' X ' 51' ' ' ILE . . . . . 0.458 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.805 0.336 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 53' ' ' ILE . . . . . 0.643 HD12 HD11 ' X' ' 90' ' ' ILE . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 54' ' ' LYS . . . . . 0.458 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 64' ' ' GLN . . . . . 0.495 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 77' ' ' VAL . . . . . 0.495 ' HA ' HE22 ' X' ' 64' ' ' GLN . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 80' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 82' ' ' TYR . . . . . 0.657 ' CZ ' HD21 ' X' ' 31' ' ' LEU . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' X' X ' 83' ' ' TRP . . . . . 0.516 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 85' ' ' LEU . . . . . 0.681 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 86' ' ' ILE . . . . . 0.474 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 87' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 89' ' ' LEU . . . . . 0.621 HD13 ' CZ ' ' X' ' 22' ' ' ARG . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 90' ' ' ILE . . . . . 0.643 HD11 HD12 ' X' ' 53' ' ' ILE . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.04 98.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -107.74 120.6 42.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 1.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.83 -43.24 93.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.879 HD21 HH21 ' X' ' 10' ' ' ARG . 37.0 tp -108.69 130.34 55.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -145.44 159.95 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.327 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.879 HH21 HD21 ' X' ' 5' ' ' LEU . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' X' ' 15' ' ' LEU . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.429 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.695 ' O ' HD12 ' X' ' 85' ' ' LEU . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 27' ' ' LYS . . . . . 0.459 ' N ' HG12 ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.408 ' N ' HG13 ' X' ' 38' ' ' VAL . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.98 -48.41 53.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -99.09 -12.04 20.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 1.0 110.855 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -141.94 89.47 8.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.439 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -2.11 11.93 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.15 1.9 . . . . 1.0 112.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.606 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 1.5 p90 -102.71 160.26 14.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.06 0.457 . . . . 1.0 110.366 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -144.57 67.46 14.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.62 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -54.09 144.04 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.758 2.305 . . . . 1.0 112.233 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -126.87 141.25 51.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.527 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 48' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' X' ' 55' ' ' ARG . 95.9 mt-10 -139.68 172.22 13.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.563 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.35 -37.49 92.02 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.421 ' O ' ' C ' ' X' ' 51' ' ' ILE . 70.9 p -79.03 165.43 23.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.434 HG22 ' H ' ' X' ' 54' ' ' LYS . 70.0 mt -36.7 107.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.366 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.741 HD12 HD11 ' X' ' 90' ' ' ILE . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.434 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' X' ' 48' ' ' GLU . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.695 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.741 HD11 HD12 ' X' ' 53' ' ' ILE . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.81 -44.24 86.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.63 -40.74 95.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.244 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' X' ' 95' ' ' VAL . 57.2 mtpt -62.22 -41.48 98.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.659 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.87 -3.38 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.61 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.5 t -116.8 132.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.336 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.92 73.02 0.64 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.27 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.8 141.54 92.47 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.557 2.171 . . . . 1.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -131.08 147.84 52.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.345 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.03 133.6 68.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.578 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.247 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.09 2.84 77.05 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 3' ' ' GLN . . . . . 0.4 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mm-40 -63.36 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 1.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.04 90.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.531 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' X' ' 9' ' ' GLU . 89.2 mt -64.04 -47.24 81.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 1.0 110.662 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p -150.78 -172.86 4.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.654 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' X' ' 5' ' ' LEU . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.565 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.465 HD22 ' HE1' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.709 ' HE ' HD13 ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.633 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.14 -45.21 92.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -97.67 -4.69 36.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.506 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.66 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -162.17 84.85 1.59 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.249 0.547 . . . . 1.0 110.49 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.525 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 35.1 Cg_exo -61.54 -31.47 87.38 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.476 2.117 . . . . 1.0 111.686 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.66 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.8 p90 -74.18 150.94 40.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.349 0.595 . . . . 1.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.592 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -163.5 43.66 0.1 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.272 -0.876 . . . . 1.0 110.809 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 49.3 Cg_exo -36.14 148.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.982 2.455 . . . . 1.0 112.46 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.43 HE22 HG12 ' X' ' 53' ' ' ILE . 98.9 mm-40 -134.18 135.24 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.568 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.07 175.08 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.444 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.94 97.19 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -85.33 164.19 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 1.0 110.151 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt -52.23 108.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.291 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.901 ' NH2' HG21 ' X' ' 86' ' ' ILE . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.459 ' O ' HG23 ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 69' ' ' THR . . . . . 0.459 HG23 ' O ' ' X' ' 65' ' ' ASP . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.908 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.687 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.908 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.709 HD13 ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' X' ' 93' ' ' LYS . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.18 -53.56 56.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -66.87 -42.26 85.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.382 . . . . 1.0 110.744 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' X' ' 90' ' ' ILE . 62.3 mmtt -114.1 119.02 35.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.175 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -101.73 -4.89 25.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.85 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.906 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -121.96 85.32 45.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.446 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.9 145.47 96.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.812 2.342 . . . . 1.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.48 154.48 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -124.96 135.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.465 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.575 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.53 -40.97 96.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.02 147.97 45.41 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.759 0.314 . . . . 1.0 110.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -108.68 122.66 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.26 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.5 tp -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -145.65 163.69 34.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.287 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.496 HD11 ' CE2' ' X' ' 11' ' ' TYR . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' X' ' 82' ' ' TYR . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.586 ' O ' HD12 ' X' ' 85' ' ' LEU . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.505 ' HE2' HE22 ' X' ' 64' ' ' GLN . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -57.74 -49.6 76.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -95.28 -56.02 2.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.219 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' X' ' 38' ' ' VAL . 31.2 t 45.93 61.88 11.96 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.441 . . . . 1.0 111.248 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.74 -26.43 13.6 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.548 2.166 . . . . 1.0 110.787 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.625 ' HE1' HG21 ' X' ' 59' ' ' VAL . 0.0 OUTLIER -147.79 -168.58 3.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.559 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 173.47 -43.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.69 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -59.2 141.89 98.52 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.548 2.165 . . . . 1.0 112.715 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.531 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 69.3 tp60 -161.99 146.83 12.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.43 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -149.83 154.0 37.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.893 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.3 -32.79 6.34 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.354 -0.699 . . . . 1.0 111.354 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 67.0 p -139.65 167.27 22.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.322 -0.251 . . . . 1.0 110.322 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.467 HG22 ' H ' ' X' ' 54' ' ' LYS . 5.2 mt -35.42 126.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 O-C-N 123.535 0.522 . . . . 1.0 109.841 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.644 HD12 HD11 ' X' ' 90' ' ' ILE . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.467 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' X' ' 47' ' ' GLN . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.581 HH21 HD13 ' X' ' 86' ' ' ILE . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.625 HG21 ' HE1' ' X' ' 44' ' ' TRP . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' X' ' 60' ' ' GLY . 8.2 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' X' ' 64' ' ' GLN . 9.3 m-20 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.497 HG23 ' HG3' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.422 ' O ' ' OE1' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.837 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.586 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.837 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.509 HD22 ' HD2' ' X' ' 22' ' ' ARG . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.644 HD11 HD12 ' X' ' 53' ' ' ILE . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.08 -48.95 79.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.95 -45.02 87.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.187 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' X' ' 90' ' ' ILE . 98.8 mttt -135.96 154.92 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 57.65 26.77 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.275 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.83 -28.97 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.21 78.47 0.31 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' X' ' 99' ' ' VAL . 46.4 Cg_exo -55.2 -35.88 92.02 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.83 2.353 . . . . 1.0 111.734 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 52.08 -87.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' X' ' 97' ' ' PRO . 38.1 t -122.4 131.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.808 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.57 58.84 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -130.89 132.94 45.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.722 0.296 . . . . 1.0 110.604 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.71 -41.26 92.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -113.26 126.07 55.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p -149.48 173.56 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' X' ' 11' ' ' TYR . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' X' ' 89' ' ' LEU . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' X' ' 82' ' ' TYR . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.49 -52.22 14.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 72.5 p -98.75 -5.75 30.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 1.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.597 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.8 OUTLIER -147.49 85.53 6.69 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.238 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.13 -0.69 9.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.212 1.941 . . . . 1.0 112.631 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.597 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.1 p90 -103.54 157.88 16.75 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.265 0.555 . . . . 1.0 110.257 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -147.12 68.0 11.14 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.435 -0.802 . . . . 1.0 110.248 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.439 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 48.8 Cg_exo -53.65 141.14 64.88 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.688 2.259 . . . . 1.0 112.295 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -120.34 136.93 54.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.481 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.54 171.34 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.11 -40.6 93.83 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 23.7 p -82.56 164.6 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.579 HD11 ' OD2' ' X' ' 91' ' ' ASP . 57.6 mt -37.08 110.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.75 HD12 HD11 ' X' ' 90' ' ' ILE . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.465 ' H ' HG22 ' X' ' 51' ' ' ILE . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.597 HE22 ' HA ' ' X' ' 77' ' ' VAL . 8.3 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.597 ' HA ' HE22 ' X' ' 64' ' ' GLN . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.467 HG23 ' H ' ' X' ' 78' ' ' THR . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.418 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.456 HD13 HH21 ' X' ' 57' ' ' ARG . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 88' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' X' ' 92' ' ' LYS . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' X' ' 22' ' ' ARG . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.75 HD11 HD12 ' X' ' 53' ' ' ILE . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.579 ' OD2' HD11 ' X' ' 51' ' ' ILE . 75.5 m-20 -98.24 -6.56 30.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' X' ' 88' ' ' GLU . 10.8 mmpt? 44.3 86.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 1.0 110.565 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' X' ' 95' ' ' VAL . 89.0 tttt -63.91 -35.01 79.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.491 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -40.47 -22.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' X' ' 93' ' ' LYS . 9.5 m -126.86 135.2 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.599 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 161.13 23.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.517 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.03 151.5 67.53 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.705 2.27 . . . . 1.0 112.162 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.29 154.28 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.58 -46.03 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 43.6 ttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.484 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.79 154.93 53.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -118.11 127.26 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.859 0.361 . . . . 1.0 110.68 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.418 ' O ' ' OE2' ' X' ' 9' ' ' GLU . 79.8 mm-40 -70.09 -41.1 74.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.787 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.859 HD21 HH21 ' X' ' 10' ' ' ARG . 35.8 tp -109.73 129.12 55.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.54 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p -149.58 167.9 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.706 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' X' ' 4' ' ' GLU . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.859 HH21 HD21 ' X' ' 5' ' ' LEU . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.671 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.671 HD11 ' CE2' ' X' ' 11' ' ' TYR . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' X' ' 22' ' ' ARG . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.753 ' O ' HD12 ' X' ' 85' ' ' LEU . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' X' ' 82' ' ' TYR . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.18 -31.92 68.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -98.27 -4.47 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.022 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -162.87 110.49 1.05 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.615 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.13 -18.14 18.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.506 2.138 . . . . 1.0 111.94 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.618 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 3.7 p90 -88.63 -171.1 3.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.475 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 160.45 -54.01 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.434 -178.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_endo -63.25 143.42 89.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.688 2.259 . . . . 1.0 112.404 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.479 ' CD ' ' HE ' ' X' ' 55' ' ' ARG . 34.6 mt-30 -142.73 -153.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.277 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.15 129.37 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.27 -115.84 4.74 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.426 ' O ' ' C ' ' X' ' 51' ' ' ILE . 82.7 p -57.66 165.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.439 HG22 ' H ' ' X' ' 54' ' ' LYS . 54.9 mt -36.18 109.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.373 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.621 HD12 HD11 ' X' ' 90' ' ' ILE . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.439 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.479 ' HE ' ' CD ' ' X' ' 47' ' ' GLN . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.41 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.402 HG23 ' O ' ' X' ' 55' ' ' ARG . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.536 HE21 ' C ' ' X' ' 75' ' ' VAL . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.536 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.753 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.54 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' CH2' ' X' ' 83' ' ' TRP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.513 HD22 ' CD ' ' X' ' 22' ' ' ARG . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.621 HD11 HD12 ' X' ' 53' ' ' ILE . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 -59.23 -42.4 90.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -63.9 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.583 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -74.86 -10.99 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.49 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -53.1 -19.53 2.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.486 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.67 148.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.433 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' X' ' 97' ' ' PRO . 1.4 m-20 171.85 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.581 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' X' ' 96' ' ' ASN . 65.8 Cg_endo -75.35 151.82 38.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.787 2.325 . . . . 1.0 112.142 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -107.74 126.07 52.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.29 131.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.602 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.58 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.44 21.18 67.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -128.4 125.5 38.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.699 0.285 . . . . 1.0 110.603 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.77 116.48 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.364 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.5 -105.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.309 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -150.14 167.03 28.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.631 ' OE2' HD22 ' X' ' 32' ' ' LEU . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.405 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' X' ' 11' ' ' TYR . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.498 HD12 HG21 ' X' ' 24' ' ' VAL . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.835 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.498 HG21 HD12 ' X' ' 19' ' ' LEU . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.631 HD22 ' OE2' ' X' ' 9' ' ' GLU . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.436 ' CG ' HG11 ' X' ' 75' ' ' VAL . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' X' ' 42' ' ' CYS . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.02 -49.55 28.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 p -95.32 -5.91 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.608 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.615 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -148.65 80.6 8.19 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.061 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.41 -38.93 93.49 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.737 2.292 . . . . 1.0 112.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.615 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.8 p90 -66.22 -170.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.165 0.507 . . . . 1.0 110.677 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -179.87 -45.18 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.421 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.9 Cg_exo -67.76 150.46 79.0 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.788 2.325 . . . . 1.0 112.746 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' X' ' 55' ' ' ARG . 47.8 tp60 -163.66 154.91 16.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.333 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -116.71 140.27 49.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.654 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 -131.95 10.17 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.8 p -59.25 167.34 1.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.563 HG22 ' H ' ' X' ' 54' ' ' LYS . 7.6 mt -34.29 113.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.668 0.605 . . . . 1.0 110.005 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.635 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.563 ' H ' HG22 ' X' ' 51' ' ' ILE . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' X' ' 47' ' ' GLN . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.653 ' O ' HG23 ' X' ' 69' ' ' THR . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.555 ' OD1' HG13 ' X' ' 77' ' ' VAL . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 69' ' ' THR . . . . . 0.653 HG23 ' O ' ' X' ' 65' ' ' ASP . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.526 HG23 ' O ' ' X' ' 75' ' ' VAL . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.555 HG13 ' OD1' ' X' ' 68' ' ' ASN . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.863 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.48 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.608 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.863 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.835 HD22 ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.627 HD11 HD12 ' X' ' 53' ' ' ILE . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.67 -44.5 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.46 -41.72 97.66 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.029 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' X' ' 95' ' ' VAL . 98.6 mttt -63.98 -40.38 96.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -44.18 -17.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.517 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' X' ' 93' ' ' LYS . 53.7 t -119.83 129.44 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.266 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 54.1 69.02 2.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.48 -40.73 71.05 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.876 2.384 . . . . 1.0 112.152 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.74 137.59 55.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.368 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.58 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.691 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.6 24.22 56.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.13 133.21 46.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.334 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 41.6 tp10 -59.72 -44.6 93.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.475 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.732 HD21 HH21 ' X' ' 10' ' ' ARG . 44.5 tp -111.65 126.75 55.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.454 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -148.03 162.45 39.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.38 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.732 HH21 HD21 ' X' ' 5' ' ' LEU . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.436 HD12 HG21 ' X' ' 24' ' ' VAL . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.436 HG21 HD12 ' X' ' 19' ' ' LEU . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.417 HG22 HG12 ' X' ' 24' ' ' VAL . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 31' ' ' LEU . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.425 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.17 -40.98 95.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.2 p -98.3 -4.87 34.14 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.87 0.367 . . . . 1.0 111.257 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.61 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.0 OUTLIER -164.59 98.29 0.88 Allowed Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.512 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.64 -4.88 15.84 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.147 1.898 . . . . 1.0 111.496 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.472 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 2.3 p90 -100.91 -174.2 2.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.328 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.7 -41.57 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.494 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_exo -60.32 142.16 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.452 2.101 . . . . 1.0 112.586 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.504 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 51.5 tt0 -174.66 163.04 3.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.442 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -117.54 150.33 39.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.567 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.97 -128.27 7.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 18.2 p -68.79 165.32 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.453 HG22 ' H ' ' X' ' 54' ' ' LYS . 43.9 mt -36.68 107.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.952 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.699 ' NZ ' ' HE ' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.553 ' O ' HG23 ' X' ' 59' ' ' VAL . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.699 ' HE ' ' NZ ' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.553 HG23 ' O ' ' X' ' 55' ' ' ARG . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.57 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.564 HD11 HD12 ' X' ' 53' ' ' ILE . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.56 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.22 -41.82 98.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 1.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' X' ' 95' ' ' VAL . 66.0 mttm -48.42 137.66 11.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.181 0.515 . . . . 1.0 110.193 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.63 4.25 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.964 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' X' ' 93' ' ' LYS . 95.4 t -76.91 95.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 58.33 71.9 0.95 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.602 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.64 145.25 98.61 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.843 2.362 . . . . 1.0 112.201 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -65.43 -45.04 85.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.716 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.14 134.67 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.22 -0.447 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.667 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.73 -166.9 45.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -103.56 132.67 49.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.65 0.262 . . . . 1.0 110.416 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 4' ' ' GLU . . . . . 0.597 ' C ' HD23 ' X' ' 5' ' ' LEU . 84.5 tt0 -108.69 120.0 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.744 HD23 ' N ' ' X' ' 5' ' ' LEU . 0.0 OUTLIER -103.21 -70.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.448 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t -147.58 149.02 31.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.46 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.71 ' OE1' HD12 ' X' ' 5' ' ' LEU . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.402 HD23 ' HD2' ' X' ' 22' ' ' ARG . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.642 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.505 ' CE2' HD22 ' X' ' 32' ' ' LEU . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.635 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' X' ' 28' ' ' TYR . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.635 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.666 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.517 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.99 -47.18 81.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.474 ' C ' ' SG ' ' X' ' 42' ' ' CYS . 69.5 p -99.92 -53.43 3.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 1.0 110.977 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.666 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.5 OUTLIER 37.02 64.79 2.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.93 -34.57 98.5 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.307 2.005 . . . . 1.0 110.982 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -129.33 -160.1 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.506 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.604 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 158.97 -37.83 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.23 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -60.68 148.93 90.0 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.537 2.158 . . . . 1.0 112.649 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' X' ' 48' ' ' GLU . 37.8 tt0 -96.68 157.75 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.597 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 48' ' ' GLU . . . . . 0.492 ' CD ' HH22 ' X' ' 55' ' ' ARG . 97.9 mt-10 -134.69 -112.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.412 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.07 2.74 19.2 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -133.33 163.4 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.7 0.286 . . . . 1.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.456 HG23 HD13 ' X' ' 90' ' ' ILE . 26.7 mt -39.82 108.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.337 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.624 HD12 HD11 ' X' ' 90' ' ' ILE . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.492 HH22 ' CD ' ' X' ' 48' ' ' GLU . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.542 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.582 ' OE1' HG12 ' X' ' 77' ' ' VAL . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.46 HD22 ' N ' ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.582 HG12 ' OE1' ' X' ' 64' ' ' GLN . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.681 ' OH ' HD11 ' X' ' 86' ' ' ILE . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.642 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.681 HD11 ' OH ' ' X' ' 82' ' ' TYR . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.611 HD22 ' NE ' ' X' ' 22' ' ' ARG . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.624 HD11 HD12 ' X' ' 53' ' ' ILE . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.58 -47.32 63.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.476 ' O ' HG23 ' X' ' 95' ' ' VAL . 51.7 mtmt -62.82 -39.07 93.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 1.0 110.575 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' X' ' 90' ' ' ILE . 97.0 mttt -91.64 171.93 8.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 55.7 32.53 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.347 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.476 HG23 ' O ' ' X' ' 92' ' ' LYS . 51.6 t -64.92 -44.07 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 1.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -162.17 76.24 2.15 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.688 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.47 144.43 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.023 2.482 . . . . 1.0 112.062 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.44 125.75 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.62 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.16 -45.93 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.518 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 51.6 ttp . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.953 -1.022 . . . . 1.0 110.656 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.591 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.64 63.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -117.31 126.23 52.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.885 0.374 . . . . 1.0 110.53 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.19 -39.94 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.505 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -114.76 129.55 56.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.565 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p -142.61 162.86 34.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.556 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.485 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.401 ' HA ' HH11 ' X' ' 22' ' ' ARG . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' X' ' 89' ' ' LEU . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' X' ' 42' ' ' CYS . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.459 ' N ' HG13 ' X' ' 38' ' ' VAL . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -61.86 -46.05 91.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.3 p -97.68 -17.36 19.5 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.532 ' N ' ' HD3' ' X' ' 43' ' ' PRO . 0.0 OUTLIER 39.32 57.2 6.24 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-O 121.747 0.784 . . . . 1.0 110.979 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' X' ' 44' ' ' TRP . 8.3 Cg_exo -70.16 -27.65 24.27 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.019 1.813 . . . . 1.0 112.223 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.541 ' O ' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 50.86 119.16 0.0 OUTLIER 'General case' 0 C--N 1.339 0.146 0 O-C-N 123.645 0.591 . . . . 1.0 110.829 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' X' ' 59' ' ' VAL . 24.4 m-85 -118.88 57.9 3.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.488 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.433 ' HA ' HH11 ' X' ' 55' ' ' ARG . 71.6 Cg_exo -31.5 134.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.147 2.564 . . . . 1.0 112.762 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -153.09 148.63 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.51 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -140.87 143.11 34.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.658 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.08 63.85 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.3 p -129.57 164.66 23.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.343 . . . . 1.0 110.345 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.51 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt -40.91 125.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.198 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.545 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.51 ' H ' HG22 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' X' ' 45' ' ' PHE . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.47 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.644 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.501 HD13 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.718 HD22 ' NE ' ' X' ' 22' ' ' ARG . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' X' ' 93' ' ' LYS . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' X' ' 92' ' ' LYS . 3.8 p-10 -58.77 -44.37 90.61 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.575 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 67.2 mttm -65.31 -44.55 87.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.752 0.31 . . . . 1.0 110.895 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' X' ' 90' ' ' ILE . 99.3 mttt -134.97 139.48 44.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.179 0.514 . . . . 1.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.35 -4.36 59.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.185 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.19 161.18 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.764 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -137.75 75.53 43.05 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.675 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.9 142.7 98.39 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.889 2.393 . . . . 1.0 111.974 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -65.64 -41.89 92.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.495 HG23 ' N ' ' X' ' 100' ' ' MET . 33.6 m -65.14 -42.12 93.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 100' ' ' MET . . . . . 0.495 ' N ' HG23 ' X' ' 99' ' ' VAL . 42.9 ttp . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.986 -1.006 . . . . 1.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.76 173.5 55.04 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -108.73 129.41 55.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.7 0.286 . . . . 1.0 110.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.42 -45.86 89.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 39.7 tp -110.64 129.99 55.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -147.5 162.08 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.211 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' O ' HG12 ' X' ' 12' ' ' VAL . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.67 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' X' ' 24' ' ' VAL . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.815 ' HE ' HD13 ' X' ' 89' ' ' LEU . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' X' ' 82' ' ' TYR . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.498 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 -60.72 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 48.3 p -98.85 -34.22 10.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.752 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.9 OUTLIER -117.89 84.48 20.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.701 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.71 -2.63 12.72 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.035 1.823 . . . . 1.0 111.967 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.665 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.7 p90 -99.17 151.83 20.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.269 0.557 . . . . 1.0 110.834 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 5.0 p90 -167.81 46.2 0.1 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.23 -0.895 . . . . 1.0 110.62 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 43.8 Cg_endo -65.78 161.93 36.95 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 123.21 2.607 . . . . 1.0 112.746 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -108.6 155.81 20.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.699 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 48' ' ' GLU . . . . . 0.558 ' CD ' HH21 ' X' ' 55' ' ' ARG . 97.1 mt-10 -137.93 46.37 2.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 6.74 73.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.419 ' O ' ' C ' ' X' ' 51' ' ' ILE . 2.2 t -137.65 163.95 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.562 HG22 ' H ' ' X' ' 54' ' ' LYS . 57.7 mt -36.89 108.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.243 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.681 HD12 HD11 ' X' ' 90' ' ' ILE . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.562 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.558 HH21 ' CD ' ' X' ' 48' ' ' GLU . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.756 HE22 ' CG ' ' X' ' 68' ' ' ASN . 0.0 OUTLIER -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.557 ' O ' HG23 ' X' ' 69' ' ' THR . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.756 ' CG ' HE22 ' X' ' 64' ' ' GLN . 3.6 m-20 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 69' ' ' THR . . . . . 0.557 HG23 ' O ' ' X' ' 65' ' ' ASP . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.447 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.494 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.609 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.815 HD13 ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.681 HD11 HD12 ' X' ' 53' ' ' ILE . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -51.43 -46.69 63.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.93 -40.64 96.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.117 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.69 163.09 24.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.738 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 56.82 12.12 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -125.9 133.52 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 13.6 t-20 47.68 55.17 16.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.492 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 39.2 Cg_endo -67.51 147.59 77.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.763 2.309 . . . . 1.0 112.152 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -138.1 158.15 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.549 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.99 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.607 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.92 96.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.885 -0.886 . . . . 1.0 110.885 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -114.46 127.13 55.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 1.0 110.665 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 -38.61 87.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.498 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -104.74 129.17 53.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -135.94 164.37 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.541 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.55 ' HZ2' HD12 ' X' ' 31' ' ' LEU . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.776 ' O ' HG23 ' X' ' 21' ' ' THR . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.608 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.439 ' HA ' HH11 ' X' ' 22' ' ' ARG . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.776 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.758 ' NE ' HD13 ' X' ' 89' ' ' LEU . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' X' ' 82' ' ' TYR . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.55 HD12 ' HZ2' ' X' ' 16' ' ' LYS . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.472 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.12 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 41' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 23.7 m -94.72 -51.44 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.336 -0.546 . . . . 1.0 110.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.601 ' N ' ' O ' ' X' ' 38' ' ' VAL . 23.5 p 39.24 59.3 6.1 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.676 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.37 -31.62 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.733 2.289 . . . . 1.0 111.119 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.748 ' HE1' HG21 ' X' ' 59' ' ' VAL . 0.0 OUTLIER -141.28 -173.06 3.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.485 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.598 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 161.92 -40.05 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.662 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_exo -62.12 144.72 96.22 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.893 2.395 . . . . 1.0 112.264 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' X' ' 51' ' ' ILE . 27.2 mt-30 -147.37 166.44 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.461 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -143.78 115.81 8.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.84 5.95 88.6 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 82.2 p -137.54 163.05 32.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.796 0.331 . . . . 1.0 110.657 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.611 ' O ' ' NE2' ' X' ' 47' ' ' GLN . 6.0 mt -59.55 126.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.885 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.495 ' OD1' ' CE1' ' X' ' 45' ' ' PHE . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.63 HD12 HD11 ' X' ' 90' ' ' ILE . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.44 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.473 ' O ' HG23 ' X' ' 59' ' ' VAL . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.436 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.748 HG21 ' HE1' ' X' ' 44' ' ' TRP . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 67' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' X' ' 73' ' ' GLU . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.43 ' HB2' ' CD2' ' X' ' 67' ' ' TYR . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.422 ' HA ' HD22 ' X' ' 68' ' ' ASN . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.607 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.407 ' H ' HG23 ' X' ' 78' ' ' THR . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' X' ' 26' ' ' VAL . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.44 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.758 HD13 ' NE ' ' X' ' 22' ' ' ARG . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.63 HD11 HD12 ' X' ' 53' ' ' ILE . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.78 -49.33 78.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -64.85 -41.11 95.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 1.0 110.615 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' X' ' 95' ' ' VAL . 64.1 tttp -63.37 -42.29 98.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.732 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -43.78 -17.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.635 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' X' ' 93' ' ' LYS . 30.7 m -132.32 159.78 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' X' ' 95' ' ' VAL . 0.9 OUTLIER 56.62 159.16 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.611 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 153.57 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.801 2.334 . . . . 1.0 112.218 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 98' ' ' GLN . . . . . 0.512 ' OE1' ' NZ ' ' X' ' 93' ' ' LYS . 57.1 tt0 -69.78 120.43 15.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.34 -33.51 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.421 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.656 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.24 -177.99 39.73 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.72 148.3 50.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.0 110.611 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.61 -39.54 80.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -104.82 123.72 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -132.03 156.97 45.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.252 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' X' ' 11' ' ' TYR . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.468 ' HZ2' ' NZ ' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.468 ' NZ ' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.513 ' O ' HD12 ' X' ' 85' ' ' LEU . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.811 HG22 ' SG ' ' X' ' 42' ' ' CYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.37 -48.41 81.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -99.47 -5.04 30.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.867 0.365 . . . . 1.0 111.35 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.811 ' SG ' HG22 ' X' ' 38' ' ' VAL . 0.0 OUTLIER -159.34 93.55 1.79 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.114 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.544 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 25.6 Cg_exo -59.98 -0.41 0.87 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.234 1.956 . . . . 1.0 111.891 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.687 ' CD2' ' SG ' ' X' ' 42' ' ' CYS . 0.3 OUTLIER -67.53 130.17 42.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.635 0.731 . . . . 1.0 110.655 -178.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.594 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -155.28 39.5 0.11 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.683 -1.144 . . . . 1.0 110.451 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 44.6 Cg_endo -64.85 148.87 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.604 2.203 . . . . 1.0 112.499 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -145.12 92.15 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.903 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -172.41 147.21 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.05 -157.57 51.37 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.212 -0.755 . . . . 1.0 111.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.433 ' O ' ' C ' ' X' ' 51' ' ' ILE . 43.6 p -47.91 165.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' X' ' 50' ' ' THR . 22.7 mt -35.68 109.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 O-C-N 123.621 0.576 . . . . 1.0 110.006 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' X' ' 86' ' ' ILE . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' X' ' 75' ' ' VAL . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.642 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.513 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' X' ' 53' ' ' ILE . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.642 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 88' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.489 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 -57.23 -50.65 72.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.641 ' O ' HG22 ' X' ' 95' ' ' VAL . 70.7 mmtt -66.8 -42.34 86.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.359 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' X' ' 95' ' ' VAL . 88.6 tttt -65.42 -34.98 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.424 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -42.2 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.633 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.641 HG22 ' O ' ' X' ' 92' ' ' LYS . 31.8 m -65.07 -26.1 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' X' ' 99' ' ' VAL . 3.2 m-20 55.59 78.07 0.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.355 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.9 -31.53 73.76 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.866 2.377 . . . . 1.0 112.103 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.43 -37.14 79.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.575 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' X' ' 96' ' ' ASN . 46.8 t -122.27 132.49 70.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.663 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.567 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.59 41.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.701 -0.959 . . . . 1.0 110.701 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -134.08 155.33 50.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 1.0 110.406 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -66.26 -37.89 86.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 24.6 tp -105.03 127.22 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.408 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -136.36 147.95 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.459 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.419 ' O ' HG23 ' X' ' 21' ' ' THR . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.498 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.419 HG23 ' O ' ' X' ' 17' ' ' GLN . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.723 ' O ' HD12 ' X' ' 85' ' ' LEU . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.528 HG12 HG22 ' X' ' 26' ' ' VAL . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.528 HG22 HG12 ' X' ' 24' ' ' VAL . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.527 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.42 ' N ' HG13 ' X' ' 38' ' ' VAL . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.44 -48.97 77.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -97.88 -18.18 18.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.889 0.376 . . . . 1.0 111.447 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.4 OUTLIER -141.99 84.23 11.98 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.519 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.06 -38.01 96.9 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.022 2.481 . . . . 1.0 111.977 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.642 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 10.3 p90 -70.78 138.0 50.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.995 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 19.0 p90 -151.01 42.49 0.23 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.764 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 50.6 Cg_exo -41.61 153.61 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.659 2.239 . . . . 1.0 112.537 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.464 ' NE2' HD11 ' X' ' 53' ' ' ILE . 44.6 tt0 -151.05 158.03 43.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.422 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 48' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' X' ' 50' ' ' THR . 85.4 tt0 -140.39 158.17 44.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -36.87 -54.83 1.43 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.405 ' O ' ' O ' ' X' ' 48' ' ' GLU . 80.6 p -74.69 164.13 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.427 ' H ' HG13 ' X' ' 51' ' ' ILE . 32.2 mt -50.61 109.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.235 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.464 HD11 ' NE2' ' X' ' 47' ' ' GLN . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.41 ' CG ' HG22 ' X' ' 51' ' ' ILE . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.834 ' NH2' HG21 ' X' ' 86' ' ' ILE . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.723 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.834 HG21 ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' X' ' 91' ' ' ASP . 46.8 t0 -41.88 -30.3 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.81 -42.02 98.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.196 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' X' ' 95' ' ' VAL . 99.1 mttt -64.34 156.41 29.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.077 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 58.13 4.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.8 t -124.08 128.89 74.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.352 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.428 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 76.8 m-20 46.52 54.7 15.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.8 Cg_endo -65.76 -22.51 56.9 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.778 2.319 . . . . 1.0 112.15 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -64.67 -42.88 95.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.583 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -123.0 133.61 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.398 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.544 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.68 -175.14 50.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -134.59 160.73 37.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.663 0.268 . . . . 1.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -113.68 128.09 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.804 HD21 HH21 ' X' ' 10' ' ' ARG . 36.1 tp -106.9 128.79 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.593 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p -149.04 163.31 37.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.647 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.404 ' O ' HG12 ' X' ' 12' ' ' VAL . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.804 HH21 HD21 ' X' ' 5' ' ' LEU . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.429 HD23 ' HD2' ' X' ' 22' ' ' ARG . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.728 ' O ' HD12 ' X' ' 85' ' ' LEU . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' X' ' 82' ' ' TYR . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.446 ' CG ' HG21 ' X' ' 75' ' ' VAL . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.489 ' N ' HG13 ' X' ' 38' ' ' VAL . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.22 -52.45 14.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 p -97.99 -4.62 35.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.047 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -146.05 83.86 8.38 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 1.0 110.37 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.47 -39.0 89.85 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.52 2.147 . . . . 1.0 111.555 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.588 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 8.7 p90 -68.67 -168.51 0.12 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 160.25 -56.74 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.484 -178.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 23.6 Cg_endo -57.85 141.99 96.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.644 2.23 . . . . 1.0 112.376 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.545 ' H ' ' CG ' ' X' ' 52' ' ' ASP . 53.3 tt0 -155.98 155.28 32.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.98 162.34 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.676 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 -117.19 5.67 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 16.7 p -67.74 167.5 13.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.198 -0.297 . . . . 1.0 110.198 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.522 HG22 ' H ' ' X' ' 54' ' ' LYS . 3.9 mt -34.77 110.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' X' ' 47' ' ' GLN . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.522 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.524 ' NE ' ' OE1' ' X' ' 47' ' ' GLN . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 68' ' ' ASN . . . . . 0.474 HD22 ' N ' ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.446 HG21 ' CG ' ' X' ' 37' ' ' PHE . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.463 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.728 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' X' ' 53' ' ' ILE . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' X' ' 22' ' ' ARG . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.424 HD12 HG22 ' X' ' 86' ' ' ILE . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -51.56 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -43.11 98.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.974 0.416 . . . . 1.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' X' ' 95' ' ' VAL . 60.9 mttm -60.53 -41.84 95.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.652 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -47.55 -14.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.414 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' X' ' 93' ' ' LYS . 55.3 t -122.02 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.937 0.399 . . . . 1.0 110.347 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 0.2 OUTLIER 177.4 -44.2 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.669 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 33.4 Cg_exo -59.8 146.67 95.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.771 2.314 . . . . 1.0 112.213 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -66.96 -38.34 85.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.705 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 147.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.516 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.585 179.829 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 2' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . -66.0 -36.73 92.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.33 -43.24 95.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.922 0.391 . . . . 1.0 110.67 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.3 -43.0 74.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.618 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.474 HD12 ' OE1' ' X' ' 9' ' ' GLU . 33.8 tp -122.82 131.69 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.597 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p -143.41 163.91 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.525 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.474 ' OE1' HD12 ' X' ' 5' ' ' LEU . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 17' ' ' GLN . . . . . 0.422 ' O ' HG23 ' X' ' 21' ' ' THR . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.548 HD23 ' HE1' ' X' ' 82' ' ' TYR . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 21' ' ' THR . . . . . 0.422 HG23 ' O ' ' X' ' 17' ' ' GLN . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.716 ' O ' HD12 ' X' ' 85' ' ' LEU . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' CE ' ' X' ' 33' ' ' LYS . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' X' ' 31' ' ' LEU . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.469 ' CE ' ' HB1' ' X' ' 29' ' ' ALA . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.8 -51.09 61.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -98.17 -10.42 24.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.261 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.719 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -147.41 82.65 8.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.486 0.66 . . . . 1.0 110.41 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.0 -27.6 79.7 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.297 1.998 . . . . 1.0 111.59 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.719 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 12.6 p90 -74.64 145.08 43.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.304 0.573 . . . . 1.0 110.63 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.585 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 57.9 t80 -157.1 44.59 0.21 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 87.2 Cg_exo -37.14 149.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.844 2.363 . . . . 1.0 112.266 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -132.28 131.81 42.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.373 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -128.82 -178.63 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.562 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.98 83.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 46.0 p -81.68 164.61 21.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 1.0 110.402 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt -46.16 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.576 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' X' ' 46' ' ' PRO . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.536 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.427 ' O ' HG23 ' X' ' 59' ' ' VAL . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' X' ' 55' ' ' ARG . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.716 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 88' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HE ' ' X' ' 22' ' ' ARG . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 -62.4 -49.49 75.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 92' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' X' ' 88' ' ' GLU . 66.8 mmtt -64.15 -40.44 96.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' X' ' 95' ' ' VAL . 65.2 tttm -80.69 134.43 35.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.47 . . . . 1.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -142.18 4.63 1.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.875 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.444 ' O ' ' NZ ' ' X' ' 93' ' ' LYS . 69.5 t -122.33 134.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.266 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.2 159.22 59.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.667 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 147.78 70.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.836 2.357 . . . . 1.0 111.874 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -135.8 155.39 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.28 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.93 129.3 75.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.481 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.562 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.18 93.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 53.35 -172.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.644 0.259 . . . . 1.0 110.386 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -110.53 117.96 34.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.808 HD21 ' NH2' ' X' ' 10' ' ' ARG . 37.4 tp -103.87 125.57 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p -138.98 163.04 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.675 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.808 ' NH2' HD21 ' X' ' 5' ' ' LEU . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' X' ' 15' ' ' LEU . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.501 HG13 ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 13' ' ' GLU . . . . . 0.501 ' N ' HG13 ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' X' ' 11' ' ' TYR . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 20' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.768 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.432 ' CG1' HG13 ' X' ' 26' ' ' VAL . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' X' ' 82' ' ' TYR . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.655 ' OH ' HD22 ' X' ' 32' ' ' LEU . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.582 HD11 HG21 ' X' ' 26' ' ' VAL . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.655 HD22 ' OH ' ' X' ' 28' ' ' TYR . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.472 ' O ' HG12 ' X' ' 38' ' ' VAL . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.21 -48.6 78.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 22.7 p -94.59 -55.49 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' X' ' 38' ' ' VAL . 35.5 t 45.53 61.43 12.31 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.959 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' X' ' 42' ' ' CYS . 20.6 Cg_exo -66.08 -31.28 46.07 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.553 2.168 . . . . 1.0 111.157 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.618 ' HE1' ' CG2' ' X' ' 59' ' ' VAL . 0.0 OUTLIER -148.34 -179.84 7.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.316 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 177.33 -45.45 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.245 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.5 Cg_exo -70.01 123.47 10.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.975 2.45 . . . . 1.0 111.856 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -152.54 151.81 31.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.369 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -145.59 121.61 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -78.91 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.321 -0.712 . . . . 1.0 111.321 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -77.37 164.12 25.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.945 0.402 . . . . 1.0 110.426 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt -49.1 117.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.435 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.661 HD12 HD11 ' X' ' 90' ' ' ILE . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.815 HH21 HD13 ' X' ' 86' ' ' ILE . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 59' ' ' VAL . . . . . 0.618 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.9 OUTLIER -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.594 ' CD2' HG12 ' X' ' 26' ' ' VAL . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.422 ' HA ' HD12 ' X' ' 86' ' ' ILE . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.515 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.815 HD13 HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.768 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.661 HD11 HD12 ' X' ' 53' ' ' ILE . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -50.56 -43.58 56.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -63.61 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 1.0 110.506 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.15 136.22 49.91 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.366 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -96.5 -4.5 41.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.25 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.21 161.9 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.633 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -166.97 74.98 1.06 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 1.0 110.605 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -60.88 148.76 91.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.046 2.497 . . . . 1.0 111.875 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -129.83 150.73 51.0 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.618 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.32 -46.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.463 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.674 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.284 -0.635 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 5.23 69.92 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 3' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' X' ' 5' ' ' LEU . 54.5 tt0 -139.09 149.17 44.24 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.418 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -64.84 -42.63 94.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.885 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.698 HD21 HH21 ' X' ' 10' ' ' ARG . 31.0 tp -109.4 131.46 55.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.414 . . . . 1.0 110.504 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p -149.24 166.09 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 8' ' ' HIS . . . . . 0.576 ' CG ' ' HZ3' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' X' ' 32' ' ' LEU . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 10' ' ' ARG . . . . . 0.698 HH21 HD21 ' X' ' 5' ' ' LEU . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' X' ' 22' ' ' ARG . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.589 ' CZ ' HD23 ' X' ' 89' ' ' LEU . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' X' ' 82' ' ' TYR . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.516 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.601 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 32' ' ' LEU . . . . . 0.579 HD11 ' HG2' ' X' ' 9' ' ' GLU . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.601 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' X' ' 42' ' ' CYS . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.85 -50.65 72.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -98.46 -26.49 14.43 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.178 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -127.15 82.18 68.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.443 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.09 -30.47 91.53 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.977 2.451 . . . . 1.0 111.81 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.647 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 8.5 p90 -76.78 144.85 38.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.42 0.629 . . . . 1.0 111.215 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.591 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 6.6 p90 -163.99 43.22 0.09 OUTLIER Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.666 -1.152 . . . . 1.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.2 Cg_endo -64.36 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.945 2.43 . . . . 1.0 111.802 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.494 HE22 ' NH1' ' X' ' 55' ' ' ARG . 87.6 mt-30 58.15 130.91 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.012 0.434 . . . . 1.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -147.02 -17.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.535 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.36 -103.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.402 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.9 p -66.69 164.24 17.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' X' ' 50' ' ' THR . 12.6 mt -39.83 108.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.403 HG21 ' HE ' ' X' ' 57' ' ' ARG . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.494 ' NH1' HE22 ' X' ' 47' ' ' GLN . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.431 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 66' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.49 HG23 HH12 ' X' ' 22' ' ' ARG . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.589 HD23 ' CZ ' ' X' ' 22' ' ' ARG . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.585 ' O ' HG23 ' X' ' 95' ' ' VAL . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.03 -47.52 86.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.77 -45.03 88.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.731 0.3 . . . . 1.0 111.311 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' X' ' 94' ' ' GLU . 68.3 mttm -142.07 163.92 31.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.546 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 94' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' X' ' 93' ' ' LYS . 30.0 tt0 83.83 22.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.606 0.567 . . . . 1.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.585 HG23 ' O ' ' X' ' 90' ' ' ILE . 38.6 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 48.71 75.24 0.68 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.515 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.45 147.66 90.38 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.103 2.535 . . . . 1.0 112.202 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.542 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.84 132.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.496 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.363 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 2' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . 103.38 167.05 25.62 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.24 -38.68 92.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.382 . . . . 1.0 110.701 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -50.94 69.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' X' ' 2' ' ' GLY . 35.3 tp -115.39 130.96 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.519 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p -147.8 162.94 38.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.577 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' X' ' 11' ' ' TYR . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.434 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.515 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' X' ' 82' ' ' TYR . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' X' ' 31' ' ' LEU . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 37' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' X' ' 75' ' ' VAL . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.15 -45.63 90.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 45.7 p -96.81 -8.97 29.72 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 1.0 111.07 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.661 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -157.17 85.53 2.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.397 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.41 -37.88 96.3 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.604 2.202 . . . . 1.0 111.568 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.661 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 9.9 p90 -70.47 178.44 2.95 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.109 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 165.37 -41.1 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.612 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 24.9 Cg_exo -63.33 143.61 89.38 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.529 2.153 . . . . 1.0 112.641 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 47' ' ' GLN . . . . . 0.493 ' OE1' ' CZ ' ' X' ' 55' ' ' ARG . 44.5 tt0 -173.2 166.75 4.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.141 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -120.25 161.33 21.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.96 -134.52 11.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.961 -0.855 . . . . 1.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.536 HG22 ' N ' ' X' ' 51' ' ' ILE . 56.1 m -58.25 163.76 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.536 ' N ' HG22 ' X' ' 50' ' ' THR . 44.8 mt -39.21 108.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.704 HD12 HD11 ' X' ' 90' ' ' ILE . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.409 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.493 ' CZ ' ' OE1' ' X' ' 47' ' ' GLN . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.718 HH21 HD13 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 65' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' X' ' 64' ' ' GLN . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 71' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 72' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.495 HG21 ' CG ' ' X' ' 37' ' ' PHE . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.434 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.49 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.718 HD13 HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.515 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.704 HD11 HD12 ' X' ' 53' ' ' ILE . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.51 -50.25 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.79 -42.34 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.884 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.443 ' C ' ' N ' ' X' ' 95' ' ' VAL . 87.8 tttt -64.05 -40.84 97.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.414 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -50.33 -13.64 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.664 HG12 ' HD3' ' X' ' 97' ' ' PRO . 38.6 t -113.13 131.19 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -130.5 75.3 79.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' X' ' 95' ' ' VAL . 58.4 Cg_endo -81.29 -12.61 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.796 2.331 . . . . 1.0 112.124 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 53.29 -85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.581 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' X' ' 97' ' ' PRO . 48.7 t -121.42 132.31 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.594 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.425 -0.584 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.05 -35.48 92.04 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 42.14 -115.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.694 0.283 . . . . 1.0 110.489 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.02 116.34 27.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.334 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 5' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' X' ' 5' ' ' LEU . 34.7 tp -116.37 129.03 56.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.342 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p -145.42 164.32 31.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.445 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.597 ' CE2' HD11 ' X' ' 15' ' ' LEU . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' X' ' 11' ' ' TYR . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 19' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.558 ' O ' HD12 ' X' ' 85' ' ' LEU . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.567 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -70.11 -34.11 72.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.5 p -95.57 -10.25 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 1.0 110.685 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.576 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 0.0 OUTLIER -154.35 107.93 2.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.821 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.4 -10.93 20.75 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 121.968 1.779 . . . . 1.0 111.61 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.554 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.3 p90 -95.41 -173.1 2.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.233 0.539 . . . . 1.0 110.428 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.578 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.61 -40.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 1.0 110.49 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 34.7 Cg_exo -60.29 143.85 99.5 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.343 2.029 . . . . 1.0 112.659 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -164.52 149.81 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.31 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.82 152.06 29.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.532 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.75 -117.93 5.49 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 50' ' ' THR . . . . . 0.436 ' O ' ' C ' ' X' ' 51' ' ' ILE . 59.4 p -68.5 165.66 18.54 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.596 HG22 ' H ' ' X' ' 54' ' ' LYS . 23.5 mt -35.98 109.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.174 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.659 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.596 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.659 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 58' ' ' ARG . . . . . 0.483 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.808 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.558 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.808 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.413 HD13 ' HD2' ' X' ' 22' ' ' ARG . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.622 HD11 HD12 ' X' ' 53' ' ' ILE . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.04 -41.68 88.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.69 -39.39 93.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.884 0.374 . . . . 1.0 110.569 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.736 ' O ' HG22 ' X' ' 95' ' ' VAL . 99.1 mttt -57.87 -40.4 80.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.18 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.33 -7.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.653 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.736 HG22 ' O ' ' X' ' 93' ' ' LYS . 31.3 m -135.46 163.33 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.13 76.52 73.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.625 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.754 ' O ' HG23 ' X' ' 99' ' ' VAL . 41.1 Cg_exo -56.01 -34.13 91.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.809 2.34 . . . . 1.0 112.128 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -38.93 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 99' ' ' VAL . . . . . 0.754 HG23 ' O ' ' X' ' 97' ' ' PRO . 39.2 t -115.95 129.26 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.364 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.513 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.57 162.96 34.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.08 131.15 51.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.7 0.285 . . . . 1.0 110.344 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.37 119.12 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.592 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.8 tp -108.82 124.68 50.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.424 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 6' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p -149.12 168.2 23.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 11' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' X' ' 15' ' ' LEU . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 15' ' ' LEU . . . . . 0.559 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 22' ' ' ARG . . . . . 0.681 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 28' ' ' TYR . . . . . 0.495 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 29' ' ' ALA . . . . . 0.459 ' HB1' ' CG ' ' X' ' 33' ' ' LYS . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 31' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' X' ' 82' ' ' TYR . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB1' ' X' ' 29' ' ' ALA . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 38' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 39' ' ' LYS . . . . . 0.537 ' N ' HG13 ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -62.09 -49.05 77.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.1 p -98.02 -20.05 17.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.724 -0.39 . . . . 1.0 111.397 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 42' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.1 OUTLIER -138.45 91.66 12.3 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.013 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.06 -1.19 11.14 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.485 2.123 . . . . 1.0 111.823 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 44' ' ' TRP . . . . . 0.6 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 1.4 p90 -109.26 -165.42 1.01 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.763 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 45' ' ' PHE . . . . . 0.47 ' CG ' ' C ' ' X' ' 44' ' ' TRP . 0.3 OUTLIER -178.84 62.2 0.14 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.725 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 46' ' ' PRO . . . . . 0.562 ' O ' ' NE ' ' X' ' 55' ' ' ARG . 37.7 Cg_exo -56.73 148.58 64.65 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.617 2.211 . . . . 1.0 111.926 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 174.03 152.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.623 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -171.94 127.52 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.549 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -22.37 40.47 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 23.3 p -134.73 164.46 27.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.755 0.312 . . . . 1.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 51' ' ' ILE . . . . . 0.458 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt -41.85 126.15 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 53' ' ' ILE . . . . . 0.643 HD12 HD11 ' X' ' 90' ' ' ILE . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 54' ' ' LYS . . . . . 0.458 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 55' ' ' ARG . . . . . 0.562 ' NE ' ' O ' ' X' ' 46' ' ' PRO . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 64' ' ' GLN . . . . . 0.495 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 77' ' ' VAL . . . . . 0.495 ' HA ' HE22 ' X' ' 64' ' ' GLN . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 80' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 82' ' ' TYR . . . . . 0.657 ' CZ ' HD21 ' X' ' 31' ' ' LEU . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' X' X ' 83' ' ' TRP . . . . . 0.516 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 85' ' ' LEU . . . . . 0.681 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 86' ' ' ILE . . . . . 0.474 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 87' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 89' ' ' LEU . . . . . 0.621 HD13 ' CZ ' ' X' ' 22' ' ' ARG . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 90' ' ' ILE . . . . . 0.643 HD11 HD12 ' X' ' 53' ' ' ILE . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -48.75 -45.23 39.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.82 -41.83 99.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 1.0 110.37 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 93' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' X' ' 95' ' ' VAL . 99.4 mttt -62.7 -40.69 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.742 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -45.74 -16.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.434 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 95' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' X' ' 93' ' ' LYS . 49.2 t -121.24 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 96' ' ' ASN . . . . . 0.501 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 5.3 m-20 50.05 51.19 10.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.47 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 97' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.6 Cg_endo -64.38 149.54 89.91 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.951 2.434 . . . . 1.0 111.998 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -111.15 127.08 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.457 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.54 134.58 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.579 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.588 -179.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.751 0.31 . . . . 1.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' X' ' 15' ' ' LEU . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.429 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.695 ' O ' HD12 ' X' ' 85' ' ' LEU . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . 0.459 ' N ' HG12 ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.408 HG13 ' N ' ' X' ' 39' ' ' LYS . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.408 ' N ' HG13 ' X' ' 38' ' ' VAL . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.434 HG22 ' H ' ' X' ' 54' ' ' LYS . 70.0 mt . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.99 0.424 . . . . 1.0 110.366 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.741 HD12 HD11 ' X' ' 90' ' ' ILE . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.434 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.695 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.741 HD11 HD12 ' X' ' 53' ' ' ILE . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.913 0.387 . . . . 1.0 110.654 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.565 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.465 HD22 ' HE1' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.709 ' HE ' HD13 ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.888 0.375 . . . . 1.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.901 ' NH2' HG21 ' X' ' 86' ' ' ILE . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.459 ' O ' HG23 ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . 0.459 HG23 ' O ' ' X' ' 65' ' ' ASP . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.908 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.687 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.908 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.709 HD13 ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.85 0.357 . . . . 1.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.496 HD11 ' CE2' ' X' ' 11' ' ' TYR . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' X' ' 82' ' ' TYR . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.586 ' O ' HD12 ' X' ' 85' ' ' LEU . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.467 HG22 ' H ' ' X' ' 54' ' ' LYS . 5.2 mt . . . . . 0 N--CA 1.462 0.144 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.644 HD12 HD11 ' X' ' 90' ' ' ILE . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.467 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.581 HH21 HD13 ' X' ' 86' ' ' ILE . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 41.8 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.455 HD22 ' N ' ' X' ' 68' ' ' ASN . 1.1 m-80 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.837 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.586 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.837 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.509 HD22 ' HD2' ' X' ' 22' ' ' ARG . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.644 HD11 HD12 ' X' ' 53' ' ' ILE . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.905 0.383 . . . . 1.0 110.651 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' X' ' 11' ' ' TYR . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' X' ' 89' ' ' LEU . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' X' ' 82' ' ' TYR . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.579 HD11 ' OD2' ' X' ' 91' ' ' ASP . 57.6 mt . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.762 0.315 . . . . 1.0 110.755 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.75 HD12 HD11 ' X' ' 90' ' ' ILE . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.465 ' H ' HG22 ' X' ' 51' ' ' ILE . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.66 HE22 HG23 ' X' ' 77' ' ' VAL . 34.6 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.66 HG23 HE22 ' X' ' 64' ' ' GLN . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.467 HG23 ' H ' ' X' ' 78' ' ' THR . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.418 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.456 HD13 HH21 ' X' ' 57' ' ' ARG . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' X' ' 22' ' ' ARG . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.75 HD11 HD12 ' X' ' 53' ' ' ILE . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.579 ' OD2' HD11 ' X' ' 51' ' ' ILE . 75.5 m-20 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.847 0.356 . . . . 1.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.671 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.671 HD11 ' CE2' ' X' ' 11' ' ' TYR . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' X' ' 22' ' ' ARG . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.753 ' O ' HD12 ' X' ' 85' ' ' LEU . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' X' ' 82' ' ' TYR . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.439 HG22 ' H ' ' X' ' 54' ' ' LYS . 54.9 mt . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 121.109 0.481 . . . . 1.0 110.373 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.621 HD12 HD11 ' X' ' 90' ' ' ILE . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.439 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.402 ' O ' HG23 ' X' ' 59' ' ' VAL . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.41 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.402 HG23 ' O ' ' X' ' 55' ' ' ARG . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.536 HE21 ' C ' ' X' ' 75' ' ' VAL . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.536 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.753 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.54 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' CH2' ' X' ' 83' ' ' TRP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.513 HD22 ' CD ' ' X' ' 22' ' ' ARG . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.621 HD11 HD12 ' X' ' 53' ' ' ILE . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.631 ' OE2' HD22 ' X' ' 32' ' ' LEU . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.405 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' X' ' 11' ' ' TYR . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.498 HD12 HG21 ' X' ' 24' ' ' VAL . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.835 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.498 HG21 HD12 ' X' ' 19' ' ' LEU . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.631 HD22 ' OE2' ' X' ' 9' ' ' GLU . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.436 ' CG ' HG11 ' X' ' 75' ' ' VAL . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.563 HG22 ' H ' ' X' ' 54' ' ' LYS . 7.6 mt . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.174 0.512 . . . . 1.0 110.005 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.635 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.563 ' H ' HG22 ' X' ' 51' ' ' ILE . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.653 ' O ' HG23 ' X' ' 69' ' ' THR . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.555 ' OD1' HG13 ' X' ' 77' ' ' VAL . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . 0.653 HG23 ' O ' ' X' ' 65' ' ' ASP . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.526 HG23 ' O ' ' X' ' 75' ' ' VAL . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.555 HG13 ' OD1' ' X' ' 68' ' ' ASN . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.863 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.48 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.608 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.863 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.835 HD22 ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.627 HD11 HD12 ' X' ' 53' ' ' ILE . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.341 . . . . 1.0 110.38 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.436 HD12 HG21 ' X' ' 24' ' ' VAL . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.436 HG21 HD12 ' X' ' 19' ' ' LEU . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.417 HG22 HG12 ' X' ' 24' ' ' VAL . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 31' ' ' LEU . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.425 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.453 HG22 ' H ' ' X' ' 54' ' ' LYS . 43.9 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.116 0.484 . . . . 1.0 109.952 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.699 ' NZ ' ' HE ' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.553 ' O ' HG23 ' X' ' 59' ' ' VAL . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.699 ' HE ' ' NZ ' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.553 HG23 ' O ' ' X' ' 55' ' ' ARG . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.0 tm0? -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.438 ' CG ' HE21 ' X' ' 64' ' ' GLN . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.57 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.564 HD11 HD12 ' X' ' 53' ' ' ILE . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.87 0.367 . . . . 1.0 110.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.402 HD23 ' HD2' ' X' ' 22' ' ' ARG . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.642 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.505 ' CE2' HD22 ' X' ' 32' ' ' LEU . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.635 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' X' ' 28' ' ' TYR . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.635 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.456 HG23 HD13 ' X' ' 90' ' ' ILE . 26.7 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.943 0.401 . . . . 1.0 110.337 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.624 HD12 HD11 ' X' ' 90' ' ' ILE . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.582 ' OE1' HG12 ' X' ' 77' ' ' VAL . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.46 HD22 ' N ' ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.582 HG12 ' OE1' ' X' ' 64' ' ' GLN . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.681 ' OH ' HD11 ' X' ' 86' ' ' ILE . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.642 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.681 HD11 ' OH ' ' X' ' 82' ' ' TYR . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.611 HD22 ' NE ' ' X' ' 22' ' ' ARG . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.624 HD11 HD12 ' X' ' 53' ' ' ILE . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.909 0.385 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.485 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.401 ' HA ' HH11 ' X' ' 22' ' ' ARG . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' X' ' 89' ' ' LEU . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.459 HG13 ' N ' ' X' ' 39' ' ' LYS . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.459 ' N ' HG13 ' X' ' 38' ' ' VAL . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.51 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.863 0.363 . . . . 1.0 110.198 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.545 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.51 ' H ' HG22 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' X' ' 68' ' ' ASN . 3.3 tm0? -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' X' ' 64' ' ' GLN . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.644 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.501 HD13 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.718 HD22 ' NE ' ' X' ' 22' ' ' ARG . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.404 HD13 HG23 ' X' ' 51' ' ' ILE . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' X' ' 88' ' ' GLU . 3.8 p-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.773 0.321 . . . . 1.0 110.211 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' O ' HG12 ' X' ' 12' ' ' VAL . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.67 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' X' ' 24' ' ' VAL . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.815 ' HE ' HD13 ' X' ' 89' ' ' LEU . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' X' ' 82' ' ' TYR . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.498 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.476 HG13 ' N ' ' X' ' 39' ' ' LYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.562 HG22 ' H ' ' X' ' 54' ' ' LYS . 57.7 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.869 0.366 . . . . 1.0 110.243 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.681 HD12 HD11 ' X' ' 90' ' ' ILE . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.562 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.586 HE22 ' CG ' ' X' ' 68' ' ' ASN . 5.0 tp60 -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.557 ' O ' HG23 ' X' ' 69' ' ' THR . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.586 ' CG ' HE22 ' X' ' 64' ' ' GLN . 1.1 m-80 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . 0.557 HG23 ' O ' ' X' ' 65' ' ' ASP . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.447 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.494 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.609 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.815 HD13 ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.681 HD11 HD12 ' X' ' 53' ' ' ILE . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.891 0.377 . . . . 1.0 110.567 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.541 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.55 ' HZ2' HD12 ' X' ' 31' ' ' LEU . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.776 ' O ' HG23 ' X' ' 21' ' ' THR . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.608 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.439 ' HA ' HH11 ' X' ' 22' ' ' ARG . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.776 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.758 ' NE ' HD13 ' X' ' 89' ' ' LEU . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' X' ' 82' ' ' TYR . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.55 HD12 ' HZ2' ' X' ' 16' ' ' LYS . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.472 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.44 HG22 ' H ' ' X' ' 54' ' ' LYS . 6.0 mt . . . . . 0 C--O 1.223 -0.322 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.63 HD12 HD11 ' X' ' 90' ' ' ILE . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.44 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.473 ' O ' HG23 ' X' ' 59' ' ' VAL . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.436 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.473 HG23 ' O ' ' X' ' 55' ' ' ARG . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' X' ' 73' ' ' GLU . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.43 ' HB2' ' CD2' ' X' ' 67' ' ' TYR . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.422 ' HA ' HD22 ' X' ' 68' ' ' ASN . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.607 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.407 ' H ' HG23 ' X' ' 78' ' ' THR . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' X' ' 26' ' ' VAL . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.44 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.758 HD13 ' NE ' ' X' ' 22' ' ' ARG . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.63 HD11 HD12 ' X' ' 53' ' ' ILE . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.839 0.352 . . . . 1.0 110.252 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' X' ' 11' ' ' TYR . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.468 ' HZ2' ' NZ ' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.468 ' NZ ' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.513 ' O ' HD12 ' X' ' 85' ' ' LEU . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' X' ' 39' ' ' LYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.159 0.504 . . . . 1.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' X' ' 86' ' ' ILE . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' X' ' 75' ' ' VAL . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.642 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.513 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' X' ' 53' ' ' ILE . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.642 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.489 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.897 0.38 . . . . 1.0 110.459 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.419 ' O ' HG23 ' X' ' 21' ' ' THR . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.498 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.419 HG23 ' O ' ' X' ' 17' ' ' GLN . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.723 ' O ' HD12 ' X' ' 85' ' ' LEU . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.528 HG12 HG22 ' X' ' 26' ' ' VAL . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.528 HG22 HG12 ' X' ' 24' ' ' VAL . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.527 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.42 HG13 ' N ' ' X' ' 39' ' ' LYS . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.42 ' N ' HG13 ' X' ' 38' ' ' VAL . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.41 HG22 ' CG ' ' X' ' 54' ' ' LYS . 32.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.822 0.344 . . . . 1.0 110.235 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.443 ' HB ' ' NH1' ' X' ' 57' ' ' ARG . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.41 ' CG ' HG22 ' X' ' 51' ' ' ILE . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.834 ' NH2' HG21 ' X' ' 86' ' ' ILE . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.723 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.834 HG21 ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' X' ' 91' ' ' ASP . 46.8 t0 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.849 0.357 . . . . 1.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.404 ' O ' HG12 ' X' ' 12' ' ' VAL . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.429 HD23 ' HD2' ' X' ' 22' ' ' ARG . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.728 ' O ' HD12 ' X' ' 85' ' ' LEU . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' X' ' 82' ' ' TYR . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.446 ' CG ' HG21 ' X' ' 75' ' ' VAL . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.489 HG13 ' N ' ' X' ' 39' ' ' LYS . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.489 ' N ' HG13 ' X' ' 38' ' ' VAL . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.522 HG22 ' H ' ' X' ' 54' ' ' LYS . 3.9 mt . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.522 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . 0.474 HD22 ' N ' ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.446 HG21 ' CG ' ' X' ' 37' ' ' PHE . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.463 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.728 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' X' ' 53' ' ' ILE . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' X' ' 22' ' ' ARG . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.424 HD12 HG22 ' X' ' 86' ' ' ILE . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.899 0.381 . . . . 1.0 110.525 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . 0.422 ' O ' HG23 ' X' ' 21' ' ' THR . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.548 HD23 ' HE1' ' X' ' 82' ' ' TYR . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . 0.422 HG23 ' O ' ' X' ' 17' ' ' GLN . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.716 ' O ' HD12 ' X' ' 85' ' ' LEU . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' CE ' ' X' ' 33' ' ' LYS . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' X' ' 31' ' ' LEU . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.469 ' CE ' ' HB1' ' X' ' 29' ' ' ALA . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.476 HG13 ' N ' ' X' ' 39' ' ' LYS . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.742 0.306 . . . . 1.0 110.576 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.536 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . 0.427 ' O ' HG23 ' X' ' 59' ' ' VAL . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' X' ' 55' ' ' ARG . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.716 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HE ' ' X' ' 22' ' ' ARG . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.892 0.377 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' X' ' 15' ' ' LEU . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.501 HG13 ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . 0.501 ' N ' HG13 ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' X' ' 11' ' ' TYR . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.768 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.432 ' CG1' HG13 ' X' ' 26' ' ' VAL . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' X' ' 82' ' ' TYR . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.655 ' OH ' HD22 ' X' ' 32' ' ' LEU . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.582 HD11 HG21 ' X' ' 26' ' ' VAL . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.655 HD22 ' OH ' ' X' ' 28' ' ' TYR . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.472 ' O ' HG12 ' X' ' 38' ' ' VAL . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.472 HG12 ' O ' ' X' ' 35' ' ' PHE . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.908 0.385 . . . . 1.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.661 HD12 HD11 ' X' ' 90' ' ' ILE . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.815 HH21 HD13 ' X' ' 86' ' ' ILE . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.1 tm0? -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.594 ' CD2' HG12 ' X' ' 26' ' ' VAL . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.422 ' HA ' HD12 ' X' ' 86' ' ' ILE . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.515 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.815 HD13 HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.768 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.661 HD11 HD12 ' X' ' 53' ' ' ILE . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.838 0.351 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . 0.576 ' CG ' ' HZ3' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' X' ' 32' ' ' LEU . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' X' ' 22' ' ' ARG . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.589 ' CZ ' HD23 ' X' ' 89' ' ' LEU . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' X' ' 82' ' ' TYR . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.516 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.601 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . 0.579 HD11 ' HG2' ' X' ' 9' ' ' GLU . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.601 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.498 HG13 ' N ' ' X' ' 39' ' ' LYS . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.403 HG21 ' HE ' ' X' ' 57' ' ' ARG . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.431 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.49 HG23 HH12 ' X' ' 22' ' ' ARG . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.589 HD23 ' CZ ' ' X' ' 22' ' ' ARG . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.425 HD12 HG22 ' X' ' 86' ' ' ILE . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.818 0.342 . . . . 1.0 110.516 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.577 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' X' ' 11' ' ' TYR . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.434 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.515 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' X' ' 82' ' ' TYR . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' X' ' 31' ' ' LEU . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' X' ' 75' ' ' VAL . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.89 0.376 . . . . 1.0 110.258 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.704 HD12 HD11 ' X' ' 90' ' ' ILE . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.409 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.718 HH21 HD13 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' X' ' 64' ' ' GLN . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.495 HG21 ' CG ' ' X' ' 37' ' ' PHE . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.434 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.49 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.718 HD13 HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.515 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.704 HD11 HD12 ' X' ' 53' ' ' ILE . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.791 0.329 . . . . 1.0 110.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.597 ' CE2' HD11 ' X' ' 15' ' ' LEU . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' X' ' 11' ' ' TYR . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.558 ' O ' HD12 ' X' ' 85' ' ' LEU . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.567 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.596 HG22 ' H ' ' X' ' 54' ' ' LYS . 23.5 mt . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.992 0.425 . . . . 1.0 110.174 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.659 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.596 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.659 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . 0.483 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.808 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.558 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.808 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.413 HD13 ' HD2' ' X' ' 22' ' ' ARG . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.622 HD11 HD12 ' X' ' 53' ' ' ILE . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' X' X ' 6' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 1.0 110.466 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 11' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' X' ' 15' ' ' LEU . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 15' ' ' LEU . . . . . 0.559 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 22' ' ' ARG . . . . . 0.681 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 28' ' ' TYR . . . . . 0.495 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 29' ' ' ALA . . . . . 0.459 ' HB1' ' CG ' ' X' ' 33' ' ' LYS . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 31' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' X' ' 82' ' ' TYR . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB1' ' X' ' 29' ' ' ALA . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 38' ' ' VAL . . . . . 0.537 HG13 ' N ' ' X' ' 39' ' ' LYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 39' ' ' LYS . . . . . 0.537 ' N ' HG13 ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' X' X ' 51' ' ' ILE . . . . . 0.458 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.805 0.336 . . . . 1.0 110.228 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 53' ' ' ILE . . . . . 0.643 HD12 HD11 ' X' ' 90' ' ' ILE . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 54' ' ' LYS . . . . . 0.458 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 64' ' ' GLN . . . . . 0.495 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 77' ' ' VAL . . . . . 0.495 ' HA ' HE22 ' X' ' 64' ' ' GLN . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 80' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 82' ' ' TYR . . . . . 0.657 ' CZ ' HD21 ' X' ' 31' ' ' LEU . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' X' X ' 83' ' ' TRP . . . . . 0.516 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 85' ' ' LEU . . . . . 0.681 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 86' ' ' ILE . . . . . 0.474 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 87' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 89' ' ' LEU . . . . . 0.621 HD13 ' CZ ' ' X' ' 22' ' ' ARG . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 90' ' ' ILE . . . . . 0.643 HD11 HD12 ' X' ' 53' ' ' ILE . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.04 98.38 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -107.74 120.6 42.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 1.0 110.308 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.83 -43.24 93.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.879 HD21 HH21 ' X' ' 10' ' ' ARG . 37.0 tp -108.69 130.34 55.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -145.44 159.95 42.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.327 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.63 -30.37 71.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.652 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -66.35 -39.1 88.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.17 -43.69 97.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.59 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.879 HH21 HD21 ' X' ' 5' ' ' LEU . 96.8 mtt180 -63.06 -37.29 86.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.753 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.544 ' CE2' HD11 ' X' ' 15' ' ' LEU . 80.0 t80 -59.62 -45.1 92.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.395 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.67 -47.59 92.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.492 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -49.42 -40.3 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.261 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.44 -43.51 94.06 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.329 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.3 mt -63.75 -40.8 97.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.888 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -52.76 -47.1 67.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.99 -48.62 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.52 -0.472 . . . . 1.0 111.939 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.29 70.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.535 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.429 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.8 mp -65.83 -31.14 71.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.536 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -59.27 -38.92 81.29 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.722 -0.391 . . . . 1.0 110.819 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -67.67 -14.23 62.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.559 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.695 ' O ' HD12 ' X' ' 85' ' ' LEU . 6.4 mmm180 -92.07 -6.74 50.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.875 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.89 21.86 7.58 Favored Glycine 0 N--CA 1.464 0.563 0 C-N-CA 120.852 -0.69 . . . . 1.0 111.448 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -101.35 130.37 50.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 1.0 111.242 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.82 92.95 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 49.2 t -135.78 158.65 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.428 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . 0.459 ' N ' HG12 ' X' ' 26' ' ' VAL . 66.6 mttm -84.31 152.63 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.059 0.457 . . . . 1.0 110.941 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' X' ' 28' ' ' TYR . 0.0 OUTLIER -58.8 -47.88 83.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.03 0.443 . . . . 1.0 110.651 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.08 83.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.161 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.44 -48.18 77.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.88 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.45 -38.97 88.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.724 0.297 . . . . 1.0 110.375 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.77 -43.36 99.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.004 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.95 -41.74 99.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.96 -45.55 94.31 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -58.74 -39.87 82.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.048 0.451 . . . . 1.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -73.9 -27.86 61.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.297 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -61.25 -51.94 66.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.995 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -66.4 -39.73 84.83 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.408 ' N ' HG13 ' X' ' 38' ' ' VAL . 86.2 tttt -63.83 -31.92 73.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 1.0 111.018 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -70.98 -48.41 53.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.695 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -99.09 -12.04 20.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 1.0 110.855 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -141.94 89.47 8.87 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.439 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -2.11 11.93 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.15 1.9 . . . . 1.0 112.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.606 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 1.5 p90 -102.71 160.26 14.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.06 0.457 . . . . 1.0 110.366 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -144.57 67.46 14.31 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.62 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -54.09 144.04 59.79 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.758 2.305 . . . . 1.0 112.233 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -126.87 141.25 51.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.527 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . 0.461 ' OE2' ' NH2' ' X' ' 55' ' ' ARG . 95.9 mt-10 -139.68 172.22 13.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.563 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.35 -37.49 92.02 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.664 -0.974 . . . . 1.0 110.664 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.421 ' O ' ' C ' ' X' ' 51' ' ' ILE . 70.9 p -79.03 165.43 23.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.434 HG22 ' H ' ' X' ' 54' ' ' LYS . 70.0 mt -36.7 107.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.366 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -67.43 -40.24 85.47 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.741 HD12 HD11 ' X' ' 90' ' ' ILE . 62.3 mt -57.61 -19.43 11.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.696 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.434 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -57.35 -49.64 75.51 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.393 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.461 ' NH2' ' OE2' ' X' ' 48' ' ' GLU . 95.1 mtt-85 -63.91 -31.67 72.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.358 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' X' ' 56' ' ' TRP . 10.9 t90 -64.75 -54.19 35.37 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.762 0.791 . . . . 1.0 110.594 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.56 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 92.6 mtt-85 -70.92 -28.54 64.59 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.553 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -53.97 -46.54 71.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.749 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 50.6 t -67.14 -42.59 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.186 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.51 -50.42 59.38 Favored Glycine 0 C--O 1.214 -1.136 0 C-N-CA 120.105 -1.045 . . . . 1.0 111.116 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -52.64 -40.81 63.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.169 0.485 . . . . 1.0 111.074 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 61.2 m -66.41 -61.25 2.1 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.595 0.712 . . . . 1.0 111.327 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' X' ' 63' ' ' PHE . 9.7 m-30 -64.74 -27.2 68.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.667 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 46.1 tt0 -64.23 -38.64 91.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -59.19 -49.15 78.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.223 -0.591 . . . . 1.0 109.55 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -69.32 -43.17 74.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.422 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -39.27 91.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.807 0.337 . . . . 1.0 110.762 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -62.86 -42.67 99.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.439 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -69.63 -41.84 75.09 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -62.19 -40.94 97.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.51 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 144.13 -47.04 0.79 Allowed Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.8 Cg_exo -49.18 99.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.507 2.138 . . . . 1.0 112.49 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.0 pt-20 -91.61 3.29 55.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.471 -0.786 . . . . 1.0 111.176 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' X' ' 73' ' ' GLU . 87.2 tttt -32.03 -43.7 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.428 0.455 . . . . 1.0 110.967 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.485 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 3.2 m -116.78 87.17 20.83 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.666 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.486 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 33.7 Cg_exo -57.8 147.85 78.46 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.818 2.346 . . . . 1.0 112.753 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.43 ' C ' ' N ' ' X' ' 79' ' ' ALA . 13.1 p -61.17 -27.34 41.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.013 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 16.4 p -49.07 -15.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.571 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.44 -37.81 87.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.896 0.379 . . . . 1.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 27.4 t80 -61.39 -43.16 99.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.383 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 5.1 t -60.82 -52.06 66.68 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 122.062 0.934 . . . . 1.0 110.605 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 51.7 m-85 -60.91 -31.97 71.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.432 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.425 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 24.2 t90 -60.13 -34.88 74.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.322 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -56.4 -42.26 77.66 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.695 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.16 -40.59 94.44 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.353 -0.939 . . . . 1.0 110.209 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.56 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 91.6 mt -63.28 -44.01 98.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 120.849 -0.341 . . . . 1.0 111.093 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.425 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 89.9 mttt -46.8 -48.98 20.64 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.247 -0.581 . . . . 1.0 110.292 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -66.46 -35.26 79.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.117 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.35 -49.48 73.71 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.708 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.741 HD11 HD12 ' X' ' 53' ' ' ILE . 57.0 mt -69.38 -41.77 80.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.007 0.432 . . . . 1.0 110.733 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -57.81 -44.24 86.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.767 -0.652 . . . . 1.0 110.494 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.63 -40.74 95.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.244 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' X' ' 95' ' ' VAL . 57.2 mtpt -62.22 -41.48 98.42 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.659 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -57.87 -3.38 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.61 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.5 t -116.8 132.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.336 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.423 ' OD1' ' NE2' ' X' ' 98' ' ' GLN . 7.3 t-20 60.92 73.02 0.64 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.27 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.8 141.54 92.47 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.557 2.171 . . . . 1.0 111.972 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . 0.423 ' NE2' ' OD1' ' X' ' 96' ' ' ASN . 93.7 mm-40 -131.08 147.84 52.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.345 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.03 133.6 68.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.578 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.247 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.09 2.84 77.05 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . 0.4 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 99.1 mm-40 -63.36 -31.59 72.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 1.0 110.548 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.04 90.37 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.531 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' X' ' 9' ' ' GLU . 89.2 mt -64.04 -47.24 81.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.94 0.4 . . . . 1.0 110.662 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 10.0 p -150.78 -172.86 4.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.654 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . 0.491 ' N ' ' NH2' ' X' ' 10' ' ' ARG . 70.9 tp60 -63.17 -25.55 68.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.312 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.55 -50.45 73.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.829 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' X' ' 5' ' ' LEU . 92.6 mt-10 -64.18 -39.1 93.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.108 0.48 . . . . 1.0 110.484 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.491 ' NH2' ' N ' ' X' ' 7' ' ' GLN . 94.8 mtm-85 -67.35 -34.69 77.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.748 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.565 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -61.23 -51.31 69.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.411 . . . . 1.0 111.424 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.37 -31.91 54.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.236 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.16 -37.77 86.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.677 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -65.24 -38.55 90.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.251 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.565 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.9 mt -63.58 -41.13 98.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.212 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.96 -46.65 81.99 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.069 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -61.78 -52.65 63.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.352 -0.539 . . . . 1.0 111.355 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.8 -44.6 89.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.197 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.465 HD22 ' HE1' ' X' ' 82' ' ' TYR . 81.8 mt -63.07 -39.56 95.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -58.26 -40.36 81.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.732 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 31.0 p -72.56 -12.58 61.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.83 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.709 ' HE ' HD13 ' X' ' 89' ' ' LEU . 66.4 mmt-85 -91.49 -7.89 49.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.306 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 22.86 6.65 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -100.08 129.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.763 -0.375 . . . . 1.0 110.937 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.92 74.71 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.495 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.4 138.97 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.999 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.28 153.03 42.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.534 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.74 -46.85 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 1.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.534 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.99 -36.49 65.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.752 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.13 -52.14 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 1.0 110.936 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.38 -39.89 94.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.279 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.5 tp -61.99 -46.22 90.17 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.076 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.5 mttm -67.05 -43.57 82.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.18 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.602 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.2 t80 -61.92 -42.37 99.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.833 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -58.85 -41.44 86.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.816 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.64 -25.0 63.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.402 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -64.3 -53.92 41.3 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 1.0 111.031 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.633 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.6 p -66.88 -34.43 69.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.06 -44.55 95.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.613 -0.435 . . . . 1.0 111.017 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.14 -45.21 92.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.513 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -97.67 -4.69 36.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.506 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.66 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -162.17 84.85 1.59 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.249 0.547 . . . . 1.0 110.49 -179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.525 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 35.1 Cg_exo -61.54 -31.47 87.38 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.476 2.117 . . . . 1.0 111.686 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.66 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.8 p90 -74.18 150.94 40.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.349 0.595 . . . . 1.0 110.768 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.592 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 1.0 OUTLIER -163.5 43.66 0.1 Allowed Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.272 -0.876 . . . . 1.0 110.809 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 49.3 Cg_exo -36.14 148.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.982 2.455 . . . . 1.0 112.46 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.43 HE22 HG12 ' X' ' 53' ' ' ILE . 98.9 mm-40 -134.18 135.24 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.568 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -131.07 175.08 9.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.444 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.55 -44.94 97.19 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.059 -0.816 . . . . 1.0 111.059 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -85.33 164.19 18.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 1.0 110.151 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 61.2 mt -52.23 108.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.291 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.2 t0 -123.74 -18.9 5.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.453 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' X' ' 56' ' ' TRP . 80.3 mt -62.88 -16.96 18.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.148 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -46.85 -28.59 1.62 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.885 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -66.24 -39.76 89.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.241 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.602 ' CZ2' ' CE2' ' X' ' 34' ' ' PHE . 12.2 t90 -62.65 -51.03 68.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.289 0.566 . . . . 1.0 110.08 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.901 ' NH2' HG21 ' X' ' 86' ' ' ILE . 1.8 mpt_? -63.92 -35.06 79.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.024 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -54.3 -45.77 72.63 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.904 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.86 -42.39 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.005 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.38 -49.96 69.26 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -56.33 -43.35 78.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.214 0.507 . . . . 1.0 110.576 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.55 -58.57 4.92 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.382 0.61 . . . . 1.0 111.06 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -35.97 79.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.787 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 43.1 tt0 -58.72 -37.67 76.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.532 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.459 ' O ' HG23 ' X' ' 69' ' ' THR . 67.4 m-20 -62.83 -47.0 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.957 0.408 . . . . 1.0 110.031 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -68.93 -43.42 75.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.214 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -64.7 -47.48 78.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.137 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.21 -41.22 90.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.253 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . 0.459 HG23 ' O ' ' X' ' 65' ' ' ASP . 4.4 p -60.8 -48.63 80.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.638 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.07 -35.57 81.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.661 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.487 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 146.81 -51.25 0.58 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 71.2 Cg_exo -43.66 100.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.467 2.111 . . . . 1.0 112.362 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' X' ' 75' ' ' VAL . 18.5 pt-20 -90.71 6.15 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.529 -0.759 . . . . 1.0 111.147 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' X' ' 73' ' ' GLU . 80.1 tttt -33.34 -36.71 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 123.438 0.461 . . . . 1.0 110.742 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.5 OUTLIER -118.95 86.44 31.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.489 . . . . 1.0 109.678 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.557 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 37.0 Cg_exo -56.51 147.93 66.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.923 2.415 . . . . 1.0 112.591 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.482 ' C ' ' N ' ' X' ' 79' ' ' ALA . 12.1 p -56.38 -26.58 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.76 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.0 p -48.44 -12.3 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.514 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.55 -46.8 86.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.101 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.46 -48.65 78.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.774 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -62.38 -41.32 98.55 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.615 0.721 . . . . 1.0 110.145 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.908 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.6 OUTLIER -58.83 -40.37 83.98 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.509 -0.769 . . . . 1.0 109.688 179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.687 ' HE1' ' NH1' ' X' ' 57' ' ' ARG . 21.3 t90 -61.1 -33.46 73.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.749 -0.659 . . . . 1.0 110.812 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -56.44 -42.94 78.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.877 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.542 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.84 -39.28 93.89 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.044 -0.662 . . . . 1.0 110.507 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.908 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.1 mt -62.44 -43.75 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.719 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -52.77 -47.33 67.58 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.87 0.367 . . . . 1.0 110.469 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.58 -31.4 70.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.286 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.709 HD13 ' HE ' ' X' ' 22' ' ' ARG . 43.4 tp -76.16 -53.01 8.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.895 -0.722 . . . . 1.0 111.94 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' X' ' 93' ' ' LYS . 63.5 mt -70.7 -44.86 76.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 1.0 111.29 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.18 -53.56 56.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.801 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -66.87 -42.26 85.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.382 . . . . 1.0 110.744 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' X' ' 90' ' ' ILE . 62.3 mmtt -114.1 119.02 35.68 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.175 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -101.73 -4.89 25.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.299 -0.864 . . . . 1.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.85 130.0 74.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.906 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -121.96 85.32 45.45 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.446 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.9 145.47 96.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.812 2.342 . . . . 1.0 112.133 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.48 154.48 41.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.554 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 66.6 t -124.96 135.19 64.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.465 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.575 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 66.1 ttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.53 -40.97 96.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -122.02 147.97 45.41 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.759 0.314 . . . . 1.0 110.516 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -108.68 122.66 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.26 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.5 tp -113.77 132.34 55.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.796 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -145.65 163.69 34.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.287 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -62.42 -37.64 86.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.473 ' ND1' ' NZ ' ' X' ' 39' ' ' LYS . 96.0 m-70 -61.25 -40.8 95.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 1.0 110.516 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.04 -51.3 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.958 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -61.07 -32.39 72.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.469 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.0 t80 -58.99 -47.62 84.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.254 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.17 -47.13 94.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.265 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -47.67 -40.32 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.426 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.42 -46.77 78.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.703 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.496 HD11 ' CE2' ' X' ' 11' ' ' TYR . 86.6 mt -62.7 -39.61 94.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.419 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -57.95 -44.84 87.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 120.761 -0.376 . . . . 1.0 111.097 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -65.34 -53.06 49.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.0 111.558 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.79 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.208 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.435 HD22 ' HE1' ' X' ' 82' ' ' TYR . 86.4 mt -63.62 -39.8 95.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.69 -36.07 71.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.693 0.282 . . . . 1.0 110.928 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 63.9 p -73.03 -13.29 61.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.803 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.586 ' O ' HD12 ' X' ' 85' ' ' LEU . 15.7 mtp85 -92.31 -9.0 43.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.941 -0.304 . . . . 1.0 111.016 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.18 21.76 6.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.78 111.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.079 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -107.27 74.62 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -131.5 135.76 58.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.222 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.11 148.07 22.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.543 -0.299 . . . . 1.0 110.305 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 1.8 p90 -61.4 -45.46 94.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 1.0 111.05 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.646 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -54.7 -35.13 63.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.495 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -55.88 -49.24 73.93 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.641 -0.423 . . . . 1.0 110.498 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.15 -38.99 92.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 1.0 110.115 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.72 -43.91 97.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -64.31 -41.95 96.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.458 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.99 -49.22 77.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.409 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.64 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 33.7 m-85 -63.07 -33.13 74.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.008 0.432 . . . . 1.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -66.65 -34.89 78.86 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.599 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 63' ' ' PHE . 41.2 t80 -65.1 -53.81 39.69 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.03 0.443 . . . . 1.0 111.495 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.4 p -65.74 -36.37 77.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.129 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.473 ' NZ ' ' ND1' ' X' ' 8' ' ' HIS . 91.9 mttt -64.74 -37.62 88.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 1.0 110.92 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -57.74 -49.6 76.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.249 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 23.2 m -95.28 -56.02 2.86 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.365 -0.534 . . . . 1.0 110.219 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.608 ' N ' ' O ' ' X' ' 38' ' ' VAL . 31.2 t 45.93 61.88 11.96 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.441 . . . . 1.0 111.248 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.74 -26.43 13.6 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.548 2.166 . . . . 1.0 110.787 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.625 ' HE1' HG21 ' X' ' 59' ' ' VAL . 0.0 OUTLIER -147.79 -168.58 3.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.559 179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 173.47 -43.8 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.69 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.4 Cg_exo -59.2 141.89 98.52 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.548 2.165 . . . . 1.0 112.715 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.531 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 69.3 tp60 -161.99 146.83 12.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.43 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -149.83 154.0 37.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.893 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.3 -32.79 6.34 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.354 -0.699 . . . . 1.0 111.354 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 67.0 p -139.65 167.27 22.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.322 -0.251 . . . . 1.0 110.322 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.467 HG22 ' H ' ' X' ' 54' ' ' LYS . 5.2 mt -35.42 126.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 O-C-N 123.535 0.522 . . . . 1.0 109.841 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 65.3 t0 -60.55 -37.75 82.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.515 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.644 HD12 HD11 ' X' ' 90' ' ' ILE . 33.0 mt -65.54 -24.01 33.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.669 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.467 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -48.28 -48.29 35.8 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.606 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' X' ' 47' ' ' GLN . 60.6 ttm-85 -58.06 -39.47 78.55 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.846 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 12.9 t90 -62.35 -48.82 78.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.7 0.762 . . . . 1.0 110.689 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.581 HH21 HD13 ' X' ' 86' ' ' ILE . 22.7 mmt180 -67.19 -35.42 79.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 mtp85 -55.44 -42.5 74.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.482 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.625 HG21 ' HE1' ' X' ' 44' ' ' TRP . 83.8 t -60.78 -47.13 94.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' X' ' 64' ' ' GLN . . . -65.15 -54.13 29.16 Favored Glycine 0 C--O 1.211 -1.294 0 C-N-CA 120.121 -1.038 . . . . 1.0 111.724 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' X' ' 65' ' ' ASP . 90.7 m-20 -46.29 -42.13 14.16 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.577 -0.955 . . . . 1.0 110.607 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.534 ' O ' ' CE2' ' X' ' 66' ' ' TYR . 57.3 m -78.04 -64.21 1.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.728 -0.789 . . . . 1.0 112.035 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.7 ' CZ ' ' CZ ' ' X' ' 37' ' ' PHE . 0.0 OUTLIER -62.7 -48.82 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.189 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' X' ' 76' ' ' PRO . 41.8 tt0 -57.09 -39.24 74.63 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.553 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' X' ' 61' ' ' ASP . 53.3 m-20 -59.79 -47.55 85.25 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.899 -0.72 . . . . 1.0 110.871 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.534 ' CE2' ' O ' ' X' ' 62' ' ' CYS . 0.9 OUTLIER -70.56 -46.43 63.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.934 0.397 . . . . 1.0 111.314 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -62.49 -40.98 98.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.961 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.455 HD22 ' N ' ' X' ' 68' ' ' ASN . 1.1 m-80 -63.02 -43.51 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 1.0 110.29 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 54.4 m -67.29 -44.44 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.539 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.94 -43.25 91.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 159.7 -57.8 0.32 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 67.8 Cg_exo -40.44 95.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.408 2.072 . . . . 1.0 112.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.53 5.52 47.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.004 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -39.95 -42.9 1.43 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.637 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.9 OUTLIER -118.39 87.55 30.9 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.051 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.573 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 51.8 Cg_exo -54.21 141.58 69.84 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.699 2.266 . . . . 1.0 112.31 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' X' ' 79' ' ' ALA . 11.5 p -56.89 -27.05 25.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.875 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -45.84 -13.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.051 0.453 . . . . 1.0 110.741 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.56 -29.68 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.691 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 19.8 t80 -59.27 -49.59 77.26 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.887 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 73.3 m -60.31 -44.01 95.82 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.68 0.752 . . . . 1.0 110.121 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.837 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 0.5 OUTLIER -58.15 -41.68 84.28 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.415 -0.812 . . . . 1.0 109.774 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' X' ' 83' ' ' TRP . 21.4 t90 -61.31 -32.24 72.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.619 -0.719 . . . . 1.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -58.39 -41.94 85.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.586 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.18 -39.39 92.52 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.139 -0.624 . . . . 1.0 110.015 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.837 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.9 mt -62.55 -45.34 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -52.64 -40.72 63.08 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.528 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.07 -33.06 74.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.55 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.509 HD22 ' HD2' ' X' ' 22' ' ' ARG . 45.2 tp -72.43 -50.28 27.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.793 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.644 HD11 HD12 ' X' ' 53' ' ' ILE . 37.1 mt -68.33 -43.7 84.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 1.0 110.775 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.08 -48.95 79.32 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.782 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.95 -45.02 87.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.187 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' X' ' 90' ' ' ILE . 98.8 mttt -135.96 154.92 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 57.65 26.77 13.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.275 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.83 -28.97 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.904 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.21 78.47 0.31 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' X' ' 99' ' ' VAL . 46.4 Cg_exo -55.2 -35.88 92.02 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.83 2.353 . . . . 1.0 111.734 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 52.08 -87.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.602 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' X' ' 97' ' ' PRO . 38.1 t -122.4 131.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.593 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.808 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.14 19.57 58.84 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -130.89 132.94 45.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.722 0.296 . . . . 1.0 110.604 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.71 -41.26 92.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -113.26 126.07 55.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.451 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 10.9 p -149.48 173.56 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -58.68 -26.51 63.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.815 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -59.75 -42.93 94.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.396 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.1 mp0 -63.19 -43.52 97.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.134 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.23 -34.82 79.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.819 0.342 . . . . 1.0 110.792 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.437 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -59.43 -47.94 83.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.286 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.419 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.4 OUTLIER -64.59 -35.08 73.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.292 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.77 -35.84 77.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.497 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.19 -41.99 89.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.387 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.437 HD11 ' CE2' ' X' ' 11' ' ' TYR . 84.3 mt -62.62 -40.81 98.16 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.582 -0.447 . . . . 1.0 109.95 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' X' ' 20' ' ' LYS . 87.9 tttt -56.67 -48.29 77.93 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.564 -0.455 . . . . 1.0 111.078 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.64 -51.07 62.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.674 -0.41 . . . . 1.0 111.661 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.09 -49.59 75.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.388 -0.369 . . . . 1.0 111.362 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.1 -35.88 82.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.774 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' X' ' 16' ' ' LYS . 30.0 mmtt -58.45 -41.48 85.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.583 0.23 . . . . 1.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 76.9 p -63.98 -14.05 50.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.831 -0.347 . . . . 1.0 110.616 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.584 ' HG3' HD21 ' X' ' 89' ' ' LEU . 34.2 mmt180 -97.87 -5.86 33.68 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.979 0.363 . . . . 1.0 111.979 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.42 21.01 7.48 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.183 -0.532 . . . . 1.0 111.814 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' X' ' 82' ' ' TYR . 61.3 t -99.01 100.34 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.445 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -91.61 76.56 5.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 54.6 t -129.41 137.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.851 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.2 155.67 40.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.566 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 28.0 p90 -62.5 -44.45 96.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.77 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.566 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -61.34 -37.26 82.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.969 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -57.93 -49.26 77.39 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.401 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.09 -36.96 84.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 1.0 110.29 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.07 -43.97 95.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.153 -0.476 . . . . 1.0 109.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' X' ' 36' ' ' ASP . 67.9 mttm -64.18 -42.84 96.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 1.0 110.35 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.76 -43.92 97.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.312 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -57.75 -45.67 85.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.876 0.37 . . . . 1.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' X' ' 37' ' ' PHE . 13.1 p30 -72.06 -24.74 61.57 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.551 ' N ' ' OD1' ' X' ' 36' ' ' ASP . 36.4 t80 -60.49 -52.29 65.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.867 -0.606 . . . . 1.0 111.296 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.2 p -67.22 -38.33 80.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.448 -0.501 . . . . 1.0 109.835 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.74 -25.61 68.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.49 -52.22 14.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.45 -0.341 . . . . 1.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 72.5 p -98.75 -5.75 30.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 1.0 110.553 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.597 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.8 OUTLIER -147.49 85.53 6.69 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.8 -0.637 . . . . 1.0 110.238 -179.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.13 -0.69 9.47 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.212 1.941 . . . . 1.0 112.631 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.597 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.1 p90 -103.54 157.88 16.75 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.265 0.555 . . . . 1.0 110.257 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -147.12 68.0 11.14 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.435 -0.802 . . . . 1.0 110.248 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.439 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 48.8 Cg_exo -53.65 141.14 64.88 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.688 2.259 . . . . 1.0 112.295 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -120.34 136.93 54.54 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.481 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.54 171.34 14.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.497 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.11 -40.6 93.83 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 23.7 p -82.56 164.6 20.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.579 HD11 ' OD2' ' X' ' 91' ' ' ASP . 57.6 mt -37.08 110.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.755 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' X' ' 46' ' ' PRO . 9.5 t0 -74.24 -36.61 63.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.695 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.75 HD12 HD11 ' X' ' 90' ' ' ILE . 87.4 mt -54.31 -24.0 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.077 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.465 ' H ' HG22 ' X' ' 51' ' ' ILE . 48.0 mttt -49.39 -45.49 46.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.411 -0.516 . . . . 1.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -68.38 -35.56 77.88 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.051 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.559 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -62.01 -54.03 47.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.025 0.441 . . . . 1.0 110.713 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.559 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 7.4 mmt180 -66.75 -29.71 69.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.376 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -60.44 -44.25 96.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.993 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.2 -43.72 97.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.943 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -66.95 -44.74 88.07 Favored Glycine 0 C--O 1.219 -0.806 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -57.76 -43.56 85.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.006 0.403 . . . . 1.0 110.668 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.5 m -67.5 -58.69 4.28 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.515 0.674 . . . . 1.0 110.569 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -59.39 -28.63 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.067 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.66 HE22 HG23 ' X' ' 77' ' ' VAL . 34.6 tt0 -63.63 -38.25 90.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 109.856 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.73 -44.99 93.52 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.94 -0.704 . . . . 1.0 109.56 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -73.97 -44.99 52.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.5 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -61.95 -41.15 97.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.829 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.25 -43.44 98.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.81 0.338 . . . . 1.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 78.4 m -64.4 -46.92 81.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.991 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -62.21 -39.37 92.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.062 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 141.24 -46.59 0.9 Allowed Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 53.1 Cg_exo -47.99 97.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.47 2.113 . . . . 1.0 112.703 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' X' ' 75' ' ' VAL . 17.0 pt-20 -91.67 3.46 55.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.977 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' X' ' 36' ' ' ASP . 82.5 tttt -31.0 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.369 0.418 . . . . 1.0 111.214 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' X' ' 73' ' ' GLU . 1.1 m -118.16 85.43 24.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.285 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -60.43 152.43 67.63 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.837 2.358 . . . . 1.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.66 HG23 HE22 ' X' ' 64' ' ' GLN . 10.4 p -63.99 -30.97 51.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.56 . . . . 1.0 111.054 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.467 HG23 ' H ' ' X' ' 78' ' ' THR . 7.0 p -44.01 -20.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.351 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -62.08 -36.22 81.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.82 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.1 t80 -59.81 -44.67 93.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.143 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -51.86 66.66 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 122.002 0.906 . . . . 1.0 110.919 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.565 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.5 -34.5 74.16 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.518 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -60.82 -31.45 70.85 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.82 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.92 -42.0 79.19 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.418 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.29 -40.03 92.62 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.503 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.456 HD13 HH21 ' X' ' 57' ' ' ARG . 89.7 mt -61.4 -42.83 95.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.26 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -54.51 -37.89 65.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.545 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' X' ' 92' ' ' LYS . 94.3 mt-10 -67.31 -36.32 81.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.568 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' X' ' 22' ' ' ARG . 7.7 mp -64.31 -46.85 81.75 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.091 -0.643 . . . . 1.0 111.869 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.75 HD11 HD12 ' X' ' 53' ' ' ILE . 29.9 mt -74.18 -25.68 20.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.084 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.579 ' OD2' HD11 ' X' ' 51' ' ' ILE . 75.5 m-20 -98.24 -6.56 30.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.084 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' X' ' 88' ' ' GLU . 10.8 mmpt? 44.3 86.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.219 0.533 . . . . 1.0 110.565 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' X' ' 95' ' ' VAL . 89.0 tttt -63.91 -35.01 79.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.491 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -40.47 -22.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' X' ' 93' ' ' LYS . 9.5 m -126.86 135.2 64.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.599 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 161.13 23.97 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.517 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.03 151.5 67.53 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.705 2.27 . . . . 1.0 112.162 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.29 154.28 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.595 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.58 -46.03 97.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 43.6 ttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.484 179.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.79 154.93 53.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -118.11 127.26 53.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.859 0.361 . . . . 1.0 110.68 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.418 ' O ' ' OE2' ' X' ' 9' ' ' GLU . 79.8 mm-40 -70.09 -41.1 74.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.787 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.859 HD21 HH21 ' X' ' 10' ' ' ARG . 35.8 tp -109.73 129.12 55.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.54 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 26.1 p -149.58 167.9 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.706 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.88 -28.72 69.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -64.25 -41.26 97.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.495 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' X' ' 4' ' ' GLU . 95.4 mt-10 -65.66 -48.18 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.538 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.859 HH21 HD21 ' X' ' 5' ' ' LEU . 95.4 mtt-85 -62.97 -35.77 81.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.555 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.671 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.4 t80 -59.06 -48.51 81.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.91 -46.27 96.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.458 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -49.42 -39.65 33.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.461 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.92 -47.98 78.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.494 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.671 HD11 ' CE2' ' X' ' 11' ' ' TYR . 60.2 mt -64.96 -31.54 72.82 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.124 -0.489 . . . . 1.0 109.999 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -56.54 -45.31 81.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.504 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.23 -49.38 43.91 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.136 0.494 . . . . 1.0 110.925 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -60.86 -50.13 74.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.475 HD23 ' HD2' ' X' ' 22' ' ' ARG . 79.8 mt -57.55 -39.19 76.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.482 -0.327 . . . . 1.0 110.896 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -56.75 -38.61 72.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 81.0 p -72.71 -29.22 63.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.601 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.753 ' O ' HD12 ' X' ' 85' ' ' LEU . 69.6 mtt180 -69.11 -16.94 63.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.689 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.25 21.91 7.77 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.543 -0.623 . . . . 1.0 111.543 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.467 HG11 ' HD2' ' X' ' 82' ' ' TYR . 31.3 t -111.68 131.97 61.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 1.0 110.66 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.07 98.62 5.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.318 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.26 162.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.831 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -73.61 147.22 44.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.537 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.75 -46.35 90.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -58.73 -30.04 67.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.697 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -59.71 -52.52 65.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.925 0.393 . . . . 1.0 111.161 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.6 mt -66.41 -38.65 87.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.681 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.46 -46.76 84.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.782 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.86 -40.46 79.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.093 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.498 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.9 t80 -64.17 -38.1 89.83 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.892 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -61.92 -44.19 97.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.098 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.26 -29.03 65.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -58.66 -51.6 69.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.719 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.7 p -69.16 -29.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.45 -46.69 78.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.755 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -71.18 -31.92 68.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.167 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -98.27 -4.47 35.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.022 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -162.87 110.49 1.05 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.615 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.13 -18.14 18.7 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.506 2.138 . . . . 1.0 111.94 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.618 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 3.7 p90 -88.63 -171.1 3.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.475 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.609 ' N ' ' HD2' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 160.45 -54.01 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.434 -178.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_endo -63.25 143.42 89.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.688 2.259 . . . . 1.0 112.404 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.842 HE21 HH21 ' X' ' 55' ' ' ARG . 85.0 mt-30 -142.73 -153.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.277 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.15 129.37 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.27 -115.84 4.74 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.426 ' O ' ' C ' ' X' ' 51' ' ' ILE . 82.7 p -57.66 165.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.439 HG22 ' H ' ' X' ' 54' ' ' LYS . 54.9 mt -36.18 109.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.373 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 36.9 t0 -67.67 -35.72 79.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.016 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.621 HD12 HD11 ' X' ' 90' ' ' ILE . 28.2 mt -62.1 -22.18 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.58 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.439 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.8 tttt -48.47 -44.89 36.02 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.028 -178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.842 HH21 HE21 ' X' ' 47' ' ' GLN . 64.0 ttm-85 -60.75 -41.52 95.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.497 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.703 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 11.2 t90 -61.69 -51.7 67.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.778 0.799 . . . . 1.0 110.979 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.703 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 19.3 mmt180 -64.83 -37.29 87.12 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.627 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.41 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 54.8 mtt-85 -54.46 -43.79 71.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.635 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.402 HG23 ' O ' ' X' ' 55' ' ' ARG . 59.1 t -65.83 -44.34 92.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.33 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.7 -50.9 58.19 Favored Glycine 0 C--O 1.212 -1.251 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -53.46 -40.19 65.06 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.476 -0.426 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.9 -56.7 4.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.242 0.544 . . . . 1.0 111.321 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.84 -45.35 90.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.202 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.536 HE21 ' C ' ' X' ' 75' ' ' VAL . 80.8 mt-30 -60.79 -38.17 84.43 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.79 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.0 -49.05 69.71 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.729 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -78.13 -41.86 33.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.239 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -60.25 -47.42 86.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.102 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -63.51 -41.29 98.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 82.5 m -63.45 -46.49 86.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.465 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -63.83 -43.95 94.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.36 -52.05 0.44 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.998 -0.841 . . . . 1.0 110.998 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 77.1 Cg_exo -42.52 95.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.682 2.255 . . . . 1.0 112.449 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.6 4.28 53.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.752 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 82.3 tttt -37.83 -44.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.6 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.536 ' C ' HE21 ' X' ' 64' ' ' GLN . 0.1 OUTLIER -117.32 87.45 24.48 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.962 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 47.6 Cg_exo -53.71 145.69 48.04 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.647 2.232 . . . . 1.0 112.454 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' X' ' 79' ' ' ALA . 2.1 m -66.57 -23.9 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.46 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 74.9 p -43.59 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -56.42 -31.09 63.58 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.2 0.524 . . . . 1.0 110.036 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.22 -47.6 68.83 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.829 -0.545 . . . . 1.0 110.456 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 13.6 t -65.25 -43.88 89.91 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.204 0.526 . . . . 1.0 110.547 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.601 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.72 -37.37 70.87 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.742 0.782 . . . . 1.0 110.357 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.565 ' N ' ' CD1' ' X' ' 82' ' ' TYR . 19.5 t90 -69.45 -29.11 66.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.392 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -59.49 -45.95 90.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.464 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.753 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.5 mm? -59.1 -41.5 88.27 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 120.436 -0.505 . . . . 1.0 110.749 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.54 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 42.4 mt -64.51 -44.67 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.119 -0.633 . . . . 1.0 110.225 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.459 ' HE3' ' CH2' ' X' ' 83' ' ' TRP . 18.7 mttt -47.1 -51.28 18.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.46 -0.496 . . . . 1.0 111.126 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -60.82 -31.24 70.66 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 123.244 0.34 . . . . 1.0 110.997 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.513 HD22 ' CD ' ' X' ' 22' ' ' ARG . 49.3 tp -72.09 -51.31 22.11 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.992 -0.683 . . . . 1.0 111.534 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.621 HD11 HD12 ' X' ' 53' ' ' ILE . 48.4 mt -76.76 -28.22 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 1.0 110.839 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' X' ' 87' ' ' LYS . 18.5 m-20 -59.23 -42.4 90.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.205 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -63.9 -39.26 93.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.583 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -74.86 -10.99 60.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.49 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -53.1 -19.53 2.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.486 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.67 148.71 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.433 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.506 ' N ' ' HD2' ' X' ' 97' ' ' PRO . 1.4 m-20 171.85 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.581 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' X' ' 96' ' ' ASN . 65.8 Cg_endo -75.35 151.82 38.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.787 2.325 . . . . 1.0 112.142 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -107.74 126.07 52.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.502 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.29 131.07 67.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.602 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 78.6 mtm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.58 179.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.44 21.18 67.52 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -128.4 125.5 38.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.699 0.285 . . . . 1.0 110.603 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.77 116.48 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.364 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.5 -105.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.309 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -150.14 167.03 28.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.815 0.341 . . . . 1.0 110.417 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -50.52 -27.11 6.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -57.96 -40.99 81.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.486 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.631 ' OE2' HD22 ' X' ' 32' ' ' LEU . 1.1 tm-20 -62.78 -42.79 99.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.496 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -66.45 -36.24 82.29 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' X' ' 15' ' ' LEU . 90.8 t80 -57.84 -49.69 75.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.339 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.405 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.6 OUTLIER -64.99 -33.43 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 1.0 110.374 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.63 -37.54 85.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.776 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -65.56 -39.79 92.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.619 HD11 ' CE2' ' X' ' 11' ' ' TYR . 93.7 mt -61.39 -46.66 89.23 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.359 -0.537 . . . . 1.0 110.339 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.39 -48.12 71.94 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.216 0.322 . . . . 1.0 111.189 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -59.17 -54.04 51.52 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.295 -0.562 . . . . 1.0 111.418 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -62.33 -47.71 83.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 1.0 111.227 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.498 HD12 HG21 ' X' ' 24' ' ' VAL . 3.8 mm? -63.32 -37.11 85.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.46 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.44 -37.47 70.29 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.726 -0.389 . . . . 1.0 110.255 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 65.6 p -70.33 -12.11 61.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.835 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.7 mtt-85 -95.71 -4.95 43.25 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.857 -0.337 . . . . 1.0 111.752 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.54 23.4 5.99 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.857 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.498 HG21 HD12 ' X' ' 19' ' ' LEU . 43.0 t -101.12 133.82 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.996 0.427 . . . . 1.0 111.218 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -130.72 74.04 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.416 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 42.0 t -130.2 134.26 62.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.537 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -61.87 145.91 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.419 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 32.4 p90 -59.71 -41.3 90.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.705 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.618 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -53.87 -39.24 65.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.471 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -58.29 -50.76 72.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.768 -0.373 . . . . 1.0 110.396 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.28 -40.02 93.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.613 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.631 HD22 ' OE2' ' X' ' 9' ' ' GLU . 63.0 tp -61.59 -48.12 82.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 1.0 110.125 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -66.76 -42.84 85.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.317 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.547 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 8.7 t80 -63.61 -34.76 78.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.663 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -61.18 -45.22 95.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 1.0 109.88 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.73 -34.98 77.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.745 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.436 ' CG ' HG11 ' X' ' 75' ' ' VAL . 39.0 t80 -58.19 -49.62 76.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.795 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' X' ' 42' ' ' CYS . 4.5 p -66.12 -34.14 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.079 0.466 . . . . 1.0 109.939 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -65.89 -33.6 76.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.065 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.02 -49.55 28.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.61 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 6.0 p -95.32 -5.91 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.608 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.615 ' SG ' ' NE1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -148.65 80.6 8.19 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.061 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.41 -38.93 93.49 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.737 2.292 . . . . 1.0 112.192 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.615 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 2.8 p90 -66.22 -170.72 0.09 Allowed 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.165 0.507 . . . . 1.0 110.677 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -179.87 -45.18 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.421 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.9 Cg_exo -67.76 150.46 79.0 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.788 2.325 . . . . 1.0 112.746 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' X' ' 55' ' ' ARG . 47.8 tp60 -163.66 154.91 16.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.333 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -116.71 140.27 49.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.654 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 -131.95 10.17 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.1 -0.8 . . . . 1.0 111.1 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.8 p -59.25 167.34 1.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.025 -0.361 . . . . 1.0 110.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.563 HG22 ' H ' ' X' ' 54' ' ' LYS . 7.6 mt -34.29 113.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 O-C-N 123.668 0.605 . . . . 1.0 110.005 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 37.6 t0 -63.4 -37.27 86.61 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.657 -0.701 . . . . 1.0 110.668 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.635 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 57.9 mt -60.91 -25.57 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.76 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.563 ' H ' HG22 ' X' ' 51' ' ' ILE . 78.8 tttt -48.93 -43.12 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.71 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' X' ' 47' ' ' GLN . 88.9 mtt180 -65.18 -37.34 87.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.685 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.64 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.3 t90 -63.91 -51.52 64.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.534 . . . . 1.0 110.845 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.64 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 23.4 mmt180 -64.09 -34.45 78.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.82 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 65.5 mtt-85 -58.94 -44.07 91.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 1.0 110.783 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.35 -44.77 99.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.143 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.58 -48.45 56.58 Favored Glycine 0 C--O 1.211 -1.297 0 N-CA-C 111.24 -0.744 . . . . 1.0 111.24 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -51.01 -41.92 60.1 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.962 -0.728 . . . . 1.0 110.746 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.05 -50.99 11.0 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.242 0.544 . . . . 1.0 111.399 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.54 -44.79 93.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.933 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 55.9 mt-30 -56.71 -39.7 74.34 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.653 ' O ' HG23 ' X' ' 69' ' ' THR . 99.8 m-20 -58.94 -47.72 84.06 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.045 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.79 -42.75 66.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 1.0 111.543 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -48.09 82.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.64 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.555 ' OD1' HG13 ' X' ' 77' ' ' VAL . 1.3 m120 -62.29 -42.49 99.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 1.0 110.53 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . 0.653 HG23 ' O ' ' X' ' 65' ' ' ASP . 77.3 p -68.31 -38.03 81.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.025 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -63.79 -43.21 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.637 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.15 -66.81 0.3 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.06 -0.816 . . . . 1.0 111.06 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.13 108.71 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 123.223 2.616 . . . . 1.0 112.869 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -91.46 6.12 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.167 -0.924 . . . . 1.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -38.15 -39.75 0.44 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.559 0.219 . . . . 1.0 110.624 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.526 HG23 ' O ' ' X' ' 75' ' ' VAL . 24.7 m -121.64 86.54 45.04 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.606 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.33 149.17 87.32 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.764 2.309 . . . . 1.0 112.527 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.555 HG13 ' OD1' ' X' ' 68' ' ' ASN . 1.3 m -69.99 -23.48 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.709 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 23.7 p -45.28 -14.32 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.168 0.509 . . . . 1.0 110.735 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.42 -24.86 58.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.381 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -59.77 -49.56 77.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.845 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 34.6 t -62.85 -44.37 96.32 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.571 0.7 . . . . 1.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.863 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 3.4 t80 -56.15 -40.09 73.31 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.609 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.48 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.8 t90 -64.28 -31.56 72.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.691 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -56.53 -45.09 81.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.173 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.608 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -63.01 -38.44 91.19 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.015 -0.674 . . . . 1.0 109.988 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.863 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -62.77 -42.73 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.059 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -55.05 -42.42 72.67 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.666 -0.414 . . . . 1.0 109.921 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.59 -27.17 66.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.763 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.835 HD22 ' NE ' ' X' ' 22' ' ' ARG . 32.1 tp -74.99 -51.01 14.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.957 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.627 HD11 HD12 ' X' ' 53' ' ' ILE . 22.5 mt -70.87 -41.63 77.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.199 0.523 . . . . 1.0 111.037 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.67 -44.5 57.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.492 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -61.46 -41.72 97.66 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.029 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' X' ' 95' ' ' VAL . 98.6 mttt -63.98 -40.38 96.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -44.18 -17.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.517 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' X' ' 93' ' ' LYS . 53.7 t -119.83 129.44 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.266 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.414 ' C ' HD22 ' X' ' 96' ' ' ASN . 0.3 OUTLIER 54.1 69.02 2.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.628 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.48 -40.73 71.05 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.876 2.384 . . . . 1.0 112.152 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.74 137.59 55.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.368 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 47.1 t -123.37 130.45 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.58 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.691 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.6 24.22 56.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.13 133.21 46.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.334 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 41.6 tp10 -59.72 -44.6 93.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.475 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.732 HD21 HH21 ' X' ' 10' ' ' ARG . 44.5 tp -111.65 126.75 55.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.454 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -148.03 162.45 39.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.971 -0.558 . . . . 1.0 110.38 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -62.41 -27.98 69.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.617 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -66.16 -39.39 89.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.262 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' X' ' 4' ' ' GLU . 95.1 mt-10 -66.5 -37.71 85.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.466 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.732 HH21 HD21 ' X' ' 5' ' ' LEU . 93.5 mtt180 -67.08 -41.75 85.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.954 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' X' ' 11' ' ' TYR . 24.9 t80 -58.57 -51.75 68.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.883 0.373 . . . . 1.0 111.583 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.642 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.95 -36.88 85.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.653 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -61.7 -39.82 92.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.008 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.99 -46.14 90.57 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 20' ' ' LYS . 60.5 tttm -51.44 -46.44 63.01 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 121.276 -0.17 . . . . 1.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.09 -52.29 63.25 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.03 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.45 -49.27 77.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.436 HD12 HG21 ' X' ' 24' ' ' VAL . 4.0 mm? -59.41 -33.52 71.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.617 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.668 ' HZ1' ' HZ1' ' X' ' 16' ' ' LYS . 28.2 mttt -58.34 -43.81 88.47 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.039 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 77.1 p -74.7 -18.17 60.55 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.325 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' X' ' 85' ' ' LEU . 39.1 mtp180 -78.73 -13.34 59.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.292 0.479 . . . . 1.0 112.292 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 23.62 5.28 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.833 -0.698 . . . . 1.0 112.206 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.436 HG21 HD12 ' X' ' 19' ' ' LEU . 44.1 t -115.41 137.49 48.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.694 0.283 . . . . 1.0 111.136 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -123.22 87.78 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.56 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.417 HG22 HG12 ' X' ' 24' ' ' VAL . 31.3 m -135.95 154.32 33.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.638 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -80.76 151.86 28.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.679 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.419 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -64.63 -44.41 90.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.457 . . . . 1.0 110.894 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -54.56 -36.28 64.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.63 -49.4 77.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.751 -0.379 . . . . 1.0 110.68 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' X' ' 31' ' ' LEU . 96.6 mt -64.96 -40.54 95.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.433 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 53.2 tp -61.97 -48.88 78.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.639 -0.424 . . . . 1.0 110.412 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.425 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.8 mttm -65.56 -41.55 92.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 1.0 109.98 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.54 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 5.2 t80 -62.17 -41.04 97.93 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.896 -0.593 . . . . 1.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.74 -44.53 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.165 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -66.24 -26.16 67.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -62.73 -52.52 62.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.907 0.384 . . . . 1.0 110.936 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.4 p -68.04 -31.75 53.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.349 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.51 -43.31 97.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.926 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.17 -40.98 95.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.054 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 12.2 p -98.3 -4.87 34.14 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.87 0.367 . . . . 1.0 111.257 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.61 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.0 OUTLIER -164.59 98.29 0.88 Allowed Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.512 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.64 -4.88 15.84 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.147 1.898 . . . . 1.0 111.496 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.472 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 2.3 p90 -100.91 -174.2 2.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.328 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.7 -41.57 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.494 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 37.9 Cg_exo -60.32 142.16 97.47 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.452 2.101 . . . . 1.0 112.586 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.504 ' OE1' ' NH2' ' X' ' 55' ' ' ARG . 51.5 tt0 -174.66 163.04 3.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.442 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -117.54 150.33 39.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.567 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.97 -128.27 7.81 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.424 ' O ' ' C ' ' X' ' 51' ' ' ILE . 18.2 p -68.79 165.32 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.986 -0.375 . . . . 1.0 109.986 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.453 HG22 ' H ' ' X' ' 54' ' ' LYS . 43.9 mt -36.68 107.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.952 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 17.9 t0 -73.1 -38.26 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.616 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.566 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 40.7 mt -59.25 -22.64 22.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.729 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.699 ' NZ ' ' HE ' ' X' ' 58' ' ' ARG . 39.3 tttm -48.21 -44.96 33.35 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.094 -0.242 . . . . 1.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.553 ' O ' HG23 ' X' ' 59' ' ' VAL . 84.7 mtm-85 -64.71 -38.42 90.95 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.56 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.619 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 13.8 t90 -62.61 -47.43 83.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.248 0.547 . . . . 1.0 111.059 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.619 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 22.9 mmt180 -67.36 -36.05 80.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.751 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.699 ' HE ' ' NZ ' ' X' ' 54' ' ' LYS . 83.7 mtt-85 -59.6 -42.99 93.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.923 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.553 HG23 ' O ' ' X' ' 55' ' ' ARG . 51.0 t -64.46 -43.95 96.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.041 0.448 . . . . 1.0 110.169 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -67.76 -49.7 47.39 Favored Glycine 0 C--O 1.217 -0.924 0 N-CA-C 111.466 -0.654 . . . . 1.0 111.466 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -61.28 -43.09 99.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.726 0.263 . . . . 1.0 111.214 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 85.6 m -64.41 -58.09 7.43 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-O 121.307 0.575 . . . . 1.0 110.998 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -62.63 -33.57 75.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.67 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.0 tm0? -61.85 -32.98 73.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.795 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.53 -47.04 77.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.088 0.471 . . . . 1.0 110.296 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 1.3 t80 -74.49 -39.48 62.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -65.45 -43.85 89.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.438 ' CG ' HE21 ' X' ' 64' ' ' GLN . 2.5 m120 -64.29 -44.95 90.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.822 0.344 . . . . 1.0 110.901 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 94.5 m -62.46 -47.21 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.952 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.01 -42.12 97.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.081 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.39 -67.44 0.31 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.75 -0.94 . . . . 1.0 110.75 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -34.4 99.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 123.127 2.552 . . . . 1.0 112.308 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -90.98 4.74 51.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.648 -0.705 . . . . 1.0 110.644 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -38.23 -38.84 0.37 Allowed 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.867 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.409 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.0 OUTLIER -119.95 85.36 34.44 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.516 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -61.5 151.7 78.12 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.884 2.389 . . . . 1.0 112.646 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.2 p -66.96 -27.58 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.863 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 73.2 p -44.02 -18.68 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.987 0.422 . . . . 1.0 110.515 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.92 -29.11 70.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.706 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -59.53 -48.87 79.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.723 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 42.3 t -62.05 -44.79 95.92 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.358 0.599 . . . . 1.0 110.621 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.585 ' OH ' ' NH2' ' X' ' 57' ' ' ARG . 0.0 OUTLIER -56.48 -42.72 78.75 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.624 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.405 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 23.1 t90 -65.97 -29.35 69.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.793 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.46 -44.97 81.07 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' X' ' 22' ' ' ARG . 4.0 mm? -62.07 -44.33 96.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.188 -1.005 . . . . 1.0 110.173 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.57 ' HA ' HH22 ' X' ' 22' ' ' ARG . 5.7 mt -56.71 -46.97 83.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.124 -0.63 . . . . 1.0 111.878 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -50.03 -43.38 50.84 Favored 'General case' 0 CA--C 1.51 -0.592 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.318 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.45 -30.74 71.57 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.85 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' X' ' 22' ' ' ARG . 39.2 tp -75.33 -50.91 14.5 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.484 -0.486 . . . . 1.0 112.165 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.564 HD11 HD12 ' X' ' 53' ' ' ILE . 51.7 mt -69.84 -26.72 30.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 1.0 110.444 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.56 -35.87 82.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.57 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.22 -41.82 98.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.789 0.328 . . . . 1.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' X' ' 95' ' ' VAL . 66.0 mttm -48.42 137.66 11.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.181 0.515 . . . . 1.0 110.193 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.63 4.25 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.964 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' X' ' 93' ' ' LYS . 95.4 t -76.91 95.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.499 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.33 71.9 0.95 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.602 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.64 145.25 98.61 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.843 2.362 . . . . 1.0 112.201 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -65.43 -45.04 85.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.716 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.14 134.67 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.441 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 C--O 1.22 -0.447 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.667 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.209 -0.664 . . . . 1.0 109.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.73 -166.9 45.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -103.56 132.67 49.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.65 0.262 . . . . 1.0 110.416 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . 0.597 ' C ' HD23 ' X' ' 5' ' ' LEU . 84.5 tt0 -108.69 120.0 41.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.744 HD23 ' N ' ' X' ' 5' ' ' LEU . 0.0 OUTLIER -103.21 -70.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.448 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t -147.58 149.02 31.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.46 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -30.48 71.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.77 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -67.23 -43.25 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.0 110.498 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.71 ' OE1' HD12 ' X' ' 5' ' ' LEU . 97.6 mt-10 -65.97 -47.13 75.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.582 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.23 -35.4 80.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.637 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' X' ' 15' ' ' LEU . 86.1 t80 -57.89 -47.32 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.343 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.58 -46.51 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.283 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -46.66 -38.59 9.98 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.444 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -66.4 -47.66 72.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.594 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.9 mt -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.444 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -57.24 -42.84 82.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.586 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -71.79 -53.41 13.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.124 0.488 . . . . 1.0 111.325 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -57.97 -49.75 75.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.02 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.402 HD23 ' HD2' ' X' ' 22' ' ' ARG . 84.2 mt -60.36 -36.48 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.91 -39.86 75.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.887 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' X' ' 18' ' ' ALA . 71.1 p -70.7 -13.28 62.01 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.959 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.642 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.9 mtt-85 -89.32 -6.32 56.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.03 -0.268 . . . . 1.0 111.052 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.41 22.18 6.89 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 49.5 t -99.05 127.89 51.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -123.84 84.11 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.72 158.69 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -78.03 162.87 26.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.514 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.505 ' CE2' HD22 ' X' ' 32' ' ' LEU . 87.7 t80 -62.23 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.013 0.435 . . . . 1.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.635 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -58.67 -27.05 64.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -62.41 -52.95 61.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.04 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.0 -38.0 69.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.989 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' X' ' 28' ' ' TYR . 32.8 tp -62.54 -46.16 89.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.332 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.635 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 67.0 mttm -66.83 -39.4 87.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.64 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -59.78 -47.54 85.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.462 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.527 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.3 OUTLIER -63.89 -32.02 73.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.222 0.534 . . . . 1.0 110.319 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -67.3 -34.42 77.34 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.313 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -65.95 -53.76 35.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.16 0.505 . . . . 1.0 111.212 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.666 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.4 p -66.4 -33.84 66.14 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.108 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.517 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 81.4 mttt -60.36 -37.83 81.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.34 -0.544 . . . . 1.0 110.635 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -63.99 -47.18 81.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.977 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.474 ' C ' ' SG ' ' X' ' 42' ' ' CYS . 69.5 p -99.92 -53.43 3.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 1.0 110.977 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.666 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.5 OUTLIER 37.02 64.79 2.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.93 -34.57 98.5 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.307 2.005 . . . . 1.0 110.982 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' X' ' 44' ' ' TRP . 0.0 OUTLIER -129.33 -160.1 1.01 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.359 -0.837 . . . . 1.0 110.506 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.604 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.3 OUTLIER 158.97 -37.83 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.23 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 32.3 Cg_exo -60.68 148.93 90.0 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.537 2.158 . . . . 1.0 112.649 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' X' ' 48' ' ' GLU . 37.8 tt0 -96.68 157.75 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.597 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . 0.492 ' CD ' HH22 ' X' ' 55' ' ' ARG . 97.9 mt-10 -134.69 -112.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.412 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.07 2.74 19.2 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.5 p -133.33 163.4 29.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.7 0.286 . . . . 1.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.456 HG23 HD13 ' X' ' 90' ' ' ILE . 26.7 mt -39.82 108.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.337 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -65.83 -36.09 82.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.624 HD12 HD11 ' X' ' 90' ' ' ILE . 68.7 mt -62.9 -15.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.856 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -57.98 -44.9 87.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.352 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.492 HH22 ' CD ' ' X' ' 48' ' ' GLU . 99.6 mtt180 -62.79 -33.62 75.57 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.731 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.527 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 11.8 t90 -63.59 -53.74 46.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 1.0 110.079 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -69.32 -25.87 64.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -57.71 -47.79 81.41 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.384 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.542 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 72.2 t -69.22 -43.5 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.362 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.39 -48.72 83.56 Favored Glycine 0 C--O 1.219 -0.817 0 N-CA-C 111.221 -0.752 . . . . 1.0 111.221 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.36 -41.45 84.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.229 0.514 . . . . 1.0 110.506 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 62.0 m -68.06 -56.86 7.33 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.385 0.612 . . . . 1.0 111.206 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -38.04 84.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.6 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.582 ' OE1' HG12 ' X' ' 77' ' ' VAL . 0.8 OUTLIER -58.01 -36.23 72.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.684 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.08 -44.8 94.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 1.0 110.288 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' X' ' 66' ' ' TYR . 2.5 t80 -76.98 -36.51 56.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.365 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -67.78 -48.9 65.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.497 -0.319 . . . . 1.0 111.185 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.46 HD22 ' N ' ' X' ' 68' ' ' ASN . 0.9 OUTLIER -65.71 -41.12 92.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.978 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 87.4 m -60.53 -48.26 82.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.287 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.71 -39.32 87.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.881 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 154.99 -55.58 0.42 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 76.6 Cg_exo -41.85 99.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.467 2.111 . . . . 1.0 112.321 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' X' ' 74' ' ' LYS . 17.3 pt-20 -90.78 5.85 46.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.9 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' X' ' 73' ' ' GLU . 86.9 tttt -36.09 -45.09 0.41 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.279 0.362 . . . . 1.0 110.75 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -117.63 87.54 26.53 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.158 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.93 150.98 74.89 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.885 2.39 . . . . 1.0 112.247 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.582 HG12 ' OE1' ' X' ' 64' ' ' GLN . 1.0 OUTLIER -65.11 -30.43 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.56 -179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 60.3 p -46.43 -19.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.515 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -62.05 -29.03 70.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.658 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 22.3 t80 -59.59 -48.66 80.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 53.5 m -61.49 -44.4 97.15 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.861 0.839 . . . . 1.0 110.229 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.681 ' OH ' HD11 ' X' ' 86' ' ' ILE . 0.1 OUTLIER -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.493 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.479 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.81 -31.8 68.77 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.37 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -58.34 -39.75 80.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.642 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.45 -39.76 88.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.75 -0.78 . . . . 1.0 109.406 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.681 HD11 ' OH ' ' X' ' 82' ' ' TYR . 96.5 mt -63.12 -44.14 99.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 119.828 -0.749 . . . . 1.0 110.842 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.479 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -47.99 -47.25 33.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.473 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -65.9 -30.7 71.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.921 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.611 HD22 ' NE ' ' X' ' 22' ' ' ARG . 51.4 tp -68.64 -50.1 53.95 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.474 -0.49 . . . . 1.0 111.526 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.624 HD11 HD12 ' X' ' 53' ' ' ILE . 31.4 mt -71.47 -40.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.467 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.58 -47.32 63.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.9 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.476 ' O ' HG23 ' X' ' 95' ' ' VAL . 51.7 mtmt -62.82 -39.07 93.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 1.0 110.575 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' X' ' 90' ' ' ILE . 97.0 mttt -91.64 171.93 8.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 55.7 32.53 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.347 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.476 HG23 ' O ' ' X' ' 92' ' ' LYS . 51.6 t -64.92 -44.07 96.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 1.0 110.833 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.411 ' ND2' ' N ' ' X' ' 96' ' ' ASN . 0.2 OUTLIER -162.17 76.24 2.15 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.688 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.47 144.43 99.52 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.023 2.482 . . . . 1.0 112.062 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.44 125.75 27.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.62 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.16 -45.93 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.518 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 51.6 ttp . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.953 -1.022 . . . . 1.0 110.656 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.406 -0.591 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.64 63.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.151 -0.779 . . . . 1.0 111.151 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -117.31 126.23 52.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.885 0.374 . . . . 1.0 110.53 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.19 -39.94 93.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.505 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 33.4 tp -114.76 129.55 56.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.565 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.1 p -142.61 162.86 34.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.556 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -60.82 -30.32 70.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.605 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -66.81 -42.06 86.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.562 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -66.61 -41.36 88.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.418 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -65.24 -35.59 81.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.412 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -59.67 -48.13 82.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.965 0.412 . . . . 1.0 111.242 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -33.18 61.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.205 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -64.9 -36.59 84.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.89 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.2 -41.77 94.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.01 -40.44 97.77 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.072 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.42 -46.52 83.45 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.879 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -63.04 -52.02 64.46 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.583 -0.447 . . . . 1.0 111.371 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.485 ' CB ' HH12 ' X' ' 22' ' ' ARG . . . -62.94 -47.28 83.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.963 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.401 ' HA ' HH11 ' X' ' 22' ' ' ARG . 82.1 mt -62.7 -37.11 85.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.56 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.8 -41.82 78.44 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.71 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 58.3 p -68.54 -19.04 64.48 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.758 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' X' ' 89' ' ' LEU . 84.2 mtt85 -85.17 -9.13 58.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.256 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.12 23.03 6.56 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.82 -0.705 . . . . 1.0 111.646 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.71 132.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.921 0.391 . . . . 1.0 110.878 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -124.15 74.47 1.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.81 134.93 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.758 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.32 155.54 34.95 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.608 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 25.7 p90 -63.98 -40.17 95.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' X' ' 28' ' ' TYR . . . -55.35 -40.14 70.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.751 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.46 -50.12 75.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.391 . . . . 1.0 110.896 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.04 -40.09 90.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.9 -47.83 83.18 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.391 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.58 -41.45 88.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.173 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.616 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.9 t80 -61.06 -44.9 96.68 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.188 -0.605 . . . . 1.0 111.12 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.642 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -59.57 -36.55 76.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.843 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -72.4 -23.94 61.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.587 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -63.74 -54.99 26.7 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.142 0.496 . . . . 1.0 111.433 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' X' ' 42' ' ' CYS . 8.8 p -69.08 -39.06 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.378 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.459 ' N ' HG13 ' X' ' 38' ' ' VAL . 68.1 mmtt -65.93 -32.91 74.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.784 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -61.86 -46.05 91.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.687 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 8.3 p -97.68 -17.36 19.5 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.466 -0.494 . . . . 1.0 110.504 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.532 ' N ' ' HD3' ' X' ' 43' ' ' PRO . 0.0 OUTLIER 39.32 57.2 6.24 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-O 121.747 0.784 . . . . 1.0 110.979 -178.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' X' ' 44' ' ' TRP . 8.3 Cg_exo -70.16 -27.65 24.27 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.019 1.813 . . . . 1.0 112.223 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.541 ' O ' ' O ' ' X' ' 43' ' ' PRO . 5.1 m-90 50.86 119.16 0.0 OUTLIER 'General case' 0 C--N 1.339 0.146 0 O-C-N 123.645 0.591 . . . . 1.0 110.829 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' X' ' 59' ' ' VAL . 24.4 m-85 -118.88 57.9 3.54 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.488 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.433 ' HA ' HH11 ' X' ' 55' ' ' ARG . 71.6 Cg_exo -31.5 134.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.147 2.564 . . . . 1.0 112.762 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -153.09 148.63 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.51 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -140.87 143.11 34.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.658 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.65 -15.08 63.85 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 44.3 p -129.57 164.66 23.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.819 0.343 . . . . 1.0 110.345 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.51 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.8 mt -40.91 125.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.198 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' NH2' ' X' ' 55' ' ' ARG . 65.3 t0 -62.75 -41.4 99.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.788 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.545 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 5.3 mt -59.0 -25.62 30.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.547 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.51 ' H ' HG22 ' X' ' 51' ' ' ILE . 87.7 tttt -48.62 -31.53 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.875 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' X' ' 52' ' ' ASP . 84.4 mtm180 -62.69 -44.8 95.32 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.345 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.642 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 13.2 t90 -66.18 -49.05 68.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.671 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.631 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 22.6 mmt180 -60.24 -33.58 72.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.891 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.495 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 73.0 mtt180 -58.29 -46.89 85.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' X' ' 45' ' ' PHE . 7.6 t -61.59 -44.59 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.39 -0.524 . . . . 1.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -65.01 -50.03 59.76 Favored Glycine 0 C--O 1.22 -0.751 0 C-N-CA 120.68 -0.771 . . . . 1.0 111.446 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -60.91 -41.56 96.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.147 0.473 . . . . 1.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 75.8 m -66.56 -59.91 3.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.285 0.564 . . . . 1.0 111.218 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -61.16 -42.87 99.33 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.818 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.536 ' NE2' ' OD1' ' X' ' 68' ' ' ASN . 3.3 tm0? -53.54 -40.57 65.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.802 -0.181 . . . . 1.0 111.104 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.29 -48.29 82.35 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.535 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' X' ' 66' ' ' TYR . 0.4 OUTLIER -73.89 -42.09 61.21 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.437 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.4 -40.89 98.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' NE2' ' X' ' 64' ' ' GLN . 2.4 m120 -63.77 -44.52 93.17 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.826 -0.349 . . . . 1.0 110.609 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 22.7 p -67.81 -41.79 82.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 1.0 110.161 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -63.17 -42.92 99.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.757 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.63 -50.62 0.57 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.655 -0.978 . . . . 1.0 110.655 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 44.3 Cg_exo -50.68 105.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.381 2.054 . . . . 1.0 112.33 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.3 pt-20 -91.7 4.47 52.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.996 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.6 tttt -37.08 -41.6 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.876 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.405 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 1.1 m -119.73 86.38 35.3 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.902 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.52 150.5 81.1 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.923 2.415 . . . . 1.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -65.16 -27.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.759 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 67.5 p -46.63 -16.15 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.518 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.6 -35.41 80.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.662 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' X' ' 80' ' ' PHE . 21.3 t80 -55.79 -48.75 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.7 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.3 t -60.59 -44.12 96.61 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.507 0.67 . . . . 1.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.578 ' CD1' ' C ' ' X' ' 82' ' ' TYR . 0.0 OUTLIER -58.06 -45.62 86.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.533 0.682 . . . . 1.0 109.694 179.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.472 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.8 t90 -58.88 -30.38 67.72 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.498 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -58.76 -40.58 84.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.745 -0.465 . . . . 1.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.644 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -61.46 -39.23 90.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.075 -0.65 . . . . 1.0 109.724 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.501 HD13 HH21 ' X' ' 57' ' ' ARG . 32.4 mt -62.37 -44.26 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.584 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.472 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.8 mttt -48.06 -43.99 30.98 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.145 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . 0.516 ' O ' ' OD1' ' X' ' 91' ' ' ASP . 83.7 mt-10 -66.0 -26.9 67.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.658 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.718 HD22 ' NE ' ' X' ' 22' ' ' ARG . 59.6 tp -76.5 -50.74 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.782 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' X' ' 93' ' ' LYS . 46.7 mt -69.01 -45.12 80.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.514 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' X' ' 92' ' ' LYS . 3.8 p-10 -58.77 -44.37 90.61 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.403 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.575 ' N ' ' OD1' ' X' ' 91' ' ' ASP . 67.2 mttm -65.31 -44.55 87.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.752 0.31 . . . . 1.0 110.895 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' X' ' 90' ' ' ILE . 99.3 mttt -134.97 139.48 44.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.179 0.514 . . . . 1.0 110.507 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -85.35 -4.36 59.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.185 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.19 161.18 41.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.764 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -137.75 75.53 43.05 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.675 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.9 142.7 98.39 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.889 2.393 . . . . 1.0 111.974 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -65.64 -41.89 92.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.401 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.495 HG23 ' N ' ' X' ' 100' ' ' MET . 33.6 m -65.14 -42.12 93.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . 0.495 ' N ' HG23 ' X' ' 99' ' ' VAL . 42.9 ttp . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.986 -1.006 . . . . 1.0 110.231 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.76 173.5 55.04 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -108.73 129.41 55.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.7 0.286 . . . . 1.0 110.519 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.42 -45.86 89.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 39.7 tp -110.64 129.99 55.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -147.5 162.08 39.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.211 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -64.96 -29.68 70.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.639 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -65.98 -38.76 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.073 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' O ' HG12 ' X' ' 12' ' ' VAL . 99.3 mt-10 -65.03 -35.62 81.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -65.55 -38.31 89.24 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.593 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.9 t80 -61.4 -44.29 97.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.19 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.467 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.32 -31.38 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.49 -178.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.07 -40.22 97.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -62.71 -37.71 87.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.4 mt -62.33 -40.14 95.39 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.114 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -57.32 -48.76 78.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.386 -0.525 . . . . 1.0 110.514 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -65.78 -51.47 58.79 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.681 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.67 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -60.89 -50.18 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.505 -0.316 . . . . 1.0 111.4 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' X' ' 24' ' ' VAL . 96.2 mt -65.08 -34.88 79.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.558 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.68 -41.26 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 62.5 p -67.03 -19.21 65.65 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.507 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.815 ' HE ' HD13 ' X' ' 89' ' ' LEU . 83.1 mtt85 -88.07 -6.96 57.65 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.746 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.45 21.48 7.59 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.273 -0.731 . . . . 1.0 111.273 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' X' ' 82' ' ' TYR . 55.5 t -99.72 102.34 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.21 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -101.15 93.13 5.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.331 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 38.3 t -135.88 154.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.558 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' X' ' 26' ' ' VAL . 95.3 mttt -72.63 147.44 45.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 1.0 110.794 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.65 -46.29 89.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.973 0.416 . . . . 1.0 110.682 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -61.54 -32.94 73.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.87 -0.604 . . . . 1.0 111.279 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -59.93 -52.63 64.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.554 -0.459 . . . . 1.0 110.985 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -67.32 -39.44 85.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.545 -0.298 . . . . 1.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -62.24 -47.66 83.39 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.077 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.498 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.0 mttm -69.31 -43.21 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.623 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.458 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.8 t80 -62.22 -43.77 98.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.042 0.449 . . . . 1.0 110.833 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.45 -43.84 84.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 40' ' ' ASP . 27.2 t0 -69.87 -24.65 63.45 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.407 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.56 -53.42 57.76 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.627 0.251 . . . . 1.0 111.38 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.7 p -67.08 -41.42 87.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.234 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 58.1 mmtt -63.3 -38.5 91.39 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.323 -0.551 . . . . 1.0 111.189 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' X' ' 36' ' ' ASP . 72.4 m-20 -60.72 -50.66 72.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.832 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 48.3 p -98.85 -34.22 10.57 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.752 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.9 OUTLIER -117.89 84.48 20.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.701 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -74.71 -2.63 12.72 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.035 1.823 . . . . 1.0 111.967 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.665 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.7 p90 -99.17 151.83 20.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.269 0.557 . . . . 1.0 110.834 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 5.0 p90 -167.81 46.2 0.1 Allowed Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.23 -0.895 . . . . 1.0 110.62 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 43.8 Cg_endo -65.78 161.93 36.95 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 123.21 2.607 . . . . 1.0 112.746 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -108.6 155.81 20.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.699 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . 0.558 ' CD ' HH21 ' X' ' 55' ' ' ARG . 97.1 mt-10 -137.93 46.37 2.08 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.418 -0.355 . . . . 1.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 6.74 73.5 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.419 ' O ' ' C ' ' X' ' 51' ' ' ILE . 2.2 t -137.65 163.95 30.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.562 HG22 ' H ' ' X' ' 54' ' ' LYS . 57.7 mt -36.89 108.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.243 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' X' ' 45' ' ' PHE . 64.9 t0 -66.4 -35.38 80.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.787 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.681 HD12 HD11 ' X' ' 90' ' ' ILE . 43.2 mt -62.12 -26.63 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.863 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.562 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.8 tttt -49.39 -40.42 36.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.318 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.558 HH21 ' CD ' ' X' ' 48' ' ' GLU . 94.9 mtt-85 -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.224 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.676 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.2 t90 -64.27 -48.47 75.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.472 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.676 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 18.5 mmt180 -61.12 -35.12 76.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.798 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.501 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 86.5 mtt-85 -60.62 -45.41 94.16 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.538 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.29 -42.88 91.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.005 0.431 . . . . 1.0 109.99 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -48.67 72.25 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.174 -0.771 . . . . 1.0 111.174 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.19 -42.07 97.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 1.0 110.946 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 71.7 m -65.17 -55.07 20.72 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.484 0.659 . . . . 1.0 110.985 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -61.05 -33.54 73.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.895 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.586 HE22 ' CG ' ' X' ' 68' ' ' ASN . 5.0 tp60 -54.35 -47.04 73.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.626 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.557 ' O ' HG23 ' X' ' 69' ' ' THR . 97.0 m-20 -58.62 -47.21 85.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.492 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -71.35 -47.07 58.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.301 -0.56 . . . . 1.0 111.963 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.1 -47.86 82.72 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.842 0.312 . . . . 1.0 111.842 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.586 ' CG ' HE22 ' X' ' 64' ' ' GLN . 1.1 m-80 -64.48 -41.31 96.56 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.696 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . 0.557 HG23 ' O ' ' X' ' 65' ' ' ASP . 17.0 p -61.5 -45.8 92.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -67.15 -38.41 85.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.674 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.423 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 148.41 -53.35 0.53 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -46.57 104.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.4 2.067 . . . . 1.0 112.35 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -93.16 5.02 52.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.68 . . . . 1.0 110.93 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -37.02 -41.5 0.35 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.241 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.78 85.58 28.2 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 121.058 -0.257 . . . . 1.0 110.947 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.36 147.88 92.35 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.965 2.443 . . . . 1.0 112.747 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -67.87 -26.14 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.376 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -46.74 -14.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.901 0.381 . . . . 1.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.63 -31.04 70.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.71 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.447 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 25.9 t80 -61.2 -46.75 89.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.571 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -63.21 -50.46 70.17 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.907 0.861 . . . . 1.0 110.75 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.563 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 52.5 m-85 -60.59 -33.91 73.43 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.321 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 20.9 t90 -61.44 -32.72 72.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.62 -0.718 . . . . 1.0 109.748 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -57.34 -42.09 81.31 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.489 -0.56 . . . . 1.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.494 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -59.99 -40.16 88.19 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 119.771 -0.772 . . . . 1.0 109.574 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.609 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.51 -43.63 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.355 -0.538 . . . . 1.0 111.081 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.421 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 96.1 mttt -46.74 -46.99 20.75 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.074 -0.651 . . . . 1.0 110.079 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -65.36 -34.33 78.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.909 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.815 HD13 ' HE ' ' X' ' 22' ' ' ARG . 62.8 tp -65.92 -50.32 64.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.856 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.681 HD11 HD12 ' X' ' 53' ' ' ILE . 45.1 mt -70.93 -41.19 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.028 0.442 . . . . 1.0 110.591 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -51.43 -46.69 63.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.701 -0.682 . . . . 1.0 110.343 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -63.93 -40.64 96.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.117 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -79.69 163.09 24.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.738 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 56.82 12.12 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.611 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 55.2 t -125.9 133.52 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.426 ' C ' HD22 ' X' ' 96' ' ' ASN . 0.1 OUTLIER 47.68 55.17 16.6 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.492 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 39.2 Cg_endo -67.51 147.59 77.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.763 2.309 . . . . 1.0 112.152 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -138.1 158.15 44.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.549 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.99 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.607 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.92 96.35 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.885 -0.886 . . . . 1.0 110.885 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -114.46 127.13 55.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.895 0.379 . . . . 1.0 110.665 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -66.54 -38.61 87.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.498 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 35.2 tp -104.74 129.17 53.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.356 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 93.8 p -135.94 164.37 28.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.03 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.677 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.43 -41.93 88.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.013 0.435 . . . . 1.0 110.457 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.59 -39.4 93.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.66 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.59 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.541 ' CE2' HD11 ' X' ' 15' ' ' LEU . 92.5 t80 -58.88 -49.55 77.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.879 0.371 . . . . 1.0 110.457 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -64.2 -46.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.891 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.84 -40.47 56.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.192 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -64.69 -43.12 94.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' X' ' 11' ' ' TYR . 96.1 mt -63.09 -42.9 99.7 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.999 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.55 ' HZ2' HD12 ' X' ' 31' ' ' LEU . 18.1 mttp -56.54 -47.54 79.2 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.466 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.776 ' O ' HG23 ' X' ' 21' ' ' THR . 93.8 mm-40 -58.63 -46.89 86.11 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.183 -0.607 . . . . 1.0 111.467 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.608 ' HB1' HH12 ' X' ' 22' ' ' ARG . . . -70.58 -52.78 19.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.948 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.439 ' HA ' HH11 ' X' ' 22' ' ' ARG . 7.8 mp -64.12 -41.47 97.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 1.0 111.298 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 87.8 tttt -55.86 -41.37 74.27 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.647 -0.421 . . . . 1.0 110.93 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.776 HG23 ' O ' ' X' ' 17' ' ' GLN . 81.5 p -63.0 -13.84 40.24 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.634 -0.426 . . . . 1.0 110.523 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.758 ' NE ' HD13 ' X' ' 89' ' ' LEU . 82.5 mtt85 -97.29 -5.29 37.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.543 -0.299 . . . . 1.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.28 23.51 6.03 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.069 -0.586 . . . . 1.0 111.727 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' X' ' 82' ' ' TYR . 58.4 t -99.97 101.59 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.025 0.44 . . . . 1.0 110.984 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . 0.539 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 68.0 mttm -102.32 98.55 8.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.729 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' X' ' 82' ' ' TYR . 28.0 m -134.87 164.9 32.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.692 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -96.01 157.63 15.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.081 -0.34 . . . . 1.0 110.081 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -59.33 -42.09 90.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.472 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -63.56 -34.56 78.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -60.12 -54.35 46.9 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.473 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.55 HD12 ' HZ2' ' X' ' 16' ' ' LYS . 25.7 mt -74.84 -40.79 60.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.381 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 40.3 tp -61.5 -46.14 91.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.962 0.41 . . . . 1.0 110.607 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.472 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 68.1 mttm -72.34 -39.89 67.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.332 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.648 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.35 -44.22 95.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.826 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -63.75 -33.88 76.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.211 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -67.26 -32.53 73.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.005 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -63.83 -53.79 45.18 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.467 0.651 . . . . 1.0 111.27 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.2 p -71.79 -34.2 50.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.176 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' X' ' 35' ' ' PHE . 49.8 mmtt -65.36 -35.4 80.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.742 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -61.12 -48.17 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . 0.482 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 23.7 m -94.72 -51.44 4.71 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.336 -0.546 . . . . 1.0 110.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.601 ' N ' ' O ' ' X' ' 38' ' ' VAL . 23.5 p 39.24 59.3 6.1 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.676 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.37 -31.62 8.95 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.733 2.289 . . . . 1.0 111.119 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.748 ' HE1' HG21 ' X' ' 59' ' ' VAL . 0.0 OUTLIER -141.28 -173.06 3.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.485 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.598 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER 161.92 -40.05 0.0 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.662 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.0 Cg_exo -62.12 144.72 96.22 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.893 2.395 . . . . 1.0 112.264 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.714 ' NE2' ' H ' ' X' ' 55' ' ' ARG . 71.8 mt-30 -147.37 166.44 27.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.461 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -143.78 115.81 8.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.84 5.95 88.6 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 82.2 p -137.54 163.05 32.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.796 0.331 . . . . 1.0 110.657 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.465 ' O ' ' OE1' ' X' ' 47' ' ' GLN . 6.0 mt -59.55 126.0 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.885 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.525 ' O ' ' NE2' ' X' ' 47' ' ' GLN . 29.8 t0 -63.63 -35.26 79.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.265 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.63 HD12 HD11 ' X' ' 90' ' ' ILE . 35.2 mt -68.79 -18.64 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.993 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.44 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.2 tttt -51.05 -47.09 61.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.809 -0.357 . . . . 1.0 111.132 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.714 ' H ' ' NE2' ' X' ' 47' ' ' GLN . 93.6 mtt-85 -64.46 -37.52 87.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.911 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.648 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 16.3 t90 -62.39 -46.62 87.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 120.212 -0.595 . . . . 1.0 111.221 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.578 ' NH2' ' CD1' ' X' ' 86' ' ' ILE . 31.7 mmt180 -70.16 -38.68 75.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.44 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.436 HH21 ' HE2' ' X' ' 54' ' ' LYS . 79.9 mtt-85 -55.58 -43.56 76.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.746 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.748 HG21 ' HE1' ' X' ' 44' ' ' TRP . 98.2 t -64.53 -42.33 94.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.951 -0.388 . . . . 1.0 109.951 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -67.26 -49.13 54.7 Favored Glycine 0 C--O 1.211 -1.334 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -51.2 -41.33 60.17 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.882 -0.775 . . . . 1.0 110.622 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' X' ' 63' ' ' PHE . 0.0 OUTLIER -72.17 -56.34 5.74 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.502 0.668 . . . . 1.0 110.769 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . 0.602 ' N ' ' SG ' ' X' ' 62' ' ' CYS . 4.4 m-85 -62.37 -47.34 84.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.872 -0.603 . . . . 1.0 111.263 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.9 mt-30 -52.51 -37.38 57.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.13 -46.8 89.07 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.984 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -76.19 -41.01 50.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.412 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' X' ' 72' ' ' PRO . 0.2 OUTLIER -62.94 -49.54 74.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.806 -179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' X' ' 73' ' ' GLU . 12.1 m120 -68.7 -44.46 73.88 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.676 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 83.3 m -63.08 -50.28 71.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.059 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -62.71 -42.8 99.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.464 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 158.52 -65.43 0.29 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.43 ' HB2' ' CD2' ' X' ' 67' ' ' TYR . 77.9 Cg_exo -39.03 101.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.957 2.438 . . . . 1.0 112.24 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.422 ' HA ' HD22 ' X' ' 68' ' ' ASN . 15.0 pt-20 -90.76 5.31 48.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.119 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.82 -41.1 1.08 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.595 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.607 HG23 ' O ' ' X' ' 75' ' ' VAL . 29.1 m -121.05 90.7 47.39 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.012 0.434 . . . . 1.0 110.264 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.37 142.56 99.23 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.398 2.065 . . . . 1.0 111.895 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' X' ' 79' ' ' ALA . 12.0 p -72.23 -22.42 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.929 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.407 ' H ' HG23 ' X' ' 78' ' ' THR . 30.7 p -46.8 -13.12 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.026 0.441 . . . . 1.0 110.86 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.54 -24.59 56.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.37 -49.43 75.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 39.9 p -62.56 -51.81 65.89 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 122.026 0.917 . . . . 1.0 110.834 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.544 ' CE2' HG12 ' X' ' 26' ' ' VAL . 52.3 m-85 -59.8 -32.7 70.88 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.065 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.43 ' CH2' ' CE ' ' X' ' 87' ' ' LYS . 22.0 t90 -64.81 -32.78 74.64 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.434 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -58.02 -40.47 80.9 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.593 0.711 . . . . 1.0 109.274 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.44 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.3 mm? -61.97 -39.48 92.3 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.03 -0.668 . . . . 1.0 109.864 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.578 ' CD1' ' NH2' ' X' ' 57' ' ' ARG . 92.3 mt -64.41 -42.73 96.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.826 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.43 ' CE ' ' CH2' ' X' ' 83' ' ' TRP . 93.1 mttt -47.71 -46.59 29.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.692 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.6 -34.1 77.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.937 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.758 HD13 ' NE ' ' X' ' 22' ' ' ARG . 36.3 tp -66.03 -50.69 63.32 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.977 -0.689 . . . . 1.0 111.846 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.63 HD11 HD12 ' X' ' 53' ' ' ILE . 39.3 mt -71.37 -42.98 73.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.446 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -58.78 -49.33 78.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.562 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -64.85 -41.11 95.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 1.0 110.615 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' X' ' 95' ' ' VAL . 64.1 tttp -63.37 -42.29 98.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.732 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -43.78 -17.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.635 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' X' ' 93' ' ' LYS . 30.7 m -132.32 159.78 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' X' ' 95' ' ' VAL . 0.9 OUTLIER 56.62 159.16 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.611 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.61 153.57 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.801 2.334 . . . . 1.0 112.218 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . 0.512 ' OE1' ' NZ ' ' X' ' 93' ' ' LYS . 57.1 tt0 -69.78 120.43 15.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.464 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.34 -33.51 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.421 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.656 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 74.5 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.24 -177.99 39.73 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.72 148.3 50.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 1.0 110.611 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -68.61 -39.54 80.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 36.5 tp -104.82 123.72 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -132.03 156.97 45.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.252 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -62.69 -34.18 76.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.845 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -65.62 -38.41 89.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.973 0.416 . . . . 1.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.25 -42.69 96.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.567 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -63.98 -36.61 84.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.8 t80 -59.58 -45.38 92.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.313 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.05 -47.18 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.106 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -47.84 -40.68 22.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.98 -46.4 81.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' X' ' 11' ' ' TYR . 98.5 mt -65.28 -35.14 80.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.017 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.468 ' HZ2' ' NZ ' ' X' ' 20' ' ' LYS . 52.9 tttm -56.67 -47.85 78.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.395 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -72.73 -47.46 46.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.033 0.444 . . . . 1.0 111.545 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.06 -51.84 67.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.271 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.23 -30.49 71.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.585 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.468 ' NZ ' ' HZ2' ' X' ' 16' ' ' LYS . 42.6 mttt -57.05 -40.7 77.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 110.582 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 69.0 p -73.26 -13.52 61.15 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.795 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.513 ' O ' HD12 ' X' ' 85' ' ' LEU . 18.1 mtt-85 -88.97 -6.79 56.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.407 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.93 7.6 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.312 -0.715 . . . . 1.0 111.312 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -103.45 132.76 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 1.0 111.205 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.3 88.68 2.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.773 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 34.7 m -139.89 156.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -78.78 160.21 27.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.508 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.591 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.64 -47.25 87.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.173 0.511 . . . . 1.0 110.669 179.232 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -60.54 -37.33 80.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.68 -0.691 . . . . 1.0 111.324 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.82 -50.83 67.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.71 -0.396 . . . . 1.0 111.138 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.65 -38.33 86.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.363 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.21 -43.11 99.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.134 -0.485 . . . . 1.0 109.911 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -42.61 99.08 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.35 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.59 -43.78 95.93 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.854 0.359 . . . . 1.0 110.373 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.574 ' CZ ' ' CH2' ' X' ' 56' ' ' TRP . 8.9 m-85 -61.19 -45.2 95.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 1.0 110.288 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.24 -24.74 61.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.8 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -61.42 -52.53 64.17 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.798 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.811 HG22 ' SG ' ' X' ' 42' ' ' CYS . 1.7 p -67.12 -40.03 84.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.647 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.426 ' N ' ' CG1' ' X' ' 38' ' ' VAL . 50.9 mtmt -62.34 -39.78 94.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.293 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.37 -48.41 81.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.458 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -99.47 -5.04 30.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.867 0.365 . . . . 1.0 111.35 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.811 ' SG ' HG22 ' X' ' 38' ' ' VAL . 0.0 OUTLIER -159.34 93.55 1.79 Allowed Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.114 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.544 ' O ' ' CE2' ' X' ' 45' ' ' PHE . 25.6 Cg_exo -59.98 -0.41 0.87 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.234 1.956 . . . . 1.0 111.891 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.687 ' CD2' ' SG ' ' X' ' 42' ' ' CYS . 0.3 OUTLIER -67.53 130.17 42.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.635 0.731 . . . . 1.0 110.655 -178.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.594 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.1 OUTLIER -155.28 39.5 0.11 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 114.683 -1.144 . . . . 1.0 110.451 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 44.6 Cg_endo -64.85 148.87 90.15 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.604 2.203 . . . . 1.0 112.499 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -145.12 92.15 2.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.903 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -172.41 147.21 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.05 -157.57 51.37 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.212 -0.755 . . . . 1.0 111.212 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.433 ' O ' ' C ' ' X' ' 51' ' ' ILE . 43.6 p -47.91 165.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' X' ' 50' ' ' THR . 22.7 mt -35.68 109.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 O-C-N 123.621 0.576 . . . . 1.0 110.006 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 25.3 t0 -90.83 -10.36 43.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.302 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' X' ' 86' ' ' ILE . 96.1 mt -72.74 -16.53 17.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.564 -0.744 . . . . 1.0 111.215 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.66 -43.71 80.65 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.34 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -64.9 -34.94 79.59 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.742 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.574 ' CH2' ' CZ ' ' X' ' 35' ' ' PHE . 14.1 t90 -67.71 -52.17 40.79 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.768 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -28.52 64.55 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.068 -0.514 . . . . 1.0 111.184 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -61.56 -46.05 91.54 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.769 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.74 -44.57 93.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.581 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -68.91 -49.12 43.92 Favored Glycine 0 C--O 1.209 -1.448 0 C-N-CA 120.379 -0.915 . . . . 1.0 110.925 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.51 -43.85 68.63 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.516 -0.402 . . . . 1.0 111.244 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 6.7 m -68.08 -59.22 3.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.624 0.726 . . . . 1.0 111.371 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -61.01 -35.7 77.55 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.626 -0.716 . . . . 1.0 110.699 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' X' ' 75' ' ' VAL . 42.9 tt0 -59.88 -36.02 76.04 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.206 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.81 -40.82 96.59 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.96 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.59 ' CE2' ' CE1' ' X' ' 70' ' ' PHE . 1.8 t80 -74.56 -43.76 54.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.813 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -67.11 -38.57 85.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.545 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -63.58 -43.66 96.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.777 0.322 . . . . 1.0 110.463 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -64.06 -47.28 80.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' X' ' 66' ' ' TYR . 5.3 m-85 -60.76 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 1.0 111.387 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.04 -67.52 0.32 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.08 96.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 123.158 2.572 . . . . 1.0 112.476 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' X' ' 75' ' ' VAL . 16.9 pt-20 -91.1 3.67 54.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.069 -0.968 . . . . 1.0 111.051 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' X' ' 73' ' ' GLU . 84.2 tttt -28.1 -41.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.705 0.628 . . . . 1.0 110.969 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 0.5 OUTLIER -116.61 88.7 25.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.668 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . 0.469 ' O ' ' NE2' ' X' ' 64' ' ' GLN . 38.7 Cg_exo -59.77 150.32 77.92 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.77 2.313 . . . . 1.0 112.73 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' X' ' 79' ' ' ALA . 10.3 p -63.37 -28.87 45.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.223 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' X' ' 82' ' ' TYR . 66.2 p -48.58 -11.78 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.772 0.32 . . . . 1.0 110.601 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -63.01 -40.36 97.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.8 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 21.8 t80 -60.96 -45.2 95.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.102 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -56.46 -53.4 57.87 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.493 0.663 . . . . 1.0 111.145 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.571 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 23.5 m-85 -61.5 -35.81 78.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.513 0.673 . . . . 1.0 109.352 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.642 ' CZ2' ' NZ ' ' X' ' 87' ' ' LYS . 22.1 t90 -62.79 -31.25 72.19 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.817 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -58.77 -39.28 80.56 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.513 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -60.54 -40.74 92.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.344 -0.943 . . . . 1.0 109.27 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' X' ' 53' ' ' ILE . 86.8 mt -62.62 -43.74 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 C-N-CA 119.92 -0.712 . . . . 1.0 111.27 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.642 ' NZ ' ' CZ2' ' X' ' 83' ' ' TRP . 61.1 mttm -47.55 -54.14 12.54 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.628 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 78.5 mm-40 -58.76 -32.84 69.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.852 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.489 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.0 tp -70.16 -50.58 38.96 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.23 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.95 -42.21 24.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.305 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 66.8 t0 -57.23 -50.65 72.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.429 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.641 ' O ' HG22 ' X' ' 95' ' ' VAL . 70.7 mmtt -66.8 -42.34 86.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.359 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' X' ' 95' ' ' VAL . 88.6 tttt -65.42 -34.98 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.424 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -42.2 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.633 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.641 HG22 ' O ' ' X' ' 92' ' ' LYS . 31.8 m -65.07 -26.1 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' X' ' 99' ' ' VAL . 3.2 m-20 55.59 78.07 0.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.355 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.9 -31.53 73.76 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.866 2.377 . . . . 1.0 112.103 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.43 -37.14 79.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.575 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' X' ' 96' ' ' ASN . 46.8 t -122.27 132.49 70.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.663 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.567 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.59 41.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.701 -0.959 . . . . 1.0 110.701 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -134.08 155.33 50.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 1.0 110.406 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -66.26 -37.89 86.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 24.6 tp -105.03 127.22 52.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.408 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 48.2 t -136.36 147.95 47.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.459 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -61.72 -28.0 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.49 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -64.43 -37.68 88.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.22 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.74 -39.65 89.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.92 -37.44 86.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.801 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' X' ' 11' ' ' TYR . 33.3 t80 -59.88 -51.18 70.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.621 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -34.13 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.719 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -65.94 -38.18 87.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -61.83 -40.34 94.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.184 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.43 -42.07 99.18 Favored 'General case' 0 C--O 1.218 -0.572 0 C-N-CA 120.262 -0.575 . . . . 1.0 110.149 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.48 -48.08 72.25 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 120.332 -0.547 . . . . 1.0 110.774 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.419 ' O ' HG23 ' X' ' 21' ' ' THR . 95.6 mm-40 -59.41 -52.18 66.71 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.305 -0.558 . . . . 1.0 111.627 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.44 -51.48 62.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.895 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.498 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.8 mp -63.35 -36.64 84.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.863 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.3 -37.07 76.79 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.648 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.419 HG23 ' O ' ' X' ' 17' ' ' GLN . 67.5 p -73.91 -13.23 60.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.73 -0.388 . . . . 1.0 110.727 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.723 ' O ' HD12 ' X' ' 85' ' ' LEU . 29.5 mmt-85 -89.96 -4.63 57.36 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.429 -0.35 . . . . 1.0 111.519 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 23.64 6.02 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.528 HG12 HG22 ' X' ' 26' ' ' VAL . 72.8 t -101.91 132.56 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.988 0.423 . . . . 1.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -125.52 77.1 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.528 HG22 HG12 ' X' ' 24' ' ' VAL . 35.7 m -135.1 134.85 52.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.428 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.32 154.7 16.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.313 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -59.68 -46.51 88.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 1.0 110.875 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -55.07 -34.81 63.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.605 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.74 -52.01 66.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.88 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.8 -40.87 95.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.524 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.48 -46.67 89.05 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.9 -0.407 . . . . 1.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.527 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 66.4 mttm -65.07 -42.83 93.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.065 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.624 ' CD2' ' CZ2' ' X' ' 56' ' ' TRP . 3.7 t80 -62.07 -43.54 98.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.988 -0.685 . . . . 1.0 110.881 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.523 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 4.6 m-85 -61.15 -39.98 92.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.286 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -72.45 -25.37 61.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.724 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.14 -53.13 58.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.839 0.352 . . . . 1.0 111.307 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.1 p -68.12 -37.71 78.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.42 ' N ' HG13 ' X' ' 38' ' ' VAL . 67.5 mttm -63.82 -37.48 87.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.863 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.44 -48.97 77.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.345 -0.389 . . . . 1.0 111.545 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -97.88 -18.18 18.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.889 0.376 . . . . 1.0 111.447 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.649 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.4 OUTLIER -141.99 84.23 11.98 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.519 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.06 -38.01 96.9 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 123.022 2.481 . . . . 1.0 111.977 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.642 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 10.3 p90 -70.78 138.0 50.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.995 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 19.0 p90 -151.01 42.49 0.23 Allowed Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.041 -0.981 . . . . 1.0 110.764 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 50.6 Cg_exo -41.61 153.61 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.659 2.239 . . . . 1.0 112.537 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.464 ' NE2' HD11 ' X' ' 53' ' ' ILE . 44.6 tt0 -151.05 158.03 43.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.422 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' X' ' 50' ' ' THR . 85.4 tt0 -140.39 158.17 44.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.492 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -36.87 -54.83 1.43 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.405 ' O ' ' O ' ' X' ' 48' ' ' GLU . 80.6 p -74.69 164.13 26.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.427 ' H ' HG13 ' X' ' 51' ' ' ILE . 32.2 mt -50.61 109.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.235 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.509 ' OD1' ' CZ ' ' X' ' 55' ' ' ARG . 62.0 t0 -129.04 -9.37 4.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.724 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.464 HD11 ' NE2' ' X' ' 47' ' ' GLN . 84.2 mt -67.42 -15.47 19.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.596 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.41 ' CG ' HG22 ' X' ' 51' ' ' ILE . 29.2 mtmt -46.54 -32.14 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.951 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.509 ' CZ ' ' OD1' ' X' ' 52' ' ' ASP . 95.9 mtm-85 -65.2 -39.86 93.42 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.436 -0.506 . . . . 1.0 110.624 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.624 ' CZ2' ' CD2' ' X' ' 34' ' ' PHE . 13.2 t90 -62.15 -50.72 70.73 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 119.805 -0.758 . . . . 1.0 110.354 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.834 ' NH2' HG21 ' X' ' 86' ' ' ILE . 3.4 mtt180 -63.0 -37.1 85.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.048 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -54.2 -41.9 69.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.365 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.86 -43.69 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.83 -50.98 50.06 Favored Glycine 0 C--O 1.213 -1.212 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.222 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.36 -41.71 52.13 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 121.803 -0.822 . . . . 1.0 110.411 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 74.3 m -72.19 -56.55 5.37 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.211 0.529 . . . . 1.0 111.691 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.26 -46.65 89.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.963 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.57 -33.76 68.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -57.87 -49.86 75.26 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.997 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -76.74 -43.12 38.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.523 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -59.47 -45.2 92.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.978 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -63.67 -42.12 98.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.103 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 98.0 m -64.3 -46.41 83.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.307 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -61.74 -41.8 98.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.038 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 150.36 -50.07 0.55 Allowed Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 75.7 Cg_exo -44.05 96.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.311 2.007 . . . . 1.0 112.585 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -90.95 4.62 51.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.905 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -39.5 -46.7 1.76 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.69 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.92 88.59 26.57 Favored Pre-proline 0 N--CA 1.452 -0.356 0 O-C-N 123.273 0.358 . . . . 1.0 110.068 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -56.02 147.42 64.0 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.55 2.167 . . . . 1.0 112.724 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' X' ' 79' ' ' ALA . 9.4 p -65.81 -26.69 39.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.547 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -49.25 -9.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -58.37 -26.01 62.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.539 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -60.39 -48.25 82.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 74.0 p -63.69 -43.02 97.87 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.455 0.645 . . . . 1.0 110.418 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.802 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.33 -38.76 74.56 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.466 178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.666 ' NE1' ' NH1' ' X' ' 57' ' ' ARG . 16.8 t90 -63.15 -36.44 83.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.1 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.52 -41.98 70.3 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.768 -0.456 . . . . 1.0 109.768 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.723 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.78 -39.22 93.55 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.035 -0.666 . . . . 1.0 110.338 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.834 HG21 ' NH2' ' X' ' 57' ' ' ARG . 94.4 mt -61.91 -43.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.343 -0.543 . . . . 1.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.5 -44.65 69.25 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.227 -0.589 . . . . 1.0 110.101 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.26 -31.24 72.29 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.358 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . . . . . . . . . 55.6 tp -72.77 -51.12 20.32 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.579 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 58.2 mt -67.54 -42.89 87.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.062 0.458 . . . . 1.0 110.807 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' X' ' 91' ' ' ASP . 46.8 t0 -41.88 -30.3 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.781 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -61.81 -42.02 98.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.196 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' X' ' 95' ' ' VAL . 99.1 mttt -64.34 156.41 29.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.077 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 58.13 4.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' X' ' 93' ' ' LYS . 54.8 t -124.08 128.89 74.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.352 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.428 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 5.6 m120 46.52 54.7 15.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.575 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.8 Cg_endo -65.76 -22.51 56.9 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.778 2.319 . . . . 1.0 112.15 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -64.67 -42.88 95.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.583 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 54.2 t -123.0 133.61 68.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.398 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.544 -179.706 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.492 -0.559 . . . . 1.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.68 -175.14 50.07 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -134.59 160.73 37.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.663 0.268 . . . . 1.0 110.473 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -113.68 128.09 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.588 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.804 HD21 HH21 ' X' ' 10' ' ' ARG . 36.1 tp -106.9 128.79 54.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.593 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 23.8 p -149.04 163.31 37.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.647 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.83 -29.65 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -64.46 -42.18 96.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.404 ' O ' HG12 ' X' ' 12' ' ' VAL . 94.4 mt-10 -62.48 -41.4 98.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.381 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.804 HH21 HD21 ' X' ' 5' ' ' LEU . 99.8 mtt180 -67.83 -35.18 78.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.867 0.365 . . . . 1.0 110.623 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.68 -49.58 76.03 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.107 0.48 . . . . 1.0 111.096 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.404 HG12 ' O ' ' X' ' 9' ' ' GLU . 0.3 OUTLIER -64.46 -34.42 69.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.41 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -63.86 -36.24 83.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.199 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -64.12 -41.17 97.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.403 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.17 -40.02 95.24 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.129 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -53.25 -44.5 68.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.1 -0.24 . . . . 1.0 110.438 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -68.78 -53.4 21.96 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.914 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.61 -46.33 90.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.884 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.429 HD23 ' HD2' ' X' ' 22' ' ' ARG . 82.3 mt -60.5 -38.0 82.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.894 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.92 -46.39 78.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.882 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 75.9 p -63.55 -32.32 73.74 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.946 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.728 ' O ' HD12 ' X' ' 85' ' ' LEU . 87.3 mtt180 -68.0 -15.83 63.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.776 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.82 22.65 7.53 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.092 -0.803 . . . . 1.0 111.092 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' X' ' 82' ' ' TYR . 19.5 t -104.75 131.34 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 1.0 111.032 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.14 84.78 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.435 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 57.7 t -128.82 139.17 52.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.704 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -64.05 149.25 47.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.985 0.421 . . . . 1.0 110.393 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -61.69 -47.52 84.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.065 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.637 ' N ' ' CD1' ' X' ' 28' ' ' TYR . . . -55.39 -35.33 65.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.468 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -59.79 -50.71 72.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.822 0.344 . . . . 1.0 110.72 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' X' ' 31' ' ' LEU . 97.2 mt -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.612 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.15 -47.78 83.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.93 0.395 . . . . 1.0 110.864 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -67.81 -38.29 83.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.057 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.615 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 4.5 t80 -64.22 -42.62 96.51 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.34 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.546 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -62.33 -36.86 83.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.444 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -75.32 -30.62 60.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.311 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.446 ' CG ' HG21 ' X' ' 75' ' ' VAL . 25.8 t80 -61.83 -52.87 62.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.043 0.449 . . . . 1.0 111.005 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' X' ' 42' ' ' CYS . 9.3 p -64.93 -41.3 91.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.31 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.489 ' N ' HG13 ' X' ' 38' ' ' VAL . 44.4 mmtt -62.36 -25.89 68.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.754 0.311 . . . . 1.0 110.816 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.22 -52.45 14.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.05 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 26.7 p -97.99 -4.62 35.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.047 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.602 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.8 OUTLIER -146.05 83.86 8.38 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.017 0.437 . . . . 1.0 110.37 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -54.47 -39.0 89.85 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.52 2.147 . . . . 1.0 111.555 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.588 ' NE1' ' SG ' ' X' ' 42' ' ' CYS . 8.7 p90 -68.67 -168.51 0.12 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.259 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.602 ' N ' ' HD2' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 160.25 -56.74 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.484 -178.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' X' ' 45' ' ' PHE . 23.6 Cg_endo -57.85 141.99 96.12 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.644 2.23 . . . . 1.0 112.376 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.545 ' H ' ' CG ' ' X' ' 52' ' ' ASP . 53.3 tt0 -155.98 155.28 32.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -110.98 162.34 14.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.676 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 -117.19 5.67 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.449 ' O ' ' C ' ' X' ' 51' ' ' ILE . 16.7 p -67.74 167.5 13.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.198 -0.297 . . . . 1.0 110.198 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.522 HG22 ' H ' ' X' ' 54' ' ' LYS . 3.9 mt -34.77 110.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.153 0.501 . . . . 1.0 110.142 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' X' ' 47' ' ' GLN . 65.9 t0 -59.32 -40.0 84.87 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.463 -0.79 . . . . 1.0 110.702 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.537 ' CG2' ' NE ' ' X' ' 57' ' ' ARG . 96.5 mt -57.28 -19.94 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.707 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.522 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.4 tttt -52.98 -42.4 65.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.107 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.524 ' NE ' ' OE1' ' X' ' 47' ' ' GLN . 64.1 ttm-85 -66.43 -39.19 88.79 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.353 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.625 ' CE3' ' NH1' ' X' ' 57' ' ' ARG . 12.9 t90 -64.19 -41.64 96.99 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.598 0.713 . . . . 1.0 110.816 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.625 ' NH1' ' CE3' ' X' ' 56' ' ' TRP . 2.1 mpt_? -73.46 -29.84 62.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.724 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -59.76 -47.72 84.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.728 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.02 -46.07 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.494 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' X' ' 64' ' ' GLN . . . -64.19 -46.3 91.35 Favored Glycine 0 C--O 1.208 -1.509 0 N-CA-C 110.835 -0.906 . . . . 1.0 110.835 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.99 -45.41 71.45 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.073 -0.663 . . . . 1.0 110.767 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 10.2 m -71.46 -55.63 7.52 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.269 0.557 . . . . 1.0 111.094 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.68 -52.28 65.8 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.331 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' X' ' 60' ' ' GLY . 51.2 mt-30 -53.53 -34.88 59.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.625 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -59.33 -49.05 79.31 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.749 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -77.26 -44.42 29.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.361 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -47.99 83.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.95 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . 0.474 HD22 ' N ' ' X' ' 68' ' ' ASN . 2.2 m120 -67.55 -45.32 76.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.762 0.315 . . . . 1.0 111.068 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -60.45 -44.65 95.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.458 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.2 -42.46 96.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.626 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 162.03 -63.49 0.27 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 52.3 Cg_exo -39.48 98.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.768 2.312 . . . . 1.0 112.504 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.86 5.09 49.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.678 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -40.4 -43.42 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.806 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.446 HG21 ' CG ' ' X' ' 37' ' ' PHE . 15.2 t -120.74 87.25 41.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.126 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -56.31 142.12 88.28 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.489 2.126 . . . . 1.0 112.168 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' X' ' 79' ' ' ALA . 7.5 p -71.35 -20.02 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.593 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 1.7 m -48.75 -13.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.463 ' N ' ' C ' ' X' ' 77' ' ' VAL . . . -56.11 -26.33 49.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.514 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -62.52 -48.87 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.831 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 15.1 t -61.03 -51.1 70.63 Favored 'General case' 0 C--O 1.252 1.227 0 CA-C-O 121.898 0.856 . . . . 1.0 110.919 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.479 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 59.3 m-85 -58.4 -36.59 73.8 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.492 -0.776 . . . . 1.0 110.629 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -62.03 -32.95 73.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.238 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -56.17 -40.33 73.74 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.728 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -61.3 -42.0 97.92 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.54 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.475 HG21 ' CD1' ' X' ' 53' ' ' ILE . 79.7 mt -64.59 -43.71 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.235 -0.586 . . . . 1.0 110.886 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -52.47 -47.96 66.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.804 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -60.39 -33.01 71.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.632 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.412 HD22 ' CD ' ' X' ' 22' ' ' ARG . 53.3 tp -75.17 -50.41 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.283 -0.567 . . . . 1.0 111.204 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.424 HD12 HG22 ' X' ' 86' ' ' ILE . 96.4 mt -66.85 -42.48 89.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.949 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -51.56 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.389 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.29 -43.11 98.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.974 0.416 . . . . 1.0 110.616 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' X' ' 95' ' ' VAL . 60.9 mttm -60.53 -41.84 95.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.652 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -47.55 -14.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.414 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' X' ' 93' ' ' LYS . 55.3 t -122.02 129.82 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.937 0.399 . . . . 1.0 110.347 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 0.2 OUTLIER 177.4 -44.2 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.669 -179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 33.4 Cg_exo -59.8 146.67 95.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.771 2.314 . . . . 1.0 112.213 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -66.96 -38.34 85.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.705 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.12 147.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.516 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.585 179.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . -66.0 -36.73 92.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.33 -43.24 95.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.922 0.391 . . . . 1.0 110.67 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -69.3 -43.0 74.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.618 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.474 HD12 ' OE1' ' X' ' 9' ' ' GLU . 33.8 tp -122.82 131.69 53.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.597 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 41.0 p -143.41 163.91 31.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.525 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -64.1 -26.61 68.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.734 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -64.25 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.474 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.474 ' OE1' HD12 ' X' ' 5' ' ' LEU . 92.1 mt-10 -66.94 -37.13 83.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.258 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -69.7 -41.23 75.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.161 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.52 -53.16 60.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.967 0.413 . . . . 1.0 110.962 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -32.49 56.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.647 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -66.52 -38.57 87.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 1.0 110.404 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.87 -38.29 90.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.554 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.09 -41.86 99.5 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.124 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' X' ' 20' ' ' LYS . 56.5 mttm -56.95 -49.53 75.4 Favored 'General case' 0 C--O 1.211 -0.97 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.075 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . 0.422 ' O ' HG23 ' X' ' 21' ' ' THR . 96.8 mm-40 -54.09 -52.98 59.26 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.215 -0.594 . . . . 1.0 111.843 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' X' ' 21' ' ' THR . . . -67.94 -52.05 40.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.899 -0.591 . . . . 1.0 111.956 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.548 HD23 ' HE1' ' X' ' 82' ' ' TYR . 7.3 mp -65.61 -33.92 77.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.01 0.433 . . . . 1.0 111.312 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.507 ' CB ' ' O ' ' X' ' 16' ' ' LYS . 86.6 tttt -59.65 -37.45 78.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.8 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . 0.422 HG23 ' O ' ' X' ' 17' ' ' GLN . 62.8 p -69.89 -10.86 60.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.741 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.716 ' O ' HD12 ' X' ' 85' ' ' LEU . 43.1 mmt-85 -96.08 -6.88 37.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.277 -0.419 . . . . 1.0 111.193 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.04 25.06 5.24 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.008 -0.615 . . . . 1.0 111.749 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 79.1 t -102.24 131.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.111 0.481 . . . . 1.0 110.715 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -137.57 92.95 2.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.708 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.504 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 16.1 m -135.8 161.8 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.609 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.28 162.4 17.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.913 0.387 . . . . 1.0 110.333 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.28 -40.01 88.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.828 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.469 ' HB1' ' CE ' ' X' ' 33' ' ' LYS . . . -61.8 -28.47 69.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.556 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -69.62 -54.88 11.88 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.385 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' X' ' 31' ' ' LEU . 92.1 mt -76.27 -43.76 40.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 1.0 111.697 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.84 -50.43 73.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.857 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.469 ' CE ' ' HB1' ' X' ' 29' ' ' ALA . 67.1 mttm -68.14 -40.03 82.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.419 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.486 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 3.9 t80 -61.29 -40.59 94.72 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.567 0.698 . . . . 1.0 111.245 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.565 ' CE1' ' CH2' ' X' ' 56' ' ' TRP . 2.6 m-85 -61.68 -36.13 79.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -74.23 -24.0 59.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.402 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -64.39 -52.2 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.908 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' X' ' 42' ' ' CYS . 14.9 p -66.51 -39.89 85.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.043 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.476 ' N ' HG13 ' X' ' 38' ' ' VAL . 98.3 mttt -64.64 -33.35 75.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.925 0.393 . . . . 1.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.8 -51.09 61.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.027 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -98.17 -10.42 24.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.261 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.719 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -147.41 82.65 8.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.486 0.66 . . . . 1.0 110.41 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.0 -27.6 79.7 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 122.297 1.998 . . . . 1.0 111.59 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.719 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 12.6 p90 -74.64 145.08 43.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.304 0.573 . . . . 1.0 110.63 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.585 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 57.9 t80 -157.1 44.59 0.21 Allowed Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.644 -0.707 . . . . 1.0 110.789 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 87.2 Cg_exo -37.14 149.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 122.844 2.363 . . . . 1.0 112.266 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -132.28 131.81 42.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.373 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -128.82 -178.63 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.562 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.2 -47.98 83.48 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 46.0 p -81.68 164.61 21.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 1.0 110.402 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 13.2 mt -46.16 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.576 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' X' ' 46' ' ' PRO . 54.1 t0 -107.97 -11.27 15.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.492 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.536 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 4.8 mt -66.01 -23.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.427 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -47.34 -35.51 8.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.915 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.427 ' O ' HG23 ' X' ' 59' ' ' VAL . 77.1 ttt180 -63.29 -41.87 99.01 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.979 0.419 . . . . 1.0 110.468 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.668 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.1 t90 -65.31 -50.2 66.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.487 0.661 . . . . 1.0 110.299 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.668 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 21.9 mmt180 -61.68 -33.57 74.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.837 -0.62 . . . . 1.0 109.822 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -59.27 -44.32 92.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.324 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.427 HG23 ' O ' ' X' ' 55' ' ' ARG . 50.3 t -65.02 -44.33 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.243 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -51.83 48.57 Favored Glycine 0 C--O 1.212 -1.247 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -51.06 -42.18 60.37 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.355 -0.497 . . . . 1.0 110.693 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 71.1 m -71.74 -59.36 2.79 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.248 0.547 . . . . 1.0 111.25 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.31 -46.01 86.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.245 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.58 -38.97 75.72 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.457 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -53.46 -49.25 67.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.539 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -78.31 -42.93 29.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.073 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.07 -48.74 80.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.108 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -63.83 -39.89 95.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.271 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 97.4 m -64.12 -46.65 83.23 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.656 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -65.2 -42.98 93.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.975 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 156.38 -52.29 0.43 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 53.9 Cg_exo -45.04 96.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.595 2.196 . . . . 1.0 112.586 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.1 pt-20 -91.58 4.09 53.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.67 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' X' ' 73' ' ' GLU . 81.8 tttt -34.82 -45.0 0.24 Allowed 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.324 0.39 . . . . 1.0 110.646 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.6 88.44 29.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.101 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.3 149.07 47.62 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.785 2.323 . . . . 1.0 112.302 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -67.49 -24.81 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.281 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 24.3 p -46.0 -16.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.442 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -57.81 -27.84 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.514 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.1 -49.65 77.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 1.0 110.757 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -62.86 -44.9 94.88 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.321 0.581 . . . . 1.0 110.778 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.73 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -57.07 -36.85 71.04 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.684 0.754 . . . . 1.0 110.424 179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 21.3 t90 -66.5 -31.28 71.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.276 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -58.41 -40.94 83.83 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.314 0.578 . . . . 1.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.716 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.3 mm? -62.22 -38.16 88.12 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.945 -0.571 . . . . 1.0 110.382 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.73 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 95.4 mt -63.75 -44.12 98.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.293 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' X' ' 91' ' ' ASP . 95.6 mttt -46.59 -50.11 17.91 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.336 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' X' ' 92' ' ' LYS . 87.9 mt-10 -64.27 -35.25 80.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.984 0.421 . . . . 1.0 111.025 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.413 ' HA ' ' HE ' ' X' ' 22' ' ' ARG . 46.3 tp -65.08 -44.99 87.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.615 -0.434 . . . . 1.0 111.221 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . . . . . . . . . 64.1 mt -85.36 -38.57 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.565 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' X' ' 87' ' ' LYS . 67.6 t0 -62.4 -49.49 75.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . 0.467 ' CG ' ' O ' ' X' ' 88' ' ' GLU . 66.8 mmtt -64.15 -40.44 96.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' X' ' 95' ' ' VAL . 65.2 tttm -80.69 134.43 35.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.088 0.47 . . . . 1.0 110.709 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -142.18 4.63 1.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.875 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.444 ' O ' ' NZ ' ' X' ' 93' ' ' LYS . 69.5 t -122.33 134.4 65.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.266 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.454 ' ND2' ' C ' ' X' ' 96' ' ' ASN . 0.0 OUTLIER -142.2 159.22 59.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.667 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.62 147.78 70.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.836 2.357 . . . . 1.0 111.874 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -135.8 155.39 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.28 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.93 129.3 75.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.481 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.562 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.18 93.67 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 53.35 -172.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.644 0.259 . . . . 1.0 110.386 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -110.53 117.96 34.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.491 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.808 HD21 ' NH2' ' X' ' 10' ' ' ARG . 37.4 tp -103.87 125.57 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 87.3 p -138.98 163.04 33.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.675 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.59 -30.41 71.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.649 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -64.61 -37.41 87.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.08 -30.99 71.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.389 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.808 ' NH2' HD21 ' X' ' 5' ' ' LEU . 92.2 mtt-85 -71.38 -38.94 71.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.899 0.38 . . . . 1.0 110.588 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' X' ' 15' ' ' LEU . 71.1 t80 -64.07 -52.88 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.522 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.501 HG13 ' N ' ' X' ' 13' ' ' GLU . 8.1 p -63.41 -42.66 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.568 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . 0.501 ' N ' HG13 ' X' ' 12' ' ' VAL . 77.0 mt-10 -59.0 -36.65 75.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.581 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -62.8 -39.58 94.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.342 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' X' ' 11' ' ' TYR . 87.6 mt -62.21 -38.81 90.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.013 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 20' ' ' LYS . 58.8 tttm -56.5 -48.59 76.87 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.837 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.82 -46.32 53.72 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.373 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.54 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.559 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.6 -29.48 70.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.513 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . 0.624 ' NZ ' ' NZ ' ' X' ' 16' ' ' LYS . 32.0 mttt -59.29 -40.22 85.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.086 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 73.4 p -68.12 -12.02 60.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.478 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.768 ' NE ' HD22 ' X' ' 89' ' ' LEU . 68.9 mtt-85 -93.7 -11.23 31.99 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.798 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.92 23.38 6.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.432 ' CG1' HG13 ' X' ' 26' ' ' VAL . 36.6 t -103.33 133.2 47.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 1.0 111.041 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . 0.562 ' O ' ' CZ ' ' X' ' 82' ' ' TYR . 27.9 ttmt -115.66 81.29 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' X' ' 82' ' ' TYR . 34.7 m -122.52 133.27 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.091 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -75.19 153.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.814 0.34 . . . . 1.0 110.348 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.655 ' OH ' HD22 ' X' ' 32' ' ' LEU . 1.9 t80 -61.13 -46.89 88.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.053 0.454 . . . . 1.0 110.907 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.61 80.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.691 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -58.78 -52.41 65.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.969 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.582 HD11 HG21 ' X' ' 26' ' ' VAL . 95.7 mt -66.13 -41.24 90.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.593 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.655 HD22 ' OH ' ' X' ' 28' ' ' TYR . 56.4 tp -60.84 -46.21 91.46 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.613 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -69.74 -42.18 74.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.067 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.623 ' CZ ' ' NE1' ' X' ' 56' ' ' TRP . 3.0 t80 -61.08 -45.59 94.1 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.237 0.541 . . . . 1.0 111.197 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.472 ' O ' HG12 ' X' ' 38' ' ' VAL . 1.7 t80 -56.28 -40.4 74.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.8 -28.34 69.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.014 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.87 -53.29 56.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.208 0.528 . . . . 1.0 111.209 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' X' ' 42' ' ' CYS . 7.1 p -62.62 -28.41 44.77 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.114 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -66.41 -41.17 89.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.847 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -57.21 -48.6 78.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.088 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 22.7 p -94.59 -55.49 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.41 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' X' ' 38' ' ' VAL . 35.5 t 45.53 61.43 12.31 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.959 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' X' ' 42' ' ' CYS . 20.6 Cg_exo -66.08 -31.28 46.07 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.553 2.168 . . . . 1.0 111.157 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.618 ' HE1' ' CG2' ' X' ' 59' ' ' VAL . 0.0 OUTLIER -148.34 -179.84 7.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.316 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.559 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.2 OUTLIER 177.33 -45.45 0.0 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.245 -179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 16.5 Cg_exo -70.01 123.47 10.05 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.975 2.45 . . . . 1.0 111.856 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' X' ' 52' ' ' ASP . 61.6 mt-30 -152.54 151.81 31.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.369 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -145.59 121.61 10.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.87 -78.91 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.321 -0.712 . . . . 1.0 111.321 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 27.0 p -77.37 164.12 25.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.945 0.402 . . . . 1.0 110.426 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . . . . . . . . . 20.3 mt -49.1 117.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.435 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.46 ' O ' ' NE2' ' X' ' 47' ' ' GLN . 36.2 t0 -71.58 -40.35 69.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.002 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.661 HD12 HD11 ' X' ' 90' ' ' ILE . 96.5 mt -63.97 -4.26 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 87.2 tttt -63.24 -45.72 90.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.736 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -67.87 -37.14 81.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.047 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.672 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 13.4 t90 -63.5 -44.9 93.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.616 0.722 . . . . 1.0 110.691 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.815 HH21 HD13 ' X' ' 86' ' ' ILE . 0.7 OUTLIER -68.48 -34.34 75.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.736 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.502 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 69.9 mtt-85 -58.37 -47.81 82.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.921 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . 0.618 ' CG2' ' HE1' ' X' ' 44' ' ' TRP . 59.9 t -62.06 -44.71 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.815 0.34 . . . . 1.0 110.333 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -61.22 -49.91 72.83 Favored Glycine 0 C--O 1.22 -0.764 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.56 -39.51 91.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.334 . . . . 1.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 73.7 m -66.82 -61.17 2.09 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.675 0.75 . . . . 1.0 111.08 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -31.07 70.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.455 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 4.1 tm0? -62.73 -38.56 91.01 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.665 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -60.11 -47.17 87.0 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.3 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -72.19 -44.37 63.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.258 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -61.81 -45.56 93.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.054 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -41.77 99.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.926 -0.31 . . . . 1.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 74.1 m -64.08 -45.63 87.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.978 0.418 . . . . 1.0 110.086 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -64.66 -39.65 94.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.705 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' X' ' 72' ' ' PRO . . . 146.91 -49.85 0.61 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.477 -1.049 . . . . 1.0 110.477 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' X' ' 71' ' ' GLY . 50.1 Cg_exo -48.35 105.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.461 2.107 . . . . 1.0 112.291 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -91.23 5.43 49.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.852 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -37.01 -41.47 0.35 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.059 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.448 ' O ' ' CG ' ' X' ' 64' ' ' GLN . 0.1 OUTLIER -120.32 87.48 40.35 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.378 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.01 149.71 87.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.097 2.531 . . . . 1.0 112.275 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' X' ' 79' ' ' ALA . 10.8 p -68.91 -26.53 32.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.671 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 82.4 p -46.66 -12.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.736 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -62.16 -33.9 75.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.586 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' X' ' 80' ' ' PHE . 23.9 t80 -59.97 -48.13 82.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 1.0 111.003 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 88.1 p -60.39 -51.89 67.59 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 122.019 0.914 . . . . 1.0 110.614 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.594 ' CD2' HG12 ' X' ' 26' ' ' VAL . 23.0 m-85 -59.24 -33.36 70.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.609 -0.723 . . . . 1.0 110.083 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.422 ' HA ' HD12 ' X' ' 86' ' ' ILE . 24.6 t90 -63.07 -33.62 75.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.145 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -56.72 -42.92 80.03 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.515 HD22 ' N ' ' X' ' 85' ' ' LEU . 4.1 mm? -63.03 -39.31 94.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.255 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.815 HD13 HH21 ' X' ' 57' ' ' ARG . 93.0 mt -63.18 -45.57 98.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -51.86 -45.68 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.403 -0.519 . . . . 1.0 110.599 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.95 -34.27 78.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.768 HD22 ' NE ' ' X' ' 22' ' ' ARG . 57.4 tp -68.01 -50.75 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.885 -0.726 . . . . 1.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.661 HD11 HD12 ' X' ' 53' ' ' ILE . 49.7 mt -69.84 -42.77 80.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.664 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -50.56 -43.58 56.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.354 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -63.61 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 1.0 110.506 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.15 136.22 49.91 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.366 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -96.5 -4.5 41.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.25 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.21 161.9 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.633 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -166.97 74.98 1.06 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 1.0 110.605 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -60.88 148.76 91.37 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.046 2.497 . . . . 1.0 111.875 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -129.83 150.73 51.0 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.618 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.32 -46.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.463 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.674 179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.284 -0.635 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.39 5.23 69.92 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' X' ' 5' ' ' LEU . 54.5 tt0 -139.09 149.17 44.24 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.418 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -64.84 -42.63 94.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.885 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.698 HD21 HH21 ' X' ' 10' ' ' ARG . 31.0 tp -109.4 131.46 55.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.414 . . . . 1.0 110.504 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 19.7 p -149.24 166.09 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.01 -31.92 72.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.004 -0.544 . . . . 1.0 111.056 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . 0.576 ' CG ' ' HZ3' ' X' ' 39' ' ' LYS . 34.8 m170 -65.93 -38.74 89.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 1.0 110.497 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.579 ' HG2' HD11 ' X' ' 32' ' ' LEU . 96.2 mt-10 -64.49 -39.57 94.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . 0.698 HH21 HD21 ' X' ' 5' ' ' LEU . 95.9 mtt-85 -62.08 -40.54 96.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.647 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -60.54 -44.07 96.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.361 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 19.1 t -61.95 -47.82 91.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.691 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.78 -38.83 35.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.696 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -63.16 -48.17 79.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.258 -0.577 . . . . 1.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 120.102 -0.639 . . . . 1.0 109.852 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 76.2 mttt -53.53 -40.54 65.57 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.801 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -69.61 -52.1 29.11 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.249 -0.58 . . . . 1.0 111.353 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.35 -42.54 98.93 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.882 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.442 HD23 ' HD2' ' X' ' 22' ' ' ARG . 81.7 mt -61.29 -39.24 89.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.749 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -58.93 -41.14 86.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.371 -0.532 . . . . 1.0 109.815 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 3.0 m -60.12 -39.78 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.359 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.589 ' CZ ' HD23 ' X' ' 89' ' ' LEU . 76.2 mtt180 -62.84 -12.79 27.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.795 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.68 21.41 7.89 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' X' ' 82' ' ' TYR . 95.4 t -90.06 128.86 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.9 0.381 . . . . 1.0 111.01 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.37 91.3 3.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.358 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.518 ' CG1' ' CE2' ' X' ' 82' ' ' TYR . 22.6 m -136.49 162.59 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.932 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -73.58 169.54 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.719 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.516 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 38.2 t80 -67.08 -55.57 13.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.355 0.598 . . . . 1.0 111.288 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.601 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -60.33 -24.14 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.481 -0.781 . . . . 1.0 112.113 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -58.42 -53.93 52.8 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.244 -0.582 . . . . 1.0 111.828 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.97 -35.4 57.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.841 0.311 . . . . 1.0 111.841 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . 0.579 HD11 ' HG2' ' X' ' 9' ' ' GLU . 11.8 tp -63.16 -44.54 95.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.682 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.601 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 52.5 mttm -66.22 -42.03 89.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.962 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.06 -47.7 82.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.657 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.4 OUTLIER -64.38 -28.3 69.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.975 0.417 . . . . 1.0 110.357 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.35 -26.13 46.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.142 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -65.35 -52.8 51.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.978 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' X' ' 42' ' ' CYS . 12.0 p -65.48 -40.64 88.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.049 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.576 ' HZ3' ' CG ' ' X' ' 8' ' ' HIS . 96.2 mttt -62.93 -38.05 89.47 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.39 -0.524 . . . . 1.0 111.134 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.85 -50.65 72.95 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.041 0.386 . . . . 1.0 112.041 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -98.46 -26.49 14.43 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.178 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.5 OUTLIER -127.15 82.18 68.61 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.443 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.09 -30.47 91.53 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.977 2.451 . . . . 1.0 111.81 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.647 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 8.5 p90 -76.78 144.85 38.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.42 0.629 . . . . 1.0 111.215 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.591 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 6.6 p90 -163.99 43.22 0.09 OUTLIER Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 114.666 -1.152 . . . . 1.0 110.588 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 38.2 Cg_endo -64.36 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.945 2.43 . . . . 1.0 111.802 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.494 HE22 ' NH1' ' X' ' 55' ' ' ARG . 87.6 mt-30 58.15 130.91 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.012 0.434 . . . . 1.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -147.02 -17.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.535 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.36 -103.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.402 ' O ' ' C ' ' X' ' 51' ' ' ILE . 11.9 p -66.69 164.24 17.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' X' ' 50' ' ' THR . 12.6 mt -39.83 108.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 1.0 110.086 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -114.09 -25.9 8.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.772 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.403 HG21 ' HE ' ' X' ' 57' ' ' ARG . 98.4 mt -52.05 -23.8 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.633 -0.712 . . . . 1.0 110.592 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.431 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 84.7 tttt -54.33 -40.46 68.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.328 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.494 ' NH1' HE22 ' X' ' 47' ' ' GLN . 96.6 mtt180 -66.27 -37.99 86.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.888 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.657 ' CH2' ' CE2' ' X' ' 35' ' ' PHE . 10.1 t90 -66.4 -49.53 66.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.484 0.659 . . . . 1.0 110.484 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.404 ' NH1' ' O ' ' X' ' 79' ' ' ALA . 95.1 mtt-85 -68.76 -34.61 75.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.447 -0.797 . . . . 1.0 111.274 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.431 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 45.3 mtt180 -53.24 -46.33 69.13 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.634 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.04 -43.56 88.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.629 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -69.57 -42.12 73.54 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.456 -0.658 . . . . 1.0 111.456 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -60.71 -43.4 97.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.014 0.435 . . . . 1.0 110.584 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 12.7 m -65.91 -55.18 18.23 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.526 0.679 . . . . 1.0 110.268 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.44 -33.86 74.44 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.03 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 0.8 OUTLIER -63.3 -29.53 70.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.665 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -65.03 -49.76 68.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.033 0.444 . . . . 1.0 110.116 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' X' ' 66' ' ' TYR . 28.1 t80 -73.29 -42.27 62.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.883 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.85 -46.68 89.61 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.426 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.98 -42.27 97.27 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.796 -0.361 . . . . 1.0 110.721 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 76.3 m -62.98 -47.6 82.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.836 -0.431 . . . . 1.0 109.836 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.31 -42.59 96.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.277 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 155.2 -67.26 0.3 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 32.4 Cg_exo -33.93 99.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.121 2.547 . . . . 1.0 112.263 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.4 pt-20 -91.0 5.2 49.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.462 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' X' ' 73' ' ' GLU . 85.9 tttt -34.59 -40.07 0.1 Allowed 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.928 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.88 87.17 32.69 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.433 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.32 146.42 96.6 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.891 2.394 . . . . 1.0 112.502 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' X' ' 79' ' ' ALA . 14.5 p -69.61 -26.27 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.065 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 33.8 p -47.35 -13.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.025 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -61.0 -36.49 79.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.0 0.429 . . . . 1.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -60.68 -43.93 97.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.538 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 89.5 p -61.99 -52.94 61.95 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.879 0.847 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.518 ' CE2' ' CG1' ' X' ' 26' ' ' VAL . 55.2 m-85 -57.72 -31.62 66.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.835 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -61.55 -37.18 82.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -52.75 -42.69 65.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' X' ' 85' ' ' LEU . 91.1 mt -64.3 -39.71 94.48 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.327 -0.949 . . . . 1.0 111.012 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.49 HG23 HH12 ' X' ' 22' ' ' ARG . 88.4 mt -62.56 -42.94 97.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.351 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -57.7 -41.95 82.74 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -61.35 -36.76 81.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.477 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.589 HD23 ' CZ ' ' X' ' 22' ' ' ARG . 32.5 tp -76.8 -47.74 20.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.18 -0.608 . . . . 1.0 111.703 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.585 ' O ' HG23 ' X' ' 95' ' ' VAL . 96.3 mt -63.46 -42.94 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.848 0.356 . . . . 1.0 110.734 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -61.03 -47.52 86.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.182 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.77 -45.03 88.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.731 0.3 . . . . 1.0 111.311 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' X' ' 94' ' ' GLU . 68.3 mttm -142.07 163.92 31.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.546 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . 0.495 ' CB ' ' O ' ' X' ' 93' ' ' LYS . 30.0 tt0 83.83 22.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.606 0.567 . . . . 1.0 110.408 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.585 HG23 ' O ' ' X' ' 90' ' ' ILE . 38.6 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 48.71 75.24 0.68 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.515 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.45 147.66 90.38 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 123.103 2.535 . . . . 1.0 112.202 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.542 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.84 132.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.496 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.363 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' X' ' 5' ' ' LEU . . . 103.38 167.05 25.62 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.24 -38.68 92.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.382 . . . . 1.0 110.701 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -50.94 69.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.85 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' X' ' 2' ' ' GLY . 35.3 tp -115.39 130.96 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.519 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 24.6 p -147.8 162.94 38.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.516 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.82 -33.55 75.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.688 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -66.71 -41.33 88.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.272 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.24 -44.92 78.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -64.79 -36.95 85.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.579 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.577 ' CE2' HD11 ' X' ' 15' ' ' LEU . 82.5 t80 -59.17 -45.46 90.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.289 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.24 -46.77 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.347 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -48.02 -40.43 22.71 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.549 -0.461 . . . . 1.0 110.639 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.3 -47.43 76.61 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.558 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' X' ' 11' ' ' TYR . 89.7 mt -64.13 -41.22 97.29 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.204 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -54.76 -45.56 74.24 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.648 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -71.26 -48.52 50.49 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.723 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.2 66.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.633 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.434 ' N ' HD12 ' X' ' 19' ' ' LEU . 7.7 mp -65.14 -41.2 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.815 0.34 . . . . 1.0 111.118 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -58.5 -32.06 68.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.883 0.373 . . . . 1.0 110.674 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 4.9 m -69.95 -17.81 63.33 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.633 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.515 HH21 ' N ' ' X' ' 89' ' ' LEU . 16.5 mmm180 -93.73 -3.95 51.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.768 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 22.04 6.72 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 121.023 -0.608 . . . . 1.0 111.708 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' X' ' 82' ' ' TYR . 98.4 t -96.3 127.98 47.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 1.0 111.125 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -115.2 75.64 0.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.85 0.357 . . . . 1.0 110.279 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . 0.567 ' CG2' ' CD2' ' X' ' 82' ' ' TYR . 47.2 t -126.76 134.8 65.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -67.75 150.93 48.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.414 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.615 ' CD2' ' N ' ' X' ' 29' ' ' ALA . 0.0 OUTLIER -60.05 -48.28 82.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.958 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.615 ' N ' ' CD2' ' X' ' 28' ' ' TYR . . . -57.38 -43.8 83.9 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.855 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -49.92 -50.23 47.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.721 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' X' ' 31' ' ' LEU . 26.1 mt -64.68 -39.41 93.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.847 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 66.5 tp -60.58 -51.43 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.259 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -65.71 -39.98 91.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.321 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.414 ' CE2' ' CZ2' ' X' ' 56' ' ' TRP . 4.3 t80 -61.6 -43.63 98.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 119.929 -0.709 . . . . 1.0 110.637 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.538 ' CZ ' ' CZ3' ' X' ' 56' ' ' TRP . 0.2 OUTLIER -60.43 -33.98 73.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.356 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -73.71 -29.0 62.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.332 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' X' ' 75' ' ' VAL . 36.3 t80 -62.65 -53.62 51.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.792 0.33 . . . . 1.0 110.701 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.3 p -64.45 -32.32 57.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.93 -42.18 99.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.688 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.15 -45.63 90.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.573 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 45.7 p -96.81 -8.97 29.72 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 1.0 111.07 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.661 ' SG ' ' CD1' ' X' ' 44' ' ' TRP . 0.1 OUTLIER -157.17 85.53 2.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.397 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.41 -37.88 96.3 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.604 2.202 . . . . 1.0 111.568 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.661 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 9.9 p90 -70.47 178.44 2.95 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.109 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.581 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 165.37 -41.1 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.612 -179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 24.9 Cg_exo -63.33 143.61 89.38 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.529 2.153 . . . . 1.0 112.641 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . 0.493 ' OE1' ' CZ ' ' X' ' 55' ' ' ARG . 44.5 tt0 -173.2 166.75 4.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.123 -0.49 . . . . 1.0 110.141 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -120.25 161.33 21.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.96 -134.52 11.86 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.961 -0.855 . . . . 1.0 110.961 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.536 HG22 ' N ' ' X' ' 51' ' ' ILE . 56.1 m -58.25 163.76 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.536 ' N ' HG22 ' X' ' 50' ' ' THR . 44.8 mt -39.21 108.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -72.38 -39.15 68.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.842 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.704 HD12 HD11 ' X' ' 90' ' ' ILE . 89.8 mt -58.88 -19.17 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.927 -0.578 . . . . 1.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.409 ' HE2' ' HE ' ' X' ' 58' ' ' ARG . 88.9 tttt -56.42 -44.79 80.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.265 -0.425 . . . . 1.0 109.919 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.493 ' CZ ' ' OE1' ' X' ' 47' ' ' GLN . 82.4 mtm-85 -65.23 -38.18 89.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.024 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.695 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -65.52 -42.8 91.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.14 -0.624 . . . . 1.0 109.936 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.718 HH21 HD13 ' X' ' 86' ' ' ILE . 1.0 OUTLIER -66.03 -34.46 78.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.934 179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' X' ' 54' ' ' LYS . 84.3 mtt-85 -59.82 -43.25 94.64 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.91 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.84 -45.35 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' X' ' 64' ' ' GLN . . . -67.14 -51.91 35.66 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -46.48 -41.49 14.11 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 121.829 -0.806 . . . . 1.0 110.33 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 76.5 m -76.41 -61.22 2.03 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.218 -0.593 . . . . 1.0 111.584 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -61.19 -46.37 90.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.785 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' X' ' 60' ' ' GLY . 4.4 pt20 -59.67 -38.71 82.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . 0.416 ' N ' ' HG2' ' X' ' 64' ' ' GLN . 27.9 t0 -58.06 -47.53 82.88 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.542 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -73.79 -45.86 48.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -57.49 -44.96 85.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.834 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -64.13 -41.86 97.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.806 0.336 . . . . 1.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 99.8 m -63.37 -47.87 80.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.646 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -62.0 -42.93 99.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.829 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' X' ' 72' ' ' PRO . . . 157.11 -53.48 0.4 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' X' ' 71' ' ' GLY . 51.7 Cg_exo -46.46 99.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.26 1.973 . . . . 1.0 112.385 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -91.03 4.11 52.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.851 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -40.26 -41.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.633 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.495 HG21 ' CG ' ' X' ' 37' ' ' PHE . 11.7 t -118.01 86.38 25.61 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.71 144.22 76.85 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.653 2.235 . . . . 1.0 112.59 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' X' ' 79' ' ' ALA . 1.3 m -72.62 -23.54 20.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.974 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 63.8 p -47.0 -13.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.705 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -60.82 -26.01 67.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.509 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.36 -49.0 78.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.962 0.41 . . . . 1.0 111.033 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 37.9 m -64.14 -49.48 71.99 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 121.821 0.82 . . . . 1.0 111.189 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.567 ' CD2' ' CG2' ' X' ' 26' ' ' VAL . 40.8 m-85 -60.64 -31.75 70.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.331 -0.85 . . . . 1.0 109.707 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.434 ' HA ' HD12 ' X' ' 86' ' ' ILE . 22.7 t90 -63.24 -36.86 85.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.382 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -53.66 -42.22 67.65 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.49 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.4 mm? -62.32 -40.62 96.95 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.646 -0.821 . . . . 1.0 110.438 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.718 HD13 HH21 ' X' ' 57' ' ' ARG . 90.8 mt -63.62 -42.51 96.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.629 0.252 . . . . 1.0 111.323 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -53.12 -46.14 68.61 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.087 0.47 . . . . 1.0 110.057 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.22 -34.38 77.36 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.524 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.515 ' N ' HH21 ' X' ' 22' ' ' ARG . 44.4 tp -65.72 -50.04 66.27 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 120.654 -0.418 . . . . 1.0 111.319 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.704 HD11 HD12 ' X' ' 53' ' ' ILE . 50.6 mt -69.62 -43.39 80.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.575 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.51 -50.25 74.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.553 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.79 -42.34 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.884 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.443 ' C ' ' N ' ' X' ' 95' ' ' VAL . 87.8 tttt -64.05 -40.84 97.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.414 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -50.33 -13.64 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.224 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.664 HG12 ' HD3' ' X' ' 97' ' ' PRO . 38.6 t -113.13 131.19 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -130.5 75.3 79.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' X' ' 95' ' ' VAL . 58.4 Cg_endo -81.29 -12.61 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.796 2.331 . . . . 1.0 112.124 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 53.29 -85.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.581 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' X' ' 97' ' ' PRO . 48.7 t -121.42 132.31 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.517 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.594 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.425 -0.584 . . . . 1.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.05 -35.48 92.04 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 42.14 -115.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.694 0.283 . . . . 1.0 110.489 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -116.02 116.34 27.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.334 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' X' ' 5' ' ' LEU . 34.7 tp -116.37 129.03 56.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.342 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . . . . . . . . . 94.5 p -145.42 164.32 31.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.445 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -63.51 -28.72 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -66.76 -39.6 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.389 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -64.38 -41.56 96.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.25 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -70.32 -38.71 74.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.907 0.384 . . . . 1.0 110.635 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.597 ' CE2' HD11 ' X' ' 15' ' ' LEU . 85.1 t80 -61.1 -49.98 75.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.785 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -34.9 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 1.0 110.446 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CD1' ' X' ' 28' ' ' TYR . 50.6 mm-40 -64.25 -39.89 94.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.623 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -63.79 -39.15 93.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.282 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.597 HD11 ' CE2' ' X' ' 11' ' ' TYR . 97.9 mt -62.92 -42.46 99.8 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.096 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.43 -48.53 74.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.545 -0.462 . . . . 1.0 111.204 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -61.81 -51.82 66.69 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.246 -0.582 . . . . 1.0 111.807 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.59 -51.61 66.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.729 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' X' ' 82' ' ' TYR . 6.1 mp -64.08 -36.78 85.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.506 -0.316 . . . . 1.0 110.981 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -56.58 -38.49 72.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.555 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 71.8 p -72.33 -13.72 61.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.675 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.558 ' O ' HD12 ' X' ' 85' ' ' LEU . 34.9 mtp85 -89.61 -3.55 58.22 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.618 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.9 22.04 6.8 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.611 -0.596 . . . . 1.0 111.611 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -99.53 133.41 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.918 0.39 . . . . 1.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -126.17 74.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.672 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.91 134.44 61.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.471 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.95 156.55 17.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 1.0 110.611 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.548 ' CD1' ' OE2' ' X' ' 13' ' ' GLU . 0.0 OUTLIER -63.67 -47.9 79.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.075 0.464 . . . . 1.0 111.0 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' X' ' 33' ' ' LYS . . . -57.23 -32.41 66.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.621 -0.718 . . . . 1.0 111.197 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -60.35 -49.31 78.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.256 -0.578 . . . . 1.0 110.574 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.27 -41.97 89.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.07 -46.53 88.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.07 0.462 . . . . 1.0 109.873 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.567 ' HE2' ' HB1' ' X' ' 29' ' ' ALA . 64.8 mttm -65.48 -43.14 91.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.45 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.599 ' CE2' ' CE2' ' X' ' 56' ' ' TRP . 5.0 t80 -60.64 -43.28 97.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.145 0.498 . . . . 1.0 110.85 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.25 -42.9 82.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.706 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -64.36 -35.01 79.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.628 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.14 -52.61 64.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.087 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' X' ' 42' ' ' CYS . 11.0 p -70.02 -31.22 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.863 0.364 . . . . 1.0 110.374 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.85 -47.36 81.05 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.734 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -70.11 -34.11 72.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.28 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.5 p -95.57 -10.25 30.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 1.0 110.685 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.576 ' O ' ' SG ' ' X' ' 42' ' ' CYS . 0.0 OUTLIER -154.35 107.93 2.41 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.821 -179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.4 -10.93 20.75 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 121.968 1.779 . . . . 1.0 111.61 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.554 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 4.3 p90 -95.41 -173.1 2.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.233 0.539 . . . . 1.0 110.428 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.578 ' N ' ' CD ' ' X' ' 46' ' ' PRO . 0.0 OUTLIER 164.61 -40.75 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.222 -0.899 . . . . 1.0 110.49 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' X' ' 45' ' ' PHE . 34.7 Cg_exo -60.29 143.85 99.5 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.343 2.029 . . . . 1.0 112.659 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -164.52 149.81 10.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.31 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -112.82 152.06 29.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.532 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.75 -117.93 5.49 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.989 -0.845 . . . . 1.0 110.989 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . 0.436 ' O ' ' C ' ' X' ' 51' ' ' ILE . 59.4 p -68.5 165.66 18.54 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.068 -0.345 . . . . 1.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.596 HG22 ' H ' ' X' ' 54' ' ' LYS . 23.5 mt -35.98 109.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.174 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 49.6 t0 -64.32 -38.9 92.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.802 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.659 ' CG2' ' HE ' ' X' ' 57' ' ' ARG . 72.2 mt -58.57 -28.51 36.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.882 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.596 ' H ' HG22 ' X' ' 51' ' ' ILE . 88.5 tttt -48.31 -40.33 24.74 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.31 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -65.83 -39.79 91.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.676 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.599 ' CE2' ' CE2' ' X' ' 34' ' ' PHE . 11.9 t90 -63.1 -51.13 67.77 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.168 0.509 . . . . 1.0 110.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.659 ' HE ' ' CG2' ' X' ' 53' ' ' ILE . 11.3 mmt180 -63.35 -31.98 73.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.84 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . 0.483 ' O ' ' SG ' ' X' ' 62' ' ' CYS . 59.6 mtt-85 -58.7 -46.02 88.23 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.78 -43.56 97.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -64.56 -47.83 79.62 Favored Glycine 0 C--O 1.223 -0.591 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.65 -40.84 98.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.736 0.303 . . . . 1.0 111.172 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' X' ' 58' ' ' ARG . 83.3 m -67.22 -58.79 4.2 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.625 0.726 . . . . 1.0 110.8 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -59.44 -40.71 87.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.186 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.44 ' CB ' ' O ' ' X' ' 60' ' ' GLY . 1.0 OUTLIER -53.48 -38.31 63.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.661 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -59.26 -47.69 84.44 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.342 -0.543 . . . . 1.0 109.711 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -73.66 -43.93 58.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.559 . . . . 1.0 112.072 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -47.6 85.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -63.99 -42.18 97.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.877 0.37 . . . . 1.0 110.391 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 73.4 m -63.46 -44.83 93.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 1.0 109.924 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.32 -44.06 97.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.31 -68.01 0.28 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.039 -0.824 . . . . 1.0 111.039 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.65 111.06 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.942 2.428 . . . . 1.0 112.47 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' X' ' 75' ' ' VAL . 22.3 pt-20 -90.32 5.91 45.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.889 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' X' ' 73' ' ' GLU . 74.5 tttt -30.13 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.694 0.621 . . . . 1.0 110.54 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' X' ' 73' ' ' GLU . 0.1 OUTLIER -119.54 86.34 34.17 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.987 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.13 152.29 60.5 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.091 2.527 . . . . 1.0 112.991 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' X' ' 79' ' ' ALA . 14.2 p -66.71 -27.16 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.111 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 48.4 p -50.94 -6.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.793 0.33 . . . . 1.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' X' ' 77' ' ' VAL . . . -61.79 -40.19 94.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.065 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.91 78.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.379 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 58.0 m -62.89 -42.7 99.87 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.4 0.619 . . . . 1.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.808 ' CZ ' HD11 ' X' ' 86' ' ' ILE . 1.3 t80 -56.13 -43.56 78.34 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.865 0.841 . . . . 1.0 109.679 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' X' ' 57' ' ' ARG . 21.3 t90 -63.7 -31.6 72.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.317 -0.856 . . . . 1.0 110.634 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -56.07 -44.36 78.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.657 -0.417 . . . . 1.0 109.917 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.558 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.2 mm? -62.28 -39.99 94.76 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 1.0 109.744 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.808 HD11 ' CZ ' ' X' ' 82' ' ' TYR . 96.7 mt -63.32 -42.94 98.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -50.55 -45.86 57.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.032 0.444 . . . . 1.0 109.995 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -66.81 -37.88 85.39 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.589 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.413 HD13 ' HD2' ' X' ' 22' ' ' ARG . 42.9 tp -62.61 -48.93 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.845 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.622 HD11 HD12 ' X' ' 53' ' ' ILE . 36.6 mt -69.49 -39.45 78.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 1.0 110.639 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -59.04 -41.68 88.43 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.954 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.69 -39.39 93.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.884 0.374 . . . . 1.0 110.569 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.736 ' O ' HG22 ' X' ' 95' ' ' VAL . 99.1 mttt -57.87 -40.4 80.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.18 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.33 -7.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.653 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.736 HG22 ' O ' ' X' ' 93' ' ' LYS . 31.3 m -135.46 163.33 35.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.269 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -132.13 76.52 73.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.625 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.754 ' O ' HG23 ' X' ' 99' ' ' VAL . 41.1 Cg_exo -56.01 -34.13 91.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.809 2.34 . . . . 1.0 112.128 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -38.93 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.636 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . 0.754 HG23 ' O ' ' X' ' 97' ' ' PRO . 39.2 t -115.95 129.26 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.364 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.513 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.57 162.96 34.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 3' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -104.08 131.15 51.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.7 0.285 . . . . 1.0 110.344 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 4' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -113.37 119.12 36.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.592 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 5' ' ' LEU . . . . . . . . . . . . . 37.8 tp -108.82 124.68 50.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.424 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 6' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' X' ' 9' ' ' GLU . 30.9 p -149.12 168.2 23.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.466 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 7' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.51 -26.35 20.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.788 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 8' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.07 -45.01 91.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.483 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 9' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' X' ' 9' ' ' GLU . 55.2 mp0 -63.07 -39.06 93.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.144 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 10' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.52 -35.94 81.47 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.631 -0.428 . . . . 1.0 110.697 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 11' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' X' ' 15' ' ' LEU . 89.3 t80 -59.01 -48.07 82.91 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.316 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 12' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' X' ' 13' ' ' GLU . 0.3 OUTLIER -63.04 -40.84 90.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.134 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 13' ' ' GLU . . . . . 0.428 ' N ' ' CG1' ' X' ' 12' ' ' VAL . 96.2 mt-10 -54.76 -37.43 65.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.484 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -65.88 -45.21 82.9 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.551 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 15' ' ' LEU . . . . . 0.559 HD11 ' CE2' ' X' ' 11' ' ' TYR . 95.0 mt -64.32 -42.39 96.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.09 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' X' ' 28' ' ' TYR . 96.2 mttt -59.61 -47.18 86.59 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.276 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.61 -52.71 42.19 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.408 -0.517 . . . . 1.0 111.764 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.36 -45.97 91.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.01 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.86 -26.08 61.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -58.94 -42.35 89.56 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.761 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 21' ' ' THR . . . . . . . . . . . . . 66.7 p -67.03 -13.12 61.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.548 -0.461 . . . . 1.0 110.69 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 22' ' ' ARG . . . . . 0.681 ' O ' HD12 ' X' ' 85' ' ' LEU . 74.6 mtt-85 -89.28 -5.17 57.81 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.843 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.65 22.8 6.51 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.148 -0.549 . . . . 1.0 111.758 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 24' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.64 121.7 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.926 0.393 . . . . 1.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 25' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.22 94.11 2.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.581 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 26' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.63 163.58 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.916 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -54.43 145.32 18.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.235 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 28' ' ' TYR . . . . . 0.495 ' O ' ' NZ ' ' X' ' 16' ' ' LYS . 4.7 m-85 -58.04 -46.3 85.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 1.0 110.74 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 29' ' ' ALA . . . . . 0.459 ' HB1' ' CG ' ' X' ' 33' ' ' LYS . . . -59.87 -26.51 65.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.525 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 30' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -49.52 -55.52 13.06 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.749 -0.781 . . . . 1.0 111.074 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 31' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' X' ' 82' ' ' TYR . 11.9 mt -76.88 -45.31 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.33 -51.7 68.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.614 -0.434 . . . . 1.0 111.064 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB1' ' X' ' 29' ' ' ALA . 69.6 mmtt -65.59 -40.54 92.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.144 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 34' ' ' PHE . . . . . 0.418 ' O ' ' CD1' ' X' ' 34' ' ' PHE . 4.3 t80 -62.13 -43.99 97.63 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.417 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 35' ' ' PHE . . . . . 0.612 ' CE2' ' CH2' ' X' ' 56' ' ' TRP . 0.1 OUTLIER -58.66 -36.13 73.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.099 -179.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 36' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -72.41 -23.89 61.16 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.557 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -64.19 -54.46 33.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.02 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 38' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' X' ' 42' ' ' CYS . 10.1 p -70.03 -41.05 79.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.295 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 39' ' ' LYS . . . . . 0.537 ' N ' HG13 ' X' ' 38' ' ' VAL . 93.0 mttt -63.11 -38.11 89.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.656 -0.418 . . . . 1.0 111.271 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 40' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -62.09 -49.05 77.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.364 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 41' ' ' THR . . . . . . . . . . . . . 38.1 p -98.02 -20.05 17.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.724 -0.39 . . . . 1.0 111.397 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 42' ' ' CYS . . . . . 0.662 ' N ' ' O ' ' X' ' 38' ' ' VAL . 0.1 OUTLIER -138.45 91.66 12.3 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.013 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -76.06 -1.19 11.14 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.485 2.123 . . . . 1.0 111.823 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 44' ' ' TRP . . . . . 0.6 ' CD1' ' SG ' ' X' ' 42' ' ' CYS . 1.4 p90 -109.26 -165.42 1.01 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.763 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 45' ' ' PHE . . . . . 0.47 ' CG ' ' C ' ' X' ' 44' ' ' TRP . 0.3 OUTLIER -178.84 62.2 0.14 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.725 178.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 46' ' ' PRO . . . . . 0.562 ' O ' ' NE ' ' X' ' 55' ' ' ARG . 37.7 Cg_exo -56.73 148.58 64.65 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.617 2.211 . . . . 1.0 111.926 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 174.03 152.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.623 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -171.94 127.52 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.549 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.48 -22.37 40.47 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 50' ' ' THR . . . . . . . . . . . . . 23.3 p -134.73 164.46 27.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.755 0.312 . . . . 1.0 110.457 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 51' ' ' ILE . . . . . 0.458 HG22 ' H ' ' X' ' 54' ' ' LYS . 4.7 mt -41.85 126.15 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 52' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' X' ' 52' ' ' ASP . 66.3 t0 -64.01 -34.95 79.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.611 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 53' ' ' ILE . . . . . 0.643 HD12 HD11 ' X' ' 90' ' ' ILE . 53.3 mt -66.36 -21.88 29.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.839 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 54' ' ' LYS . . . . . 0.458 ' H ' HG22 ' X' ' 51' ' ' ILE . 75.1 tttt -50.01 -43.8 50.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.028 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 55' ' ' ARG . . . . . 0.562 ' NE ' ' O ' ' X' ' 46' ' ' PRO . 62.6 ttm-85 -65.94 -39.98 90.95 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.147 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 56' ' ' TRP . . . . . 0.652 ' CZ3' ' NH1' ' X' ' 57' ' ' ARG . 12.0 t90 -60.11 -52.33 65.82 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.449 0.643 . . . . 1.0 111.17 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 57' ' ' ARG . . . . . 0.652 ' NH1' ' CZ3' ' X' ' 56' ' ' TRP . 25.0 mmt180 -63.37 -34.77 78.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.677 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 58' ' ' ARG . . . . . . . . . . . . . 68.0 mtt-85 -58.75 -44.74 90.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.7 -44.02 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 60' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' X' ' 64' ' ' GLN . . . -62.55 -48.21 83.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 61' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.03 -40.4 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.68 0.276 . . . . 1.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 62' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.68 -60.33 2.63 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.568 0.699 . . . . 1.0 111.094 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -31.04 68.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.743 . . . . 1.0 110.051 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 64' ' ' GLN . . . . . 0.495 HE22 ' HA ' ' X' ' 77' ' ' VAL . 29.9 tt0 -59.53 -42.95 93.46 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.236 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 65' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -57.76 -48.78 78.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.392 -0.523 . . . . 1.0 110.721 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 66' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -69.97 -42.02 73.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.561 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.51 -39.31 81.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 1.0 111.146 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.81 -45.79 88.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 1.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 69' ' ' THR . . . . . . . . . . . . . 96.7 m -64.25 -45.87 86.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.734 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 70' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -63.56 -42.96 98.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.461 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.67 -67.37 0.33 Allowed Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 72' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -33.94 102.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 123.153 2.569 . . . . 1.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 73' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' X' ' 74' ' ' LYS . 22.9 pt-20 -91.55 4.41 52.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.091 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 74' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' X' ' 73' ' ' GLU . 61.9 tttt -36.64 -39.0 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.725 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 75' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.52 82.91 16.16 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.108 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -76.59 163.04 32.4 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 123.138 2.558 . . . . 1.0 112.839 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 77' ' ' VAL . . . . . 0.495 ' HA ' HE22 ' X' ' 64' ' ' GLN . 11.1 p -64.89 -30.65 50.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.848 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 78' ' ' THR . . . . . . . . . . . . . 66.9 p -42.76 -22.58 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.18 0.514 . . . . 1.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 79' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' X' ' 77' ' ' VAL . . . -68.99 -35.63 76.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.881 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 80' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' X' ' 77' ' ' VAL . 25.7 t80 -56.07 -48.13 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.691 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 81' ' ' SER . . . . . . . . . . . . . 69.3 p -61.57 -44.68 96.58 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.634 0.73 . . . . 1.0 110.51 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 82' ' ' TYR . . . . . 0.657 ' CZ ' HD21 ' X' ' 31' ' ' LEU . 0.0 OUTLIER -58.27 -38.94 77.95 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.786 0.803 . . . . 1.0 109.707 178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' X' X ' 83' ' ' TRP . . . . . 0.516 ' CD2' ' NZ ' ' X' ' 87' ' ' LYS . 20.7 t90 -62.04 -32.69 73.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.706 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -40.19 79.3 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.102 0.477 . . . . 1.0 110.214 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 85' ' ' LEU . . . . . 0.681 HD12 ' O ' ' X' ' 22' ' ' ARG . 4.1 mm? -60.35 -39.86 88.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.745 -0.782 . . . . 1.0 109.434 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 86' ' ' ILE . . . . . 0.474 HD13 HH21 ' X' ' 57' ' ' ARG . 96.7 mt -63.93 -42.88 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.917 -0.713 . . . . 1.0 110.931 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 87' ' ' LYS . . . . . 0.516 ' NZ ' ' CD2' ' X' ' 83' ' ' TRP . 63.5 mttp -46.2 -47.67 17.77 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 120.249 -0.581 . . . . 1.0 110.224 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 88' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -66.45 -33.42 75.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.25 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 89' ' ' LEU . . . . . 0.621 HD13 ' CZ ' ' X' ' 22' ' ' ARG . 50.5 tp -64.92 -50.53 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.099 -0.64 . . . . 1.0 111.68 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 90' ' ' ILE . . . . . 0.643 HD11 HD12 ' X' ' 53' ' ' ILE . 34.2 mt -71.07 -43.27 76.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.075 0.464 . . . . 1.0 110.703 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 91' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -48.75 -45.23 39.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.0 110.469 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.82 -41.83 99.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 1.0 110.37 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 93' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' X' ' 95' ' ' VAL . 99.4 mttt -62.7 -40.69 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.742 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 94' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -45.74 -16.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.434 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 95' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' X' ' 93' ' ' LYS . 49.2 t -121.24 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.649 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 96' ' ' ASN . . . . . 0.501 ' N ' ' CD ' ' X' ' 97' ' ' PRO . 5.3 m-20 50.05 51.19 10.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.47 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 97' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' X' ' 96' ' ' ASN . 35.6 Cg_endo -64.38 149.54 89.91 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.951 2.434 . . . . 1.0 111.998 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 98' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -111.15 127.08 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.457 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 99' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.54 134.58 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.579 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 100' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.588 -179.846 . . . . . . . . 0 0 . 1 stop_ save_